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ABSTRACT 
Acinetobacter baumannii is responsible for an increasing number of 
nosocomial infections in patients receiving intensive care and comprehensive 
antibiotic resistance of these organisms hampers treatment of infections due 
to A.baumannii. The molecular basis of antibiotic resistance in A.baumannii 
has not been extensively investigated. A few studies have demonstrated the 
1 role of plasm ids and transposons in resistance in this organism, but there is 
little data on the role of integrons and integron-associated antibiotic 
resistance. This study was undertaken to determine the incidence of integrons 
in clinical isolates of Acinetobacterfrom Groote Schuur Hospital (GSH), Cape 
Town and Universitas Hospital (UH), Bloemfontein, and to characterise the 
resistance genes carried in the variable regions of these integrons. 
Fifty-seven clinical isolates of A.baumannii were studied, the majority of which 
were multi-resistant. DNA-DNA hybridisation studies showed the presence of 
integrons in 63.2% (36/57) of the isolates (53.5% of the GSH isolates and 
92.9% of the UH isolates). A polymerase chain reaction assay using primers 
directed at the 5'-conserved region and 3'-conserved region of class 1-type 
integrons was performed on genomic DNA from the 36 isolates. Twenty-four 
of these isolates yielded products. Products of 0.65kb, 0. 7kb, 2.0kb, and 
2.5kb were obtained. The 0.7kb and 2.0kb products were investigated further. 
DNA sequence analysis of the 0.7kb product from one strain (A.baumannii 
strain CAR) showed that it carried an integron-related dfrV/1 gene, encoding 
resistance to trimethoprim. DNA-DNA hybridisation studies showed that all the 
0.7kb products contained dfrV/1 sequences, suggesting that 22 of the isolates 
carried integron-associated trimethoprim resistance. Further DNA sequence 
analysis, of the regions flanking the dfrV/1 from strain CAR, suggested that it is 
carried in an integron similar to the one described for Tn5086, a Tn21-like 
integron containing a dfrV/1 cassette. 
The two 2kb products were cloned into pUC19 and partially sequenced. 
A.baumannii strain G37 carried an ant(2")-la (or aadB) gene cassette 
(encoding AAD(2")) and a putative cassette in the variable region of a class 
1-type integron. The 5'-conserved region upstream of the ant(2")-/a and the 
59 _base element associated with the putative cassette were both atypical. 
A.baumannii strain G39 carried a putative gene cassette, orfX, and an 
ant(3")-la (or aadA encoding AAD(3")). The ant(3")-Ja was also associated 
with an atypical 59 base element. The region upstream of orfX did not contain 
sequences related to the 5'-conserved region as expected. Instead, the 16bp 
of data contained a 14bp inverted repeat sequence. 
Partial DNA sequence analysis of an integrase-related 6.5kb Hind Ill fragment 
from a multi-resistant A.baumannii isolate, strain PAU, revealed that it did not 
carry an integron as was expected. The fragment carried a truncated 
integrase gene which had been interrupted by an insertion sequence, IS 15-
Lill. The insertion of this element also deleted the variable region and 3'-
conserved region of the integron. Downstream of the truncated integrase 
gene was the tnpM gene (encoding the Tn21 modulator protein) and the 5'-
end of the tnpR gene (encoding the Tn21 resolvase protein). Upstream of the 
insertion sequence and Tn21-related genes, was an aac(3)-l/a (or aacC2) 
encoding an AAC(3)-II aminoglycoside resistance gene. This gene was 
flanked by a portion of an insertion sequence, IS1133 (on the 5'-end) and an 
ORF, the product of which has not been identified (on the 3'-end). 
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CHAPTER 1: INTRODUCTION 
1.A. General Description of the Genus 
The genus Acinetobacter (Brisou and Prev6t, 1954) consists of non-motile, 
Gram-negative coccobacilli (Henriksen, 1973). These ubiquitous saprophytes 
are non-fastidious and are thus able to survive in relatively poor conditions, 
for example, in dry conditions tBer~ogne-Berezin: eta/., 1996). 
Acinetobacters are non-fermentative, strictly aerobic and grow at 
temperatures ranging from 20°C to 37°C (Bergogne-Berezin and Towner, 
1996). All members of the genus are oxidase-negative and catalase-positive 
(Bergogne-Berezin and Towner, 1996). 
In the last two decades, Acinetobacterspp., particularly A.baumannii, have.· 
emerged as significant nosocomial pathogens and have been implicated in 
the infection of patients, particularly those receiving intensive care (Bergogne-
Berezin and Towner, 1996). Recent investigations have shown that 
acinetobacters are responsible for an average of 5% of infections in certain 
hospitals (Bergogne-Berezin, 1996). Nine to ten percent of nosocomial 
pneumonia can be attributed to acinetobacter (Struelens eta/., 1993). A 
problem with infection due to Acinetobacter is that treatment can be difficult 
due to the comprehensive resistance of these organisms and combination 
therapy is usually recommended (Bergogne-Berezin and Towner, 1996). 
1.8. Taxonomy 
Acinetobacter has been through many taxonomic changes. Over the years 
they have been classified in various genera, including Bacterium anitratum 
(Schaub and Hauber, 1948), Herella vaginicola, Mirna polymorpha (De Bord, 
1939), Achromobacter, Alcaligenes, Neisseria, Micrococcus ca/coaceticus, 
Diplococcus, 'B5W', and Cytophaga (Juni, 1972). The original concept 
(Brisou and Prev6t, 1954) of the genus included non-motile, Gram-negative, 
oxidase-negative and -positive saprophytes which lacked pigmentation. In 
1971, the Subcommittee on the Taxonomy of Moraxella and Allied Bacteria 
proposed that the genus include only oxidase-negative strains (Lessel, 1971 ). 
In Bergey's Manual of Systematic Bacteriology, the genus Acinetobacterwas 
classified in the family Neisseriaceae (Juni, 1984) and consisted of one 
species, Acinetobacter calcoacticus, and two varieties, var anitratus (formerly 
Here/lea vaginicola) and var lwoffii (formerly Mirna polymorpha). In 1986, 
Bouvet and Grimont defined the Acinetobacter genomic species and divided 
them into their current classification. Rossau, et. a/. (1991) proposed that 
members of the genus be classified in a new family, Moraxellaceae, 
consisting of Moraxella, Acinetobacter, Psychrobacter, and related 
organisms. 
A critical 'feature which distinguishes the genus is that DNA extracted from 
members of the genus is able to transform the mutant strain BD413 trpE27 to 
the wild-type phenotype (Juni, 1972). Classification using modern methods of 
taxonomy and identification such as genetic transformation, DNA 
hybridisation, and rRNA sequence comparisons, has Acinetobacterdivided 
into 19 DNA-DNA homology groups or genomic species (Bouvet and Grimont, 
1986; Bouvet and Jeanjean, 1989, Tjernberg and Ursing, 1989, Nishimura, et 
a/., 1987; Nishimura, eta/., 1988). Of these, 7 have been named: A. 
calcoaceticus, A. baumannii, A. haemolyticus, A. junnii, A. lwoffii,A. 
radioresistans, and A. johnsonii. A definitive numbering scheme has not yet 
been decided on and Table 1.1. shows a comparison of the delineation of 
Acinetobactergenomic species by different laboratories (Towner, 1996). 
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Table 1.1.: Comparison of the delineation of Acinetobacter genomic 
species by different laboratories 
Species 
name 
A. ,a/coautJCus 
A. l>aumannu 
A. hatmi111111CUS 
A. 1unu 
A. 1ohnsonu 
A. lu'Ot(il 
:\. raJwrc'SIStc'ns 
(taken from Towner, 1996) 
Cenomic species number according to 
Refe~nces Refe~nce References 
1 and 2 3 4and 5 
I I 
2 2 
3 3 nt 
ug 13 nt 
4 4 4 
5 5 nt 
& 6 4 
1 1 3 
8 8 2 
9 8 nt 
10 10 ug 
11 11 ug 
ll:!l" 12 5 
13 14 nt 
14 nt nt 
IS nt nt 
16 ug nt 
17 nt nt 
nt 15 nt 
Nlltt: ug. ungrouped: nt. not tested: •unpublished result. 
Type 
strain 
ATCC 23055 
CIP 70.34 
ATCC19004 
ATCC 17903 
ATCC 11906 
ATCC 17908 
ATCC 17979 
ATCC 17909 
ATCC 15309 
ATCC 9957 
ATCC 17924 
ATCC 11171 
lAM 13186 
ATCC 17905 
Bouvet 382 
Bouvet240 
ATCC 17988 
Bouvet942 
T,emberg 151a 
References: (I) Bouvet and Grimont <1986): (2) Bouvet and Jeanjean (1989); (3) 
Tjernberg .md Ursang <1989); (4) Nishimura et al. (1987); and (5) 
Nishimura et al. ( 1988). 
The essential features of the genus are now clearly defined (Bergogne-
Berezin and Towner, 1996; Towner, 1996): Acinetobacters are Gram-
negative coccobacilli with a DNA G+C content of 39-47 mol%. They are 
strictly aerobic, non-motile, catalase-positive, and oxidase-negative and grow 
at temperatures ranging from 20°C to 37°C. A simple minimal medium 
containing a single carbon source and ammonium and nitrate salts supports 
the growth of most Acinetobacter strains. 
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1.C. Habitats of Acinetobacter Species 
Acinetobacter spp. can be isolated from virtually all soil and water samples, 
provided the correct enrichment cultures are used (Baumann, 1968; Joly-
Guillou and Brun-Buisson, 1996). It was estimated that acinetobacters make 
up no less than 0.001% of the total heterotrophic aerobic population of the 
soil and water and tend to be the predominant species in some water 
samples (Baumann, 1968). The different Acinetobacter genomic species can 
be further divided on the basis of the environment they predominantly inhabit 
(Bouvet and Grimont, 1987; Tjernberg and Ursing, 1989). Clinically, A. 
baumannii is the most important species and accounts for 84 - 90% of 
acinetobacters isolated from hospitalised patients (Joly-Guillou eta/., 1991 ). 
Humans are the primary reservoir and no other natural habitat has been 
identified for this species (Joly-Guillou and Brun-Buisson, 1996). A. 
calcoaceticus inhabits the soil and is rarely involved in human infections 
(Baumann, 1968; Joly-Guillou and Brun-Buisson, 1996). Acinetobacter 
genomic species 3 has been recovered from both the soil and clinical 
samples (Joly-Guillou and Brun-Buisson, 1996). A. haemolyticus and 
genomic species 6 have been isolated from patients, the hospital 
environment, and activated sludge samples (Bouvet and Grimont, 1986), 
while A. junii has been isolated from both patients and the environment (Joly-
Guillou and Brun-Buisson, 1996). A. johnsonii and A. lwoffii have been 
isolated from a variety of sources, namely, the skin of hospitalised patients 
and the hands of uninfected hospital staff, animals and animal products, soil, 
and activated sludge (Joly-Guillou and Brun-Buisson, 1996). Theyhave also 
been isolated from clinical specimens, but only rarely. A. radioresistans has 
also been recovered from a number of different environments including 
irradiated poultry, cotton, soil, and, more recently, patients (Nishimura eta/., 
1988; Tjernberg and Ursing, 1989; Christensen, eta/., 1991). The habitats of 
the remaining Acinetobacter species are poorly defined at present (Joly-
Guillou and Brun-Buisson, 1996). What has become known as "the A. 
baumannii- A. calcoaceticus complex" consists of genomic species 1, 2, 3 
and 13TU (Gerner-Smidt eta/., 1991; Kampfer eta/., 1993). These species 
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are phenotypically similar and strains isolated from infected patients normally 
fall within this group. 
1.0. Clinical Importance 
1.0.1. Sources of Infection 
Acinetobacters form a part of the normal bacterial flora of the skin, particularly 
the moist regions such as the axillae, groin, and toe webs (Taplin eta/., 1963; 
Joly-Guillou and Brun-Buisson, 1996). Studies conducted by Taplin eta/. 
(1963) suggested that 25% of normal males carry Here/lea vaginicola and 
10% carry Mima polymorpha. The skin is often the source of contamination in 
outbreaks of infection and the organisms can be transmitted from patient to 
patient via the hands of healthy staff members (Taplin eta/., 1963; AI-Khoja 
and Darrell, 1979; French eta/., 1980; Holton, 1982). Acinetobacters have 
also been recovered from the oral cavities, respiratory tracts, and rectums of 
healthy adults (Rosenthal and Tager, 1975; Glew eta/., 1977, Allen and 
Green, 1987). The rectum does not appear to be an important reservoir, 
although Allen and Green (1987) reported a 33% incidence of rectal 
colonisation with Acinetobacter, which is higher than other reports. In addition 
to human reservoirs, the sources of various outbreaks have been traced to 
the inanimate environment. Strains causing outbreaks have been isolated 
from soaps, plastic urinals, blood-collection tubes, catheters, respirometers, 
ventillatory equipment, humidifiers, tap water, basins, and wet mattresses 
(Smith and Massanari, 1977; Abrutyn eta/., 1978; Ramphal and Kluge, 1979; 
Cunha eta/., 1980, McBride, 1984; Sheretz and Sullivan, 1985; Musa eta/., 
1990; Pearse, 1995). 
1.0.2. Virulence Factors 
Although acinetobacters are considered to be low-grade pathogens they have 
certain inherent properties which enhance their virulence (Bergogne-Berezin 
and Towner, 1996; Joly-Guillou and Brun-Buisson, 1996). A polysaccharide 
capsule increases the bacterium's invasiveness and helps protect it from 
phagocytosis (Rosenberg eta/., 1983; Kaplan eta/., 1985). They possess two 
types of fimbrae: the thin fimbrae are involved in adherence to epithelial cells 
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and the thick fimbrae mediate "twitching" motility (Henriksen and Blom, 1975; 
Rosenberg eta/., 1982). They have enzymes which cause damage to tissue 
lipids (Poh and Loh, 1985). Since iron is essential for the growth of bacteria, 
Acinetobacter strains producing siderophores, like aerobactin, which aid iron 
acquisition, are more virulent (Smith eta/., 1990). Acinetobacters also 
produce an endotoxin which is responsible for some of the symptoms of 
septicaemia experienced by the patient (Bergogne-Bem~zin and Towner, 
1996; Joly-Guillou and Brun-Buisson, 1996). Certain strains also produce 
slime, which has been reported to increase virulence (Obana eta/., 1985). 
The comprehensive antibiotic resistance of many clinical isolates of 
Acinetobactercan exacerbate virulence (Bergogne-Bem§zin and Towner, 
1996; Joly-Guillou and Brun-Buisson, 1996). 
1.0.3. Role in Human Disease 
1.D.3.a. Predisposing factors 
Different predisposing factors for Acinetobacter infection are associated with 
specific cases but there are common factors. Patients with severe underlying 
disease, such as malignancy or burns, and patients who have undergone 
major surgery or are immunosuppressed are at particular risk (Rosenthal, 
1974; Peacock eta/., 1988; Lortholary eta/., 1995). The setting plays an 
important role since most outbreaks occur in intensive care units, burn units, 
and renal wards (Bergogne-Berezin et a/., 1987). Sites of entry include tubes, 
catheters, and artificial devices (Bergogne-Berezin eta/., 1987). 
Patients who have received previous antibiotic therapy are at increased risk 
since the antimicrobial selects for resistant strains (McGowan, 1983; Peacock 
', 
eta/., 1988; Bergogne-Berezin and Towner, 1996). Some studies have found 
that advanced age is also a predisposing factor, (Bergogne-Berezin and Joly-
Guillou, 1991) and that neonates are more at risk than older children (Ng et 
a/., 1989). Tobacco smoking and alcoholism have also been identified as risk 
factors in community-acquired Acinetobacter pneumonia (Rudin eta/., 1979; 
Levi and Rubinstein, 1996). It has also been noted by some authors 
(Retailliau, 1979; Smith, 1979) that there is a seasonal pattern to 
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Acinetobacter infections. The number of infections in late summer is greater 
than those in early winter. The exact reason for this observation has not been 
investigated but it has been suggested that the growth conditions for 
Acinetobacters are improved due to an increase in humidity, temperature, and 
perspiration (Retailliau, 1979; Smith, 1979). 
1.D.3.b. Types of Infection 
Since certain Acinetobacter spp. form a part of the normal skin flora, it is not 
always possible to differentiate between infection and colonisation (Streulens 
eta/., 1993). Acinetobacters are low-grade pathogens and they have been 
isolated from a variety of opportunistic infections, including septicaemia, 
pneumonia, endocarditis, meningitis, urinary tract infections, and skin and 
wound infections (Buxton eta!., 1978; French eta/., 1980; Bergogne-Bem3zin 
eta/., 1987; Ng eta/., 1989;Levi and Rubinstein, 1996). Although infections 
occur predominantly in the intensive care setting, community-acquired 
infections have been reported and may be more significant than realised 
(Rudin eta/., 1979; Hoffman eta/., 1982). The existence of community-
acquired infections does illustrate the potential primary pathogenicity of 
acinetobacters (Rudin eta/., 1979; Hoffman eta/., 1982; Bergogne-Bem3zin et 
a/., 1996). 
The main site of infection is the lower respiratory tract (Giew eta/., 1977; 
Retailliau et a/., 1979). Acinetobacter is responsible for about 9-10% of 
nosocomial pneumonias (Struelens eta/., 1993). The mortality rate 
associated with such infections ranges from 30-75% (average of 40%) which 
is higher than that for pulmonary infections caused by other Gram-negative 
(except Pseudomonas) and Gram-positive bacteria (Torres eta/., 1990; 
Bergogne-Ben3zin and Joly-Guillou, 1991). Infection tends to be prevalent in 
patients with severe underlying disease requiring ventilation, intubation, or 
tracheostomies (Buxton eta/., 1978; Peacock eta/., 1988; Bergogne-Berezin 
and Joly-Guillou, 1991; Struelens eta/., 1993; Lortholary eta/., 1995). 
Reports of community-acquired Acinetobacter pneumonia are infrequent. One 
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study, however, (Rudin eta/., 1979) did report a 10% frequency of 
community-acquired Acinetobacter pneumonia. 
A. baumannii is the most common species involved in Acinetobacter-
associated bacteraemia (Smego, 1985). The largest group of patients with 
Acinetobacter bacteraemia are immunocompromised patients (Bergogne-
Ben~~zin and Towner, 1996; Levi and Rubinstein, 1996). In most cases, the 
source of the bacteraemia can be traced to a respiratory tract infection 
(Bergogne-Berezin and Towner, 1996; Levi and Rubinstein, 1996). However, 
further risk factors have been identified: malignant disease, surgical wounds, 
burns, and vascular catheterisation (Bergogne-Berezin and Towner, 1996; 
Levi and Rubinstein, 1996). Acinetobacter can present as either a single 
pathogen or as part of a polymicrobial bacteraemia (Bergogne-Berezin and 
Towner, 1996; Levi and Rubinstein, 1996). 
Acinetobacter is an infrequent cause of meningitis and it is normally as a 
result of secondary infection following neurosurgical procedures or head 
trauma (Berk and McCabe, 1981 ). Most cases of Acinetobacter meningitis are 
nosocomial, but a few community acquired cases have been reported (Levi 
and Rubinstein, 1996). As with bacteraemia, the predominant species in 
Acinetobactermeningitis is A. baumannii (Levi and Rubinstein, 1996). The 
mortality rate ranges from 20-27% (Levi and Rubinstein, 1996). 
UTis caused by Acinetobactertend to be rare (Levi and Rubinstein, 1996). 
The portion of the population particularly at risk are elderly, debilitated males, 
patients confined to the ICU and patients with permanent indwelling catheters 
(Hoffman eta/., 1982). Again, community-acquired Acinetobacter UTis are 
infrequent but have been reported (Hoffman eta/., 1982). 
Other infections caused by Acinetobacter include peritonitis (Levi and 
Rubinstein, 1996), infective endocarditis (Grad on eta/., 1992), neonatal 
septacaemia (Ng eta/., 1989), and skin and wound infections (Giew eta/., 
1977; Levi and Rubinstein, 1996). 
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1.0.4. Therapy for Acinetobacter Infections 
Acinetobacters often exhibit multiple resistance to antibiotics and combination 
therapy is thus recommended (Bergogne-Berezin and Towner, 1996). 
Normally a combination an aminoglycoside with imipenem or a broad 
spectrum cephalosporin is used (Levi and Rubinstein, 1996). In conjunction 
with combination therapy, strict measures need to be implemented which 
prevent the further dissemination of outbreak strains within hospitals (Pearse, 
1995; Levi and Rubinstein, 1996). 
1.E. Antibiotic Resistance in Acinetobacter 
1.E.1. Introduction 
A feature of Acinetobacter, particularly A. baumannii, is their ability to acquire 
and develop antibiotic resistance extremely rapidly (Amyes and Young, 1996; 
Bergogne-Berezin and Towner, 1996). At least in part, the "success" of A. 
baumannii as a nosocomial pathogen can be attributed to its ability to 
respond rapidly to antibiotic challenge and the widespread use of antibiotics 
in hospitals, which selects for resistant strains (Amyes and Young, 1996; 
Bergogne-Berezin and Towner, 1996). 
In earlier times (up until the early 1970s), Acinetobacter infections were 
successfully treated with gentamicin, minocycline, nalidixic acid, ampicillin, or 
carbenicillin, either singly or as part of a combination of agents (Bergogne-
Berezin and Towner, 1996). Resistance to these and other drugs was first 
detected between 1971 and 1974 (Bergogne-Berezin and Towner, 1996) and, 
since then, resistance to virtually all commercially available antibiotics has 
been documented in A. baumannii; including resistance to aminopenicillins, 
ureidopenicillins, cephalosporins, cephamycins, most aminoglycoside-
aminocyclitols, chloramphenicol, trimethoprim, and tetracycline (Morohoshi 
and Saito, 1977; Dowding, 1979; Devaud eta/., 1982; Garcia eta/., 1983; 
Goldstein eta/., 1983). Although MICs of most drugs are increasing, partial 
susceptibility remains for some antibiotics such as broad-spectrum 
cephalosporins (like cefotaxime and ceftazidime), tobramycin, amikacin, 
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fluoroquinolones, and imipenem (Bergogne-Berezin and Towner, 1996). 
lmipenem is the most active drug and 100% susceptibility was the norm until 
recently. Go eta/. (1994) reported an Acinetobacter infection which was 
resistant to nearly all antibiotics, including imipenem, and could only be 
treated with polymixin B and sulbactams. Another cause for concern was the 
report by Schaife eta/. (1995) describing a clinical isolate of Acinetobacter, 
which carries a transferable imipenem resistance. The nosocomial spread of 
imipenem resistance amongst strains of Acinetobacter poses a serious 
potential threat for the treatment of Acinetobacter infections (Bergogne-
Berezin and Towner, 1996). 
Other strains, like A. junii and A. lwoffii, are isolated from the hospital 
environment but less frequently and they tend to be more susceptible to 
antibiotic treatment (Traub and Spohr, 1989). Strains of A.lwoffii are more 
susceptible to P-lactams than is A.baumannii, while A.haemolyticus isolates 
are normally resistant to aminoglycosides and rifampin (Bergogne-Berezin 
and Joly-Guillou; 1985). 
1.E.2. P-Lactam Resistance 
The first p-lactamase identified in Acinetobacter spp. was the plasmid-
encoded class A TEM-1 P-lactamase (Philippom eta/., 1980; Goldstein eta/., 
1983). TEM-2 and CARB-5 P-lactamases were identified later and found to be 
plasmid-encoded (Devaud eta/., 1982). However, it has been reported that, 
despite the presence of these enzymes which have activity against penicillins, 
cephalosporinases are the predominant p-lactamases in Acinetobacter (Vila 
eta/., 1993). 
Four chromosomal P-lactamases have been identified and designated ACE 
(Acinetobacterchromosomal enzymes) 1-4 (Hood and Amyes, 1991). All 4 
enzymes are cephalosporinases, although some activity against penicillins 
was detected (Hood and Amyes, 1991 ). None of them had any detectable 
hydrolysing activity against aztreonam, caftazidime, or cefotaxime (Hood and 
Amyes, 1995). Their maximum activity was against cephaloridine and, except 
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for ACE-4, they had good activity against cephradine (Hood and Amyes, 
1991). ACE-1 also showed some hydrolysis of cefuroxime (Hood and Amyes, 
1991 ). It is a moot point as to whether these organisms are inducible (Joly-
Guillou eta/., 1988; Hood and Amyes, 1991). It is thought that, although the 
contribution of these enzymes to the expression of p-lactam resistance is 
important, they work in concert with the inherent resistance conferred by 
permeability reduction and altered penicillin binding proteins (Obara and 
Nakae, 1991; Sato and Nakae, 1991 ). 
Surprisingly, despite the presence of extended spectrum P-lactamase (ESBL) 
progenitors, TEM-1 and TEM-2 P-lactamases, the acquisition of plasmid-
encoded P-lactamases does not appear to be of importance in acinetobacters 
(Amyes and Young, 1996; Bergogne-Bem§zin and Towner, 1996). Until 
recently there had been only one suggestion of the presence of ESBLs in 
Acinetobacter (Amyes and Young, 1996). PER-1 is a non-TEM, non-SHV 
derived class A ESBL which was first described in Pseudomonas. The 
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presence of this cephalosporinase in nosocomial A. baumannii was 
discovered by Vahaboglu eta!. (1997). In the study, 46% of Acinetobacter 
strains were found to harbour PER-1-type P-lactamases. These strains were 
highly resistant to ceftazidime and gentamicin, intermediately resistant to 
amikacin, and susceptible or moderately susceptible to imipenem and 
meropenem. A plasmid location for the gene encoding the PER-1 enzyme 
could not be shown but was not ruled out. The authors suggest that, although 
the PER-1-type P-lactamases appear to be restricted to Turkey, their clonal 
diversity and high prevalence indicate a high spreading potential. 
ARI-1, another novel P-lactamase, which mediates resistance to imipenem, 
has also been described in Acinetobacter spp (Paton eta/., 1993). Unlike 
other class C enzymes, ARI-1 is not a metallo-p-lactamase and is thought to 
be a serine-based enzyme, like class A enzymes. The gene encoding ARI-1 
is carried on a 45kb plasmid, pUK1356, which is self-transferable within 
Acinetobacterand to other bacterial species (Schaife eta/., 1995). This was 
the first report of plasmid-encoded imipenem resistance in any bacterial 
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species isolated in Europe. In 1998, Brown eta/. described another new P-
lactamase, ARI-2, which was isolated from a multiresistant clinical isolate of 
A.baumannii from Argentina. ARI-2 is also a class A P-lactamase which 
hydrolyses imipenem. Evidence suggests that it is plasmid-encoded and 
preliminary studies have demonstrated its presence in a number of clinical 
isolates of Acinetobacterfrom Europe and south-east Asia. These studies 
augur badly for the future treatment of Acinetobacter infections. Previously, 
up to 1 00% of Acinetobacter isolates were sensitive to imipenem (Amyes and 
Young, 1996). 
Vila eta/. (1998) reported the presence of a gene encoding an oxacillinase in 
a clinical strain of A.baumannii (strain Ab41). The strain was resistant to all P-
lactam antibiotics tested except ceftazidime, ceftriaxone, ceftizoxime, and 
imipenem. It produced 3 P-lactamases: a chromosomal cephalosporinase, a 
TEM-1-Iike P-lactamase, and a novel OXA-derived p-lactamase, designated 
OXA-21. 
A summary of all the P-lactamases described in Acinetobacter spp. is listed in 
Table 1.2. 
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Table 1.2: Summary of the p-lactamases described in 
Acinetobacter spp. 
(adapted from Amyes and Young, 1996) 
Enzyme or Location of Predominant Molecular Ref 
strain gene substrate size (kDa) 
TEM-1 Plasmid Penicillin 29 1 
TEM-2 Plasmid Penicillin 29 2 
CARB-5 Plasmid Penicillin 29 3 
ARI-1 Plasmid Carbapenem 23 4 
ARI-2 Plasmid Carbapenem Unknown 5 
OXA-21 Integ ron Oxacillin Unknown 6 
NCTC7844 Chromosome Cephalosporin 30 7 
ML4961 Chromosome Cephalosporin 38 8 
ACE-1 Chromosome Cephalosporin ca.500 9 
ACE-2 Chromosome Cephalosporin 60.5 9 
ACE-3 Chromosome Cephalosporin 32.5 9 
ACE-4 Chromosome Cephalosporin >1000 9 
PER-1 Chromosome Cephalosporin Unknown 10 
SHV-Iike Unknown Penicillin Unknown 11 
SHV-Iike Unknown Penicillin Unknown 12 
.. References: 1. Ph11ippon era/. (1980); 2. Devaud eta/. (1982), 3. Bauernfemd (1985); 4 Paton eta/. (1993); 5. Brown 
eta/. (1998); 6. Vila eta/. (1997); 7. Morohoshi and Saito (1977); 8. Hikida eta/. (1989); 9. Hood and Amyes (1991 ); 
10. Vahaboglu et al. (1997); 11. Joly-Guillou and Bergogne-Berezin (1990); 12. Vila et al. (1993) 
As briefly mentioned above, Acinetobacter also display an inherent high-level 
resistance to P-lactam antibiotics. Impermeability or reduced permeability of 
the outer membrane may play a role in this respect (Sato and Nakae, 1991 ). 
These authors reported that the permeability of A. calcoaceticus to 
cephalosporins was 2-7 fold lower than that of Pseudomonas aeruginosa. 
They show that the reason for this observation is due to A. calcoaceticus 
having a small number of small-sized porins. The penicillin binding proteins 
(PBPs) of Acinetobacter are unlike those in E. coli and Pseudomonas and are 
most similar to those in Bacteroides (Piddock and Wise, 1986). Six PBPs 
have been found in Acinetobacter (Obara and Nakae, 1991) and were 
designated PBP 1 a, 1 b, 1 c, 2, 3, and 4. Resistance to P-lactams is enhanced 
by the presence of altered PBPs (Obara and Nakae, 1991). The PBPs have 
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an enhanced expression so that more antibiotic is required to bind before 
inhibition can occur and/or a reduced affinity for ~-lactam which reduces 
uptake and effectiveness of the antibiotic (Obara and Nakae, 1991 ). 
1.E.3. Aminoglycoside Resistance 
The most common mechanism of aminoglycoside resistance is enzymatic 
inactivation (Shaw eta/., 1993). Three types of aminoglycoside modifying 
enzymes (AMEs) exist: acetyltransferases (AAC),adenylyl-or nucleotidyl-
transferases (AAD or ANT, respectively), and phospho-transferases (APH). 
The AMEs are further classified according to site of modification on the 
aminoglycoside molecule. Several of the enzymes can be subdivided further 
according to their aminoglycoside resistance profile or their unique protein 
nature (Shaw eta/., 1993). All 3 types of AMEs have been identified in clinical 
strains of Acinetobacter. These are summarised in Table 1.3. Geographic 
variation has been observed in the incidence of particular genes and it was 
found that certain strains have as many as 6 different aminoglycoside 
resistance genes (Shaw eta/., 1993). Lambert eta/. (1993) identified an 
aac(6)-lg responsible for amikacin resistance in an isolate of A. 
haemolyticus. Evidence from hybridisation studies led the authors to suggest 
that this gene was species specific and could be used for the identification of 
A. haemolyticus. Rudant et. a/. (1997), showed that AAC(6')-Ig is not essential 
for the viability of A.haemolyticus, although the aac(6')-lg was detected in all 
members of this species. Similarly, the aac(6')-/j was found in the 
chromosome of Acinetobacter genospecies 13 strains, but not in other 
genospecies (Lambert eta/., 1994) and Rudant eta/. (1994) showed the 
presence of aac(6')-lk in the 3 strains of Acinetobacter genospecies 6. These 
results indicate that the genes may also be species specific. 
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Table 1.3.: Aminoglycoside-Modifying Enzymes in Acinetobacterspp. 
(taken from Amyes and Young, 1996) 
Enzyme RntsUnce profile IAGRPl 
Acetylatmg: 
AA0b') Tob Dbk Ntl f)Ntl 2'!'Jtl Siso Amk 
AA0211 Tob Dbk Ntl 6'Ntl Gm 
AAC!Jll Apr Lvdm Pnn Rs.m I Bull INeol 
AAOJHI Tob Dbk Ntl b'Ntl Z'Ntl Siso Gm 
IAACIJlVI 
AAC!JliV Tob Dbk :-Jtl b"Ntl n.;tl Siso Gm Apr 
Adcnylahng: 
ANTI3il Sm Spcm 
IAADI3i19ll 
ANTI2il Tob Dbk Siso Gm Km 
(AADI2il 
Phosphorylahng: 
APHIJ'll Km Neo Pnn Rs.m Lvdm GmB 
APHI3'lll Km Neo Pnn Rs.m But GmB <Amkl 
APH<J')lll Km Neo Pnn Rs.m Lvdm But GmB 
Amk lsp 
APH<J1VI Km Neo Pnn Rs.m But GmB Amk lsp 
AI'H<Jil Sm 
Ref. 
Shannon et al. (1978) 
Murray and MoeUering 
((979) 
Lambert et al. (1990; 1993) 
Dowding (1979) 
Bergogne-Berezin et al. 
(1980) 
Vila et al. (1993) 
Murray and MoeUering 
(1980) 
Elisha and Steyn (199tal 
Shaw et al. (1993) 
Shaw et al. (1993) 
Shannon et al. (1978) 
Murray and MoeUering 
(1980) 
Devaud et al. (1982) 
Goldstein et al. (1993) 
Vila et al. (1993) 
Murray and MoeUering 
(1980) 
Elisha and Steyn (1991a) 
Shaw et al. (1993) 
Bergogne-Berezin et al. 
(1980) 
Devaud et al. (1982) 
Goldstein et al. (1983) 
Shaw et al. (1993) 
Murray and MoeUering 
(1979) 
Murray and 
MoeUering (1979) 
)oly-Guillou et al. (1987) 
Martinet al.·(\978) 
Lambert et al. (1988; 1990) 
Vila et al. (1993) 
Shaw et al. (1993) 
Elisha and Steyn (1989) 
Note: Amk. arriikacin; Apr, apramycin; But, butirosin; Dbk, dibekacin; Gm, gentamicin; 
GmB. gentamicin B; lsp, isepamicin; Km, kanamycin; Lvdm, lividomycin; Neo, 
neomycm; Ntl, nehlmicin; 2'Ntl. 2'·N-ethylnetilmicin; 6'Ntl. 6'-N-ethylnetilmicin; 
Sm. streptomycin; Pnn, paromycin; Rsm, ribostamycin; Siso, sisomidn; Span. 
spectmomycin; Tob. tobramyctn. Parentheses indicate enzymic activity detectable 
only rn vrtro. 
1.E.4. 4-Quinolone Resistance 
DNA gyrase (topoisomerase II) is the target of the fluoronated 4-quinolone 
action and resistance to these antibiotics in other bacteria is attributed to 
changes in the structure of DNA gyrase subunits (mainly by mutations in the 
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gyrA) (Amyes and Young, 1996). After the introduction of the 
fluoroquinolones, Acinetobacter readily developed resistance to these 
antibiotics (Amyes and Young, 1996). Vila eta/: (1995) studied mutations in 
gyrA of quinolone resistant A. baumannii isolates. In E. coli, substitutions of 
the residues Gly-81, Ser-83, Ala-84, and Gln-1061ead to resistance. They 
found these residues to be conserved in the sensitive isolates but found 
substitutions or Ser-83 to leucine and Ala-84 to proline in resistant isolates. 
The Ser-83 substitution was correlated to the observed resistance. The 
observed 4-quinolone resistance levels in a set of A.baumannii isolates 
studied by Vila eta!. (1997) could not be solely attributed to the Ser-83 
substitution in gyrA and, since Pare (from topoisomerase IV) is a secondary 
target of 4-quinolones in E. coli, it was thought that the reason for the high-
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level resistance in the A.baumannii isolates could be found there. The authors 
discovered Ser-80 to leucine and Glu-84 to lysine substitutions in the Pare of 
resistant isolates and it was concluded that the high-level resistance to c 
ciprofloxacin displayed by these isolates was due to mutations in gyrA and 
parC. 
Also, potentially involved in 4-quinolone resistance is the reduced 
permeability of the outer membrane described previously for P-lactam 
resistance (Amyes and Young, 1996). Since selection for resistance to 4-
quinolones in E. coli and P. aeruginosa has been shown to result in cross-
resistance to p-lactams (Neu, 1988). As is the case with Staphylococcus 
aureus, active efflux of quinolones has also been suggested as a mechanism 
of resistance but at this point it is no more than conjecture (Ng eta/., 1994; 
Amyes and Young, 1996). Amyes and Young (1996) also propose that, due to 
the selection pressure resulting from wide use of 4-quinolones, a plasmid-
encoded resistance mechanism is likely to emerge. 
1.E.5. Trimethoprim Resistance 
Trimethoprim competitively inhibits the bacterial dihydrofolate reductase 
(DHFR) enzyme which is required for the reduction of dihydrofolate to the 
essential cofactor tetrahydrofolate (Bushby and Hitchings, 1968). Resistance 
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to trimethoprim in Gram-negative bacteria is mediated by an addtional DHFR 
which is resistant to the antibiotic (Amyes and Towner, 1990). A range of 
DHFRs have been identified- DHFR type Ia is the predominant one in Gram-
negative pathogens - however, little is known about the types in 
Acinetobacter (Am yes eta/., 1992; Amyes and Young, 1996). 
Acinetobacter spp. are inherently resistant to low levels of trimethoprim (MICs 
of 16-32mg/l). The first report on high-level (MIC of >1000mg/l) trimethoprim 
resistance in a clinical isolate of Acinetobacter was by Goldstein et a/. ( 1983). 
The mechanism of resistance was not investigated but hybridization studies 
showed that resistance was not mediated by a type Ia DHFR nor was it 
carried on a Tn7-related transposon. A plasmid carrying resistance to 
trimethoprim and sulphamethoxazole was isolated from an isolate of 
Acinetobacter by Chirnside eta/. (1985). However, the gene responsible for 
the resistance was not characterized. More recently, Amyes and Young 
(1996) describe a study of the genetic basis of high-level trimethoprim 
resistance in isolates of A. baumannii from Chile. In this case, the resistance 
gene was characterised and was found to be encoded by a dfrla gene. 
1.E.6. Chloramphenicol Resistance 
Elisha and Steyn (1991b) cloned and sequenced a CAT1 structural gene from 
a clinical isolate of A. baumannii (strain SAK). CAT1 encodes a 
chloramphenicol acetyltransferase and mediates chloramphenicol resistance 
by the transfer of an acetyl group to the chloramphenicol molecule, thereby 
rendering it inactive. The CAT1 structural gene was shown to be on both the 
chromosome and a 120kb plasmid. 
1.E.7. Location of Resistance Genes 
In several studies, more than 80% of Acinetobacter isolates have been found 
to contain multiple indigenous plasm ids (Gerner-Smidt, 1989; Seifert eta/., 
1994). The plasmids are generally small in size (<23kb) and are often cryptic 
(Towner, 1996). Those whose functions have been elucidated usually encode 
unusual metabolic activities or antibiotic resistance genes (Towner, 1996). 
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However, the absence of a suitable detection system may hamper studies of 
plasmid-mediated resistance (Towner, 1991 ). Transposons and integrons are 
thought to play an important role in resistance by ensuring the establishment 
of novel genes from plasmids, which are unstable in Acinetobacter, in a new 
gene pool (Devaud eta/., 1982; Towner, 1991, Towner, 1996). 
Both plasmid and transposon locations have been identified for 
aminoglycoside resistance genes in Acinetobacter (Murray and Moellering, 
1980). Few studies have effectively investigated the genetic nature of 
aminoglycoside resistance mainly because of the lack of an efficient plasmid 
transfer model (Towner, 1991 ). It has been noted that Acinetobacter spp. 
readily acquire plasmids from Enterobacteriaceae but the reverse is not true 
(Towner, 1991 ). 
Devaud eta/. (1982) were the first to demonstrate transposon-encoded 
aminoglycoside resistance in A. ca/coaceticus. Transfer of this resistance to 
E. coli, P. aeruginosa, or A. calcoaceticus could not be shown by conjugation 
but the plasmid RP4 effected the mobilization of resistance determinants to a 
wild-type strain. After mobilization it was shown that RP4 had increased in 
size by 16MD. This suggested the acquisition of a multi-resistance 
transposon which the authors proposed was chromosomally located in the 
host Acinetobacter strain. 
Goldstein eta/. (1983) described a multi-resistance plasmid, piP1031 from a 
clinical isolate of A. calcoaceticus, which has 2 deletion derivatives of the 
insertion sequence, IS15. One of these deletion derivatives was shown to be 
on the same EcoRI restriction fragment as the gene encoding the APH(3')-I 
enzyme. This gene has been found to reside on well-characterised compound 
transposons such as Tn6. It was therefore suggested that the APH(3')-I gene 
of piP1031 may also be within a compound transposon. 
The aac(6')-lh of A.baumanniiwas found to be located on a 13.7kb non-
conjugative plasmid (Lambert eta/., 1994). The most recent report of 
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plasmid-encoded aminoglycoside resistance in Acinetobacter, however, is by 
Segal and Elisha (1997). They report the identification and characterisation of 
an ant(2")-la (or aadB) gene cassette on a plasmid, pRAY, from 
Acinetobacter. 
High-level trimethoprim resistance in Acinetobacter has also been shown to 
be plasmid-mediated in certain instances [section 1.E.5.]. In the two cases 
described (Goldstein eta/., 1983; Chirnside eta/., 1985), the resistance gene 
was carried on a self-transferable plasmid but the gene responsible for the 
resistance was not characterised. 
The CAT1 structural gene (Elisha and Steyn, 1991b) was shown to be on 
both the chromosome and a 120kb plasmid. These results suggested that the 
gene could be transposon-encoded. The transposon was thought to be Tn21-
related and linked to IS 1 in a manner similar to the organisation of Tn2670. 
The significance of this is in the fact that Tn21 contains recombinational hot-
spots which may be involved in the acquisition of additional resistance genes. 
Plasmid-mediated carbapenem resistance in Acinetobacter has also been 
described. A novel carbapenemase (ARI-2) isolated from a multiresistant 
clinical isolate of A.baumanniiwas plasmid-mediated (Brown eta/., 1998). 
While there remains a paucity of data regarding the exact nature and extent 
of the role plasm ids, transposons, and integrons play in antibiotic resistance 
in Acinetobacter, it is nonetheless clear that they are potentially very 
important factors in both the acquisition and dissemination of resistance 
genes (Towner, 1991, Bergogne-Berezin and Towner, 1996). 
1.F. Conclusions 
The increasing threat posed by Acinetobacter spp. in the intensive care 
setting is not due to the inherent virulence of the organisms. The ability of 
Acinetobacter spp. to acquire antibiotic resistance genes, thereby posing a 
therapeutic problem, is where the real danger lies. The increased reliance on 
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antibiotics in hospitals due to advances in invasive surgical procedures has 
allowed Acinetobacter to fill an ecological niche left vacant by the elimination 
of its competitors (Bergogne-Bem§zin eta/., 1996). 
1.G. Aim of this work 
Increased reliance on antibiotic therapy due to advances in invasive surgery 
has paved the way for the emergence of opportunistic pathogens. Numbered 
among the more important opportunistic pathogens is Acinetobacter 
baumannii (Joly-Guillou and Bergogne-Berezin, 1996). This organism is 
responsible for an increasing number of nosocomial infections in patients 
receiving intensive care. Treatment of these infections is hampered by the 
comprehensive antibiotic resistance of A. baumannii (Amyes and Young, 
1996). The molecular basis of antibiotic resistance has not been extensively 
investigated in Acinetobacter (Amyes and Young, 1996; Bergogne-Berezin 
and Towner, 1996). A few studies have demonstrated the role of plasmids 
and transposons in resistance in this organism. In Enterobacteriaceae, gene 
cassettes and integrons have played an important role in the progressive 
acquisition and spread of resistance, however, little is known about their 
importance in Acinetobacter. A feature of integrons is their ability to effect the 
"capture" of resistance genes by the integron-encoded enzyme, integrase 
(Stokes and Hall, 1989). Resistance genes are inserted as cassettes 
consisting of the structural gene and sequences involved in recombination, at 
specific sites of integrons (Collis and Hall, 1992; Collis eta/., 1993). The role 
of integrons and integron-associated resistance genes in Acinetobacter has 
not been studied extensively. 
The aim of this project was two-fold: 
a) to determine the incidence of integrons in clinical isolates of Acinetobacter 
from two South African hospitals, Groote Schuur Hospital (GSH), Cape Town 
and Universitas Hospital (UH), Bloemfontein. 
b) to characterise the antibiotic resistance genes carried in the variable 
regions of these integrons. 
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CHAPTER 2: SCREENING OF CLINICAL ISOLATES OF 
ACINETOBACTER FOR THE PRESENCE OF THE INTEGRASE GENE 
2.A. INTRODUCTION 
The term integron was originally coined to describe a family of novel mobile 
DNA elements (Stokes and Hall, 1989). lntegrons have been defined as 
natural cloning and expression vectors containing the determinants for a site-
specific recombination and expression system (Hall and Collis, 1995). Based 
on the DNA sequences of their associated integrases, 4 classes of integrons 
have been described (fig.2.1.). Fig. 2.1. shows an alignment of the 4 
integrases. 
1 15 u ]0 31 45 46 60 u 75 76 90 
MJtSQ!'t.I.SVRUKQT RtJJ.n'riEA YLBWt TJI.YIB----PitH-n BPSLMGDJI:EVEE!'"L T TLA V()GJtVATnOSL 
R SRSPFLNSIRTDKRQ XGYALXT!KT'!LHVt KRFIL----fHK-lR BPQTMGSEEVRLFLS SLANSRHVAINTOki 
KXTATAPLPPL RSVXVLDQLRERIRY ~YSLRTEQATVBWV RAFI----RPBC-VR BPA:LCSSEVEAFLS wLANERKVSVSTBRQ 
KKRYNGSAJU'DWVPP RSI~VRY ~YSLQTEUYVYWA ltAFVLWTARSBGGn BPRZMGQAEVI:GfLT KLATEP\QVAPATIIRQ 
91 105 106 120 121 135 136 150 151 165 166 180 
ALMSLSFLY~ILKT PLSLEIRPQRSQLER ~VVLTRO£IRRLL !IVDPlBOLPlXLLY CSCLRLKECMRLRVQ DIOFDYCAIRIWQGX 
ALNALAl"LYNRn.QO PLG-DIOYIPASDJ\ IU.PSVISAHEVQRIL OVMDTRNQVInt.Ll GAG:.J\lNECUUJWit Dl'OTONGCITV1!0GP\ 
Al.AA:.LlFYCKVLCT DLPWLQEI c:JUIJU' S1l JU.PVVL':l'OEWRIL GFU:C!!JUZ AQLLY CtcKRISECLQLRVIt DLDFDBGT Il'w"RECJI: 
A.LRA.I.LrLTRQVLGM !:UtWKQQIGUPEU li.IPVVLTVOEVQTLL S!MAGTEALI.AAI.LY CSGLJ\LREALCLRVX DVO!"ORRAIIVRSG'It 
181 195 196 210 211 225 226 240 241 255 256 270 
GGDRTVTLAJtZLYP lll.JtZQIALAXRYYDJ\ DI.IIQDYCCVWLPTA LQ:J:YPRAPYEFJ\WB r...FPSFQLSLDPESO VMJUUIBMNETVLQU 
CCUJUISLI.PTJI.LIP AI:JtXLIEOARLIQ()D DHLOC--VCOPSLPFA LOBKYPSAYROAAWM rvt'PSSTLCNBPYNG U.C:RBlU.HOSVAIUtA 
CSXDRALKLPESLAP SLk!OLSRARAWWLK DQAECR-S~ALPDA LERXYPRACBSWPWP WVFAQftTBSTDPRSC VVRRRBMYDQTFORA 
GDJtZ)RVVKI.PJ\ALVP ILRAQLIQVRAVWGO DAA'r<ia-GC;Vn.P BA LEUlnAGZSWAWP WVFPSAJU.SVDPQTO VZRRBB.Ll"EERLNRQ 
211 215 286 300 301 315 ]16 ]]0 331 345 346 
VM.SAOEAG- I!KTV TCBTUUISP'A'l'Bl.LZ VGADIR'rVOEOI.GBT DVXTTQI!'ri!VLDRQ ASGVLSPLSJU. 
L1tAA VOXA~IVSXRV TCBTl'J\BSFA'I'BLLO ACRDIJ\TVCEt..:.Glnl DVICTTOI!'rii\'LGOB LP--APPVI.IUU) 
PG.AVEQA~ITKPA TPBTUUISFATALl.S' SGYDIR'!'VODLLGBl DVSftMIYTRVLJCVG GAGVRSPLOALPPLT S!R 
LnAWQAG-tAJtBV SVBTUUISFATBLLO AGTDIRTVOELLGBS DVSTTMIYTBVLJtVA AGGTSSPUlALALBL SPG 
Fig. 2.1.: Alignment of the 4 integrases (taken from Mazel eta/., 1998) 
Single letter abbreviations for the amino acid residues are as follows: C, Cys; 0, Asp; E, Glu; F, Phe, G, Gly; I, lie, 
K, Lys; M, Met; P, Pro, R, Arg, S, Ser; T, Thr; and V, Val 
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Class 1-type integrons are made up of three regions: the B. - onser ed 
segment ~B. -C ), the ariable region, and the 3 - onser ed segment ~3 -C ) 
~fig. 2.2.; tokes and Hall, 1989). The B. -C ontains the gene for the lnt1 
integrase whi h is responsible for there ombination of gene assettes into 
the ariable region of integrons ~ tokes and Hall, 1989; Hall and Collis, 199B.). 
The ariable region onsists of the gene assettes whi h are made up of a 
stru tural gene, usually an antibioti resistan e gene ~Re hia and Hall, 
199B.), and a re ombination site -the f\9 base element or attC site ~Hall and 
Collis, 199B.; Collis and Hall, 199B.; Hansson eta/., 1997). The gene assettes 
are mobile and their number and order in an integron does not appear to be 
restri ted. It an be altered by the insertion of new assettes and the ex ision 
or rearrangement of existing ones, through the a tion of integrase. ~Re hia 
and Hall, 199B.; Collis and Hall, 1992a). Most lass 1-type integrons ontain a 
qacE:11 gene ~en odes a quaternary ammonium ompound exporter protein 
whi h mediates resistan e to antisepti sand disinfe tants) and a sui/ gene 
~en odes a sulfonamide resistant dihydropteroate synthase) in the 3 -C 
~ tokes and Hall, 1989; Re hia and Hall, 199B.). The outer boundaries of the 
5 -C and 3 -C of lass 1-type integrons ontain 2B. base in erted repeats, 
ailed Brown's repeats ~Brown eta/., 1986). 
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111111 = lntegrase gene 
qacE11 = gene encoding the exporter protein 
sul11 = gene encoding dihydropteroate synthase 
59-be = 59 base element 
P... e cassette promoter 
P2 = second cassette promoter 
P... = integrase gene promoter 
5' -conserved segment gene 1 gene 2 3'-conserved segment 
Fig. 2.2: A schematic diagram of a class 1-type integron 
showing 2 gene cassettes in the variable region 
The arrows indicate the direction in which the 
genes are transcribed (adapted from 
Bissonnette and Roy, 1992) 
PANT is the common promoter from which all the inserted gene cassettes are 
transcribed (Collis and Hall, 1995). The gene transcripts all originate at this 
promoter which is located 214 bases from the inner boundary of the 5'-
conserved segment (Collis and Hall, 1995). PANT has a strong similarity to the 
E. coli promoter consensus and sequence variations at the PANT location 
affects the relative strength of the promoter and thus the level of resistance 
(Hall and Collis, 1995; Collis and Hall, 1995). P2 is located 119 bases 
downstream of PANT in some integrons and, when present, transcription of the 
gene cassettes occurs from both promoters (Collis and Hall, 1995). P2, a 
weaker promoter, arises from the insertion of 3 G residues which increase the 
spacing between the -10 and -35 regions to the optimal17 bases (Hall and 
Collis, 1995; Collis and Hall, 1995). The level of expression from a weak PANT 
is compensated for by combined expression from P2 (Collis and Hall, 1995). 
The int1 is transcribed from PINT in the opposite direction to PANT and P2 
(Collis and Hall, 1995). The qacELJ 1 and sui/ genes are transcribed from their 
own promoters (Hall and Collis, 1995). 
Class 1-type integrons are sometimes referred to as Tn21-like integrons. This 
is because the initial descriptions of integrons were of elements associated 
with Tn21. They were similar in structure to Tn21 and included the sui/ and 
the ant(3")-la (or aadA; Hall and Stokes, 1993). If further resistance genes 
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were present they were located on either side of the ant(3")-/a, and in one 
case replaced it with an oxacillin resistance gene, oxa2 (Hall and Stokes, 
1993). Class 1-type integrons were further classified as ln1, ln2, ln3, ln4, InS, 
ln6, In?, InS, ln1 0, ln13, ln18, ln30, and I nO for the elements from R46, Tn21, 
R388, Tn1696, pSCH884, pSa, pDG0100, Tn2603, p8P201, pLM020', 
pLM0229, p8WH301, and pVS1, respectively (Stokes and Hall, 1989; Hall 
and Stokes, 1993; Recchia and Hall, 1995). 
Tn7 and its close relatives make up the class 2 integrons. The general 
organisation of the left end of Tn7 is similar to that of class 1 integrons. There 
is a putative, but defective, int1 gene (Hall and Vockler, 1987). This int2 gene 
is interrupted by a termination codon (Hall and Vockler, 1987) and its product, 
lnt2, is 40% identical to lnt1 (Sundstrom eta/., 1991; Young eta/., 1994). 
Gene cassettes have been found downstream of the int2 gene but the 3'-
sequences flanking these cassettes are not related to those flanking the 
cassettes associated with class 1 integrons. 
The putative integrase, lnt3, of class 3 integrons is 61% identical to the lnt1 
integrase (Arakawa eta/., 1995). This is the only class 3 integron described 
thus far. The integrase gene is located 5' to the b/aiMP cassette (Arakawa et 
a/., 1995). 
Class 4-type integrons have only recently been described. The integrase 
gene, int4, was identified in Vibrio cholerae (Maze I eta/., 1998) and the gene 
product was found to have 45 to 50% identity with the 3 previously described 
integrases. Interestingly, the gene cassettes associated with this class of 
integron do not encode antibiotic resistance genes. Rather, they are "gene-
VCR" cassettes (VCRs are V.cho/erae repeated sequences) similar to the 
well-characterised antibiotic resistance gene cassettes. A 90% sequence 
identity was found between the VCR sequences and the 59-base element 
associated with b/aP3, which is an integron-associated antibiotic resistance 
gene encoding the carbenicillinase, CARB-4, isolated from Pseudomonas 
(GenBank accession number U14749). Their results have also shown that 
VCR cassettes have been in the Vibrio lineage since before the emergence of 
antibiotic resistance integrons. 
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Class 1 integrons have played an important role in the spread of antibiotic 
resistance genes and are the most prevalent integrons in clinical isolates of 
Enterobacteriaceae and pseudomonads (Recchia and Hall, 1995). To 
determine whether Acinetobacter isolates from Groote Schuur Hospital (GSH) 
and Universitas Hospital (UH) contain these elements, a portion of the int1 
integrase gene was used to screen a total of 57 clinical isolates of multi-
resistant A. baumannii- 43 from GSH and 14 from UH. 
2.8. MATERIALS AND METHODS 
2.8.1. Bacterial isolates and plasmids 
Acinetobacter spp. were isolated in the Clinical Microbiology Laboratory, 
Groote Schuur Hospital and the Department of Medical Microbiology, 
Universitas Hospital, Bloemfontein. The iso.lates were all identified as 
Acinetobacter baumannii by standard biochemical tests. The year of isolation 
of the acinetobacters is shown in Table 2.1. 
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Table 2.1.: Year of isolation of the acinetobacters 
Isolate number Year isolated Isolate number Year isolated 
G1 1993 G31 1997 
G2 1993 G32 1997 
G3 1993 G33 1997 
G4 1993 G34 1997 
GS 1993 G35 1997 
G6 1993 G36 1997 
G7 1996 G37 1997 
G8 1996 G38 1997 
G9 1994 G39 1997 
G10 1996 G58 1996 
G11 1996 G60 1996 
G12 1996 G61 1996 
G13 1996 G95 1996 
G14 1996 G98 1996 
G15 1996 81 1994 
G16 1996 82 1994 
G17 1996 83 1994 
G18 1996 84 1994 
G19 1997 85 1994 
G20 1997 86 1994 
G21 1997 87 1994 
G23 1997 88 1994 
G24 1997 89 1994 
G25 1997 810 1994 
G26 1997 811 1994 
G27 1997 812 1994 
G28 1997 813 1994 
G29 1997 814 1994 
G30 1997 
Acinetobacter calcoaceticus 80413 C91 strain, which does not carry an 
integron or integron-related sequences, was used as a negative control in 
hybridisation and PCR experiments and was kindly supplied by A. Vivian 
(University of Western England, Bristol, U.K.). 
Acinetobacter baumannii strain CW20 carries an integron with a gene 
cassette of 0.7kb in the variable region. This strain was used as a positive 
control in the PCR experiments and was kindly supplied by R. Seward and 
K.J. Towner (Department of Microbiology and PHLS Laboratory, University 
Hospital, Queen's Medical Centre, Nottingham). 
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E. coli DH5a (~80d/acZL1M15) (Hanahan, 1983), which does not carry an 
integron or integron-related sequences, was used as a negative control in 
hybridisation experiments. 
Plasmid pGSH1 08, which contains a 1.7kb BamHI/Hindlll insert encoding 
integrase and ANT(2") activity, was used as the source of the int1 probe and 
as a positive control in hybridisation experiments (Elisha, 1991 ). 
2.8.2. Antibiotic sensitivity testing 
Antibiotic susceptibility of the acinetobacters was determined by the Kirby 
Bauer disc diffusion test on Mueller Hinton agar at 37°C for 18 hours. 
Resistance profiles were determined based on NCCLS criteria. Oxoid discs 
containing the following antibiotics (amount of antibiotic in ).!g) were used: 
amikacin (30), amoxicillin (1 0), cefapime (30), cefazolin (30), cefotaxime (30), 
cefoxatin (30), cefuroxine (30), chloramphenicol (30), coamoxiclav (amoxicillin 
(20), clavulanic acid (1 0)), cotrimoxazole (30), gentamicin (1 0), imipenem 
(1 0), meropenem (1 0), ofloxacin (5), oxacillin (1 ), penicillin (1 0 units), and 
piperacillin/tazobactam (piperacillin (1 00), tazobactam (1 0)). 
2.8.3. Agarose gel electrophoresis (AGE) 
AGE resolves DNA fragments on the basis of their differing rates of migration 
in an agarose gel (Ausubel eta/., 1987). Smaller fragments migrate faster 
than larger ones when an electrical field is applied across the gel and, since 
DNA is negatively charged, it migrates from the anode to the cathode. DNA 
was separated in horizontal gels of 1% (w/v) agarose dissolved in 0.4M Tris-
acetate, 0.01M EDTA (1x TAE, Appendix A) using the standard submerged 
gel system described by Sambrook eta/. (1989). Ethidium bromide (EtBr), a 
fluorescent dye containing a planar group that intercalates between the 
stacked bases of DNA, was included in the gels. The fluorescent yield of 
EtBr-DNA complexes is much greater than that of unbound dye, and DNA can 
thus be visualised by UV transillumination at 302nm (the wavelength at which 
the bound dye absorbs the ultraviolet radiation) (Sam brook eta/., 1989). The 
agarose was dissolved by heating the solution to boiling in a microwave oven. 
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The gel was poured into a mould and a comb was inserted. Once the gel had 
polymerised, the comb was removed and the gel was submerged in 1 x TAE 
in the electrophoresis tank. 
Before DNA samples were loaded into the wells formed by the comb, they 
were mixed with a gel tracking dye (Appendix A) which served 3 purposes: 
the sucrose increased the density of the sample ensuring that the DNA 
remained in the well, the bromophenol blue in the dye allowed one to monitor 
the rate of migration of the DNA, and the EDTA chelated Mg2+ ions thereby 
inhibiting enzymatic activity (ie. it stops the reaction). Molecular weight 
markers were included so that the DNA fragment sizes could be determined. 
Molecular weight marker VI (Boehringer Mannheim; Mannheim, Germany) 
and/or the 1 kb ladder (Promega; Madison, USA) were used in this study 
(Appendix B). Electrophoresis was performed at 2-1 OV/cm for 1-2 hours. 
2.8.4. Genomic DNA extraction 
Genomic DNA was extracted using the method described by Ausubel et at. 
(1987). A single colony of each Acinetobacter isolate was inoculated into 
10ml of 2X Yeast-Tryptone (YT) broth (Appendix A) and incubated aerobically 
at 37°C for ±18 hours. The bacterial cells were harvested in a Beckman 
Model J2-21 Centrifuge at 6000 rpm for 10 minutes. The bacterial cell pellets 
were resuspended in 567!-!1 of Tris-EDTA buffer (Appendix A) by repeated 
pi petting and the cell walls lysed following the addition of 30!-!1 of the detergent 
SDS (Appendix A). Three microlitres of proteinase K (20mg/ml) was added to 
digest the cellular proteins released as a result of cell wall lysis. This 
suspension was mixed thoroughly and lysis and protein digestion were 
allowed to continue at 37°C for 1 hour. After lysis, the solution became 
viscous and 1 00~-tl of 5M NaCI (Appendix A) and 80!-!1 of CTAB/NaCI 
(Appendix A) were added and the solution was mixed thoroughly and 
incubated at 65°C for 10 minutes. This removed the cell wall debris, 
denatured/digested protein, and polysaccharides, which became complexed 
to CTAB, by selective precipitation. The presence of the 5M NaCI prevents 
the formation of a CTAB-nucleic acid precipitate and the nucleic acids thus 
remain in solution. The CTAB-protein/polysaccharide complexes were then 
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extracted with an equal volume of chloroform-isoamylalcohol (Appendix A). 
After centrifuging the mixture for 10 minutes in a microfuge (Eppendorf 
Centrifuge 5415C) at 14000 rpm a white interface was visible. The aqueous 
phase was removed to a clean microfuge tube and the DNA was further 
purified by extraction with an equal volume of phenol-chloroform-
isoamylalcohol (Appendix A) and centrifugation for 10 minutes at 14000 rpm 
in a microfuge (Eppendorf Centrifuge 5415C). This step was repeated until 
the aqueous phase was completely clear of the CTAB-protein/polysaccharide 
complexes. Once the aqueous phase was clear, the DNA was precipitated 
with 0.6 volumes of isopropanol. Shaking the tube back and forth allowed 
visualisation of stringy white DNA precipitate. This was collected by 
centrifugation for 1 0 minutes in a microfuge (Eppendorf Centrifuge 5415C) at 
14000rpm. With certain preparations, no stringy precipitate was visible since 
the DNA had been sheared during the extraction process. However, DNA 
could still be pelleted by centrifugation. DNA pellets were washed with 70% 
ethanol to remove residual CTAB and recentrifuged. The supernatant was 
carefully removed and the DNA was allowed to dry for 10-15 minutes at 37°C. 
The DNA was then resuspended in 70-100~1 TE buffer at 4°C overnight. 
The concentration of DNA in each genomic DNA preparation was determined 
using fluorescent quantitation. Ethidium bromide intercalates between DNA 
bases [section 2.8.3] and there is a relationship between the amount of 
fluorescence and the quantity of DNA in the sample -the more DNA in a 
given sample, the more it will fluoresce. To estimate the concentration of DNA 
in a sample it was subjected to AGE [section 2.8.3] alongside a sample of 
known DNA concentration. The fluorescence emitted by the sample of 
unknown DNA concentration was compared with that of the DNA of known 
concentration. 
2.8.5 DNA-DNA hybridisation 
2.8.5.a. DNA transfer 
Ten micrograms of genomic DNA from each of the Acinetobacter isolates was 
transferred to a Hybond™-N+ membrane (Amersham International; 
Buckinghamshire, UK) using the Minifold II Slot-Blot Apparatus (Schleicher 
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and Schuell; Germany). Each sample was made up to a 501-ll volume with 
distilled water (dH20). The DNA was then denatured at 95°C for 10 minutes 
and placed on ice to prevent renaturation. Fifty microlitres of transfer buffer, 
20X sse (Appendix A), which provides the ionic strength necessary for the 
binding of DNA to the nylon membrane (Sambrook eta/., 1989), was added 
to the denatured DNA. The slot-blot apparatus was then assembled according 
to the manufacturer's instructions with the Hybond ™ -N+ membrane (prewet 
with 1 Ox SSC) resting on filter paper (also prewet with 1 OX SSC). The 
samples were then carefully loaded into separate slots and a vacuum was 
applied until transfer to the membrane was complete. The apparatus was 
dismantled and the Hybond™-N+ membrane with the DNA was removed. To 
denature the DNA, the membrane was placed on filter paper soaked in a 
solution of 1.5M NaCI and 0.5M NaOH for 5 minutes. Neutralisation was 
achieved by soaking it in a solution of 0.5M Tris pH 7.2, 1.5M NaCI, and 1mM 
EDTA for 5 minutes. After allowing the membrane to air-dry, the DNA was 
cross-linked to the membrane using UV light for 30 seconds at a wavelength 
of 254nm in a Hoefer Scientific Instruments (California, USA) UV Cross-linker. 
The membrane was stored in a sealed plastic sleeve at 4°C until required. 
2.8.5.b. Preparation of the int1 probe 
pGSH108 contains a 1.7kb insert which carries genes encoding ANT(2") and 
integrase. Immediately downstream of the int1 stop codon is a BamHI site 
(GJ..GATCC) and inside the structural gene are 2 Sphl sites (GCATGJ..C). 
These two enzymes were used to cleave a 589bp BamHI/Sphl fragment 
containing a portion of the int1 structural gene (Elisha, 1991) from pGSH1 08 
for use as a probe (Fig. 2.3.). This portion of the int1 shares a 52% homology 
with the same portion of the int2. Four micrograms of pGSH 108 were 
digested at 37°C with 30 units (U) of BamHI (Boehringer Mannheim; 
Mannheim, Germany) and 30U of Sphl (Boehringer Mannheim; Mannheim, 
Germany) in 1x buffer B (Boehringer Mannheim; Mannheim, Germany). This 
was allowed to continue for ±18 hours to ensure complete digestion of the 
plasmid. 
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Ba nHI STOP 
G~ GATCCCTAC CTCTCACTAG TGAGGGGCGG CAGCGCATCA AGCGGTGAGC GCACTCCGGC 60 
'ACCGCCAACT TTCAGCACAT GCGTGTAAAT CATCGTCGTA GAGACGTCGG AATGGCCGAG 120 
CAGATCCTGC ACGGTTCGAA TGTCGTAACC GCTGCGGAGC AAGGCCGTCG CGAACGAGTG 180 
GCGGAGGGTG TGCGGTGTGG CGGGCTTCGT GATGCCTGCT TGTTCTACGG CACGTTTGAA 240 
GGCGCGCTGA AAGGTCTGGT CATACATGTG ATGGCGACGC ACGACACCGC TCCGTGGATC 300 
GGTCGAATGC GTGTGCTGCG CAAAAACCCA GAACCACGGC CAGGAATGCC CGGCGCGCGG 360 
ATACTTCCGC TCAAGGGCGT CGGGAAGCGC AACGCCGCTG CGGCCCTCGG CCTGGTCCTT 420 
CAGCCACCAT GCCCGTGCAC GCGACAGCTG CTCGCGCAGG CTGGGTGCCA AGCTCTCGGG 480 
TAACATCAAG GCCCGATCCT TGGAGCCCTT GCCCTCCCGC ACGATGATCG TGCCGTGATC 540 
Sph 
GAAATCCAGA TCCTTGACCC GCAGTTGCAA ACCCTCACTG ATCCGCATG~ C CCGTTCCATA 600 
CAGAAGCTGG GCGAACAAAC GATGCTCGCC TTCCAGAAAA CCGAGGATGC GAACCACTTC 660 
ATCCGGGGTC AGCACCACCG GCAAGCGCCG CGACGGCCGA GGTCTTCCGA TCTCCTGAAG 720 
CCAGGGCAGA TCCGTGCACA GCACCTTGCC GTAGAAGAAC AGCAAGGCCG CCAATGCCTG 780 
ACGATGCGTG GAGACCGAAA CCTTGCGCTC GTTCGCCAGC CAGGACAGAA ATGCCTCGAC 840 
TTCGCTGCTG CCCAAGGTTG CCGGGTGACG CACACCGTGG AAACGGATGA AGGCACGAAC 900 
CCAGTGGACA TAAGCCTGTT CGGTTCGTAA GCTGTAATGC AAGTAGCGTA TGCGCTCACG 960 
START 
CAACTGGTCC AGAACCTTGA CCGAACGCAG CGGTGGTAAC GGCGCAGTGG CGGTTTTCAT 1020 
GGCTTGTTAT GACTGTTTTT TTGGGGTACA GTCTATGCCT CGGGCATCCA AGCAGCAAGC 1080 
GCGTTACGCC GTGGGTCGAT GTTTGATGTT ATGGAGCAGC AACGATGTTA CGCAGCAGGG 1140 
CAGTCGCCCT AAAACAAAGT TAGGCCGCAT GGACACAACG CAGGTCACAT TGATACACAA 1200 
AATTCTAGCT GCGGCAGATG AGCGAAATCT GCCGCTCTGG ATCGGTGGGG GCTGGGCGAT 1260 
CGATGCACGG CTAGGGCGTG TAACACGCAA GCACGATGAT ATTGATCTGA CGTTTCCCGG 1320 
CGAGAGGCGC GGCGAGCTCG AGGCAATAGT TGAAATGCTC GGCGGGCGCG TCATGGAGGA 1380 
GTTGGACTAT GGATTCTTAG CGGAGATCGG GGATGAGTTA CTTGACTGCG AACCTGCTTG 1440 
GTGGGCAGAC GAAGCGTATG AAATCGCGGA GGCTCCGCAG GGCTCGTGCC CAGAGGCGGC 1500 
TGAGGGCGTC ATCGCCGGGC GGCCAGTCCG TTGTAACAGC TGGGAGGCGA TCATCTGGGA 1560 
TTACTTTTAC TATGCCGATG AAGTACCACC AGTGGACTGG CCTACAAAGC ACATAGAGTC 1620 
Sphi 
CTACAGGCTC GCATGkACCT CACTCGGGGC GGAAAAGGTT GAGGTCTTGC GTGCCGCTTT 1680 
CAGGTCGCGA TATGCGGCCT AACAATTCGT CCAAGCCGAC GGCTTCGCGG CGCGGCTTAA 1740 
CTCAGGTGTT AGGCCGCATG GACACAGGCA TGCAAG 1776 
Fig. 2.3.: Sequence of the pGSH108 insert showing the 589bp int1 probe. The BamHI and Sphl sites and the 
start and stop codons of the integrase gene are indicated. The blocked off area corresponds to the 589bp int1 probe 
sequence (Elisha, 1991; Elisha and Steyn, 1991 a). 
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Ten microlitres of gel tracking dye was added and the digest was subjected to 
AGE [section 2.8.3] for 75 minutes at 80V. The band corresponding to 589bp 
was excised and the DNA was eluted from the agarose: the agarose was cut 
into very small pieces and placed in a microfuge tube. An equal volume of 
phenol was added to solubilize the agarose (Sam brook et a/., 1989) as 
described by Seth (1984) and mixed by vortexing the tube. The tube was 
placed at -70°C for 15 minutes and then centrifuged at 14000rpm for 10 
minutes in a microfuge (Eppendorf Centrifuge 5415C). After centrifugation, 
the upper aqueous phase containing the DNA w~s removed and the DNA 
was further purified by extraction with phenol-chloroform-isoamylalcohol as 
described by Sambrook eta/. (1989). An equal volume of phenol-chloroform-
isoamylalcohol was added and, after mixing, the solution was centrifuged as 
before to remove any residual agarose and phenol. The DNA in the resulting 
supernatant was concentrated by precipitation .with 1/10 volume of 4M LiCI 
(Appendix A) and 3 volumes of 100% ethanol. After placing the tube at -70°C 
for -10 minutes to allow for precipitation, the DNA was collected by 
centrifugation as before. The resulting DNA pellet was washed in 70% 
ethanol, dried at 37°C for 10-15 minutes, and resuspended in 20f..ll of dH20. 
The DNA was allowed to resuspend for ~30 minutes and, following 
quantitation [section 2.8.4], 500ng of the 589bp BamHI!Sphl int1 fragment 
was labelled using the ECL ™ direct nucleic acid labelling and detection 
system (Amersham International; 8uckinghamshire, UK), according to the 
manufacturer's instructions (Fig. 2.4.): the DNA fragment was denatured by 
boiling for 5 minutes, snap cooled on ice for a further 5 minutes and labelled 
with horseradish peroxidase (which is responsible for the loose attachment 
formed between the label and the DNA), complexed with a positively charged 
polymer. Addition of glutaraldehyde resulted in the formation of chemical 
cross-links between the DNA and the peroxidase-polymer complex so that the 
enzyme was covalently attached to the fragment. The labelled fragment was 
used in hybridisation experiments. 
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2.8.5.c DNA-DNA hybridisation 
The 589bp int1 probe was hybridised to the genomic DNA immobilized on the 
Hybond ™-N· membrane [section 2.8.5.a] using a modification of the protocol 
for the ECL direct nucleic acid 'labelling and detection system: a vo.lume of 
hybridisation buffer(Appendix A) equivalent to 0.125ml/cm2 of membrane was 
used. A blocking agent which is designed to pre-coat all the sites on the 
membrane to which the probe would bind non-specifically, was added to the 
buffer to a final concentration of 5% (w/v). NaCI was also added to a final 
concentration of 0.5M. The hybridisation was performed in a Hybridiser HB-
1 D oven (Techne: Cambridge. UK) at 42°C. 
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Fig. 2.4.: Principles of the ECL direct nucleic acid labelling and 
detection system (taken from the kit manual) 
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Prehybridisation was allowed to continue for -1 hour, during which time the 
non-specific binding sites on the membrane were blocked. Thereafter, the 
probe was added to the buffer and hybridisation was allowed to continue 
overnight at 42°C. 
After hybridisation, the membrane was washed to remove unbound, excess 
probe. Firstly, the membrane was rinsed in 50-100ml of 5X SSC at 42°C. 
Thereafter it was washed twice in 1 OOml of wash buffer (Appendix A) 
containing 6M urea, 0.4% SDS, and 0.1x SSC, at 55°C for 10 minutes. Using 
a buffer containing urea and a low concentration of SSC and washing at 55°C 
increased the stringency of the wash, thereby creating conditions which allow 
for the formation of only well-matched hybrids of probe and target DNA. The 
third wash was performed twice at room temperature (RT) on a Stovall Low 
Profile Roller (Stovall Life Science, Inc; North Carolina, USA) for 5 minutes in 
±1 ooml 2X sse. 
Signal generation and detection were performed following the protocol 
supplied by the manufacturers of the ECL kit. Detection reagents 1 and 2 
were mixed in equal volumes to give enough solution to cover the membrane. 
On completion of the post-hybridisation washes, excess buffer was drained 
from the membrane, which was then flooded with the detection reagent mix 
and allowed to incubate for 1 minute at room temperature. Excess detection 
reagent was drained from the membrane, which was sealed between two 
pieces of plastic. Detection reagent 1 decays to hydrogen peroxide, the 
substrate for peroxidase- with which the probe was labelled [section 2.B.5.c]. 
Reduction of the hydrogen peroxide by peroxidase is coupled to a light-
producing reaction catalysed by detection reagent 2, which contains luminal 
and produces blue light on oxidation. An enhancer prolongs and increases 
the light output which can be detected on a blue-light sensitive film. The 
membrane was exposed to X-ray film (AGFA CP-BU; Mortsel, Belgium) for 2 
hours and the autoradiograph was developed. 
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2.C. RESULTS 
2.C.1. Antibiotic sensitivity testing 
The antibiotic resistance profile of the 57 Acinetobacter isolates are shown in 
Table 2.2. 
Table 2.2.:Antibiotic resistance profile of the Acinetobacter isolates 
Isolate number Antibiotic resistance profile Blot" PCR" 
Gl Gent, Amox, Co am, Chlo, Cfox, Crox + + 
G2 Amik, Gent, Amox, Co am, Ctri, Chlo, Cfox, Crox + + 
G3 Amik, Gent, Amox, Co am, Ctri, Chlo, Cfox, Crox + + 
G4 Amik, Gent, Amox, Ctri, Chlo, Cfox, Crox + + 
GS Amik, Gent, Amox, Co am, Pip, Ctri, Chlo, Cfox, Crox + + 
G6 Amik(I), Gent, Amox, Ctri, Chlo, Cfox, Crox + + 
G7 Amik - -
GB Gent, Pip, Ctri, Chlo, Oflo, Cpim(I), Ctaz(I) - -
G9 Amik, Gent, Amox, Co am, Ctri, Chlo, Cfox, Crox - -
GlO Amik, Gent, Chlo, Cpim - -
Gll Amik, Gent, Chlo, Cpim - -
G12 Gent, Chlo + + 
Gl3 Amik, Oflo - -
Gl4 Amik, Gent, Chlo - -
Gl5 Gent, Pip, Ctri, Chlo, Cpim(I), Ctaz + + 
Gl6 Amik - -
Gl7 Amik, Gent, Chlo, Cpim, Ctaz(I) - -
Gl8 Oflo - -
Gl9 Amik, Gent, Chlo, Cpim - -
G20 Amik, Gent, Pip, Ctri, Chlo, Ci_pr, Oflo + + 
G21 Gent(!), Pip, Oflo, Cipr, Ctaz - -
G23 Amik, Gent, Pip, Ctri, Chlo, Cipr, Oflo, Cpim, Ctaz(I) + + 
G24 Amik, Gent, Ctri, Chlo, Cipr, Oflo + -
G25 Gent, Chlo + -
G26 Amik, Gent, Pip, Ctri, Chlo, Cipr, Oflo + -
G27 Amik, Gent, Chlo, Cpim - -
G28 Amik, Gent, Pip, Ctri, Chlo, Cipr, Oflo + -
G29 Gent, Pip, Chlo + -
G30 Amik, Gent, Pip, Ctri, Chlo, Cipr, Oflo + -
G31 Amik, Gent, Pip, Ctri, Chlo, Cipr, Oflo - -
G32 Amik, Gent, Pip, Ctri, Chlo, Oflo, Cpim, Ctaz, Mero + 
G33 Amik, Gent, Cpim, Ctaz - -
G34 Gent, Pip, Ctri, Chlo, Cipr, Oflo, Cpim, Ctaz + -
G35 Amik, Gent, Pip, Ctri, Chlo, Oflo, Cpim + -
G36 Amik, Gent, Pip, Ctri, Chlo, Oflo, Cpim + -
G37 Amik, Gent, Pip, Ctri, Chlo, Oflo, Cpim + + 
G38 Amik(I), Gent, Pip, Ctri, Chlo, Cipr (I), Oflo(I), Ctaz + -
G39 Amik, Gent, Pip, Ctri, Chlo, Cipr, Oflo, Cpim, Ctaz(I) + + 
GSB Amik, Gent 
G60 Amik - -
G61 Amik - -
G95 Amik - -
G98 Amik, Gent - -
Bl Gent, Amp, Pip, Ctri, Chlo, Cfox, Ctax, Ctaz + + 
B2 Gent, Amp, Pip, Chlo, Cfox, Ctaz + + 
B3 Gent, Amp, Pip, Ctri, Chlo, Cfox, Ctax, Ctaz + + 
B4 Gent, Amp, Pip, Ctri, Chlo, Cfox, Ctax, Ctaz + + 
BS Gent, Amp, Pip, Ctri, Chlo, Ctax + -
B6 Amp, Ctri, Chlo, Cfox, Ctax, Ctaz + + 
B7 Gent(!), Amp, Chlo, Cfox Ctax - -
BB Gent, Amp, Pip, Ctri, Chlo, Cfox, Ctax + + 
B9 Gent, Amp, Pip, Ctri, Chlo, Ctax + + 
BlO Gent, Amp, Pip, Ctri, Chlo, Cfox, Ctax, Ctaz + + 
Bll Gent, Amp, Pip, Ctri, Chlo, Ctax + + 
Bl2 Gent, Amik, Amp, Pip, Chlo, Cfox, Ctax, Ctaz + + 
Bl3 Gent, Amp, Pip, Ctri, Chlo, Cfox, Ctax, Ctaz(I) + + 
Bl4 Gent, Amp, Pip, Ctri, Chlo, Cfox, Ctax (I), Ctaz + + 
... . .. Am1k, am1kacm; Amox, amox1C1IIin; Amp, ampiCillin; Cp1m, cefap1me; Cpn, c1profloxacm; Czol, cefazolln; Ctax, 
cefotaxime; Ctaz, ceftazidime, Cfox, cefoxatin; Crox, cefuroxine; Chlo, chloramphenicol; Coam, coamoxiclav; Ctri, 
cotrimoxazole; Gent, gentamicin; lmpn, imipenem; Mero, meropenem; Oflo, ofloxacin; Oxa, oxacillin; Pen, penicillin; 
Pip, piperacillin/tazobactam; I, Intermediate resistance; " Results of the hybridisation (p36); + = signal, - = no signal; 
b Results of the PCR assay (p49); + = product, - = no product 
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2.C.2. DNA-DNA hybrisation with the int1 probe 
The int1 probe gave no signal with the DNA from the integron-free strains, 
E. coli DH5a and A.calcoaceticus BD413 C91. A signal was obtained with 
pGSH1 08, the source of the probe. The probe hybridised to genomic DNA 
from 23/43 acinetobacters from GSH and 13/14 isolates from USH, 
suggesting the presence of integrons in these strains (Fig. 2.5.) 
A B c A B c 
1 NT Gl9 G58 
2 pGSH108 G20 G60 
3 NT G21 G6 1 
4 NT G23 G95 
'> 5 Gl G24 G98 
6 G2 G25 NT 2 
7 G3 G26 Bl 
8 G4 G27 B2 3 . 
9 GS G28 B3 4 
10 G6 G29 B4 
11 G7 G30 BS 5 
12 G8 G31 B6 6 
13 G9 G32 B7 
-14 GlO G33 B8 7 
- -15 Gll G34 B9 
16 Gl2 G35 Bl O 8 
-17 Gl3 G36 Bll 9 
-18 Gl4 G37 Bl2 
1 9 GlS G38 Bl3 10 
-
-20 Gl6 G39 Bl4 11 
-
21 Gl7 -NT NT 
22 Gl 8 NT NT 12 
23 NT NT NT 
24 NT DHSa C91 13 
·-14 
-
pGSH 108 = p ositive control 
15 
-
DHSa and C91 = negative controls 16 
-NT = lane left blank 17 
-18 
-19 
- . 
20 
-
-Zl 
22 
23 
24 
Fig. 2.5.: Autoradiograph of the slot blot of the genomic DNA from the clinical 
A.baumannii isolates hybridised to the int1 probe. 
pGSH108 plasmid DNA from wh ich the probe was derived was used as a positive control. 
Genomic DNA from E. coli DH5a and A.calcoaceticus BD413 C91 were used as negative 
controls. Autoradiography was for 2 hours. 
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2.0. DISCUSSION 
The hybridisation studies indicate the presence of integrons in 53.5% of the 
GSH isolates and 92.9% of the UH isolates (63.2% overall). As a number of 
antibiotic resistance patterns were observed in the strains it was not possible 
to associate a particular phenotype with the presence of an integron. 
Nevertheless, 35 of the isolates that were resistant to gentamicin gave a 
signal with the int1 probe (see Table 2.2.). The incidence of int1 observed in 
this study is higher than that found in acinetobacter isolates investigated by 
Tait and Amyes (1994). They investigated the presence of Tn21-like 
transposons and the integron elements (class 1-type integrons) associated 
with this family of transposons in various isolates of Acinetobacter spp. 
collected in Britain and the Netherlands. They performed colony- and dot-blot 
hybridisations on these isolates using a probe for the integrase gene. Of the 
1 08 isolates (67 blood culture isolates and 41 isolates collected from various 
sites) from Edinburgh Royal Infirmary, none of the blood culture isolates 
hybridised to the integrase probe, however, a positive signal was obtained 
with the DNA from 2 of the other isolates. This set of isolates thus has a 1.8% 
incidence of int1. Further hybridisation studies on the integrase positive 
isolates, using probes directed againstTn21-associated genes (tnpA, tnpR, 
and tnpM) were carried out. These studies suggested that the integron in one 
of the Acinetobacter isolates is associated with Tn21, since a signal was 
obtained with each of the probes. The other isolate had only tnpM in addition 
to int1. 
Acinetobacterstrains from outbreaks in Aberdeen, Glasgow, Basildon and 
Utrecht were also examined. A total of 11 strains gave a positive signal with 
the int1 probe: 1 from Glasgow, 3 from Aberdeen, 2 from Basildon, and 5 
from Utrecht. Hybridisation studies indicated that the integrons from only 2 of 
the acinetobacters (1 from Glasgow and 1 from Basildon) are associated with 
Tn21-like transposons. In addition, 2 isolates, provided by W. Noble (the 
origins of which were unknown), were also studied. Both were found to be 
positive for integrase and were Tn21-associated. 
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In a recent study, Gonzalez eta/. (1998) determined the presence of class 1-
and class 2-type integrons in 100 isolates of multi-resistant isolates of 
A.baumannii, by hybridisation with probes specific for the int1 and int2 genes. 
They found int1 in only 5.1% of the isolates (biotype 9) -much lower than the 
incidence observed for this study (63.2%)- and int2 in 52.6% of biotype 9 and 
16.7% of biotype 8 isolates. Positive hybridisation for both int1 and int2 was 
obtained for 23.7% of biotype 9 isolates. A.baumannii biotype 9 was the most 
prevalent biotype in Chilean hospitals. The biotype 9 isolates were multi-
resistant and had the highest frequency of integron carriage. The authors 
suggest that the biotype 9 isolates may be favouring the spread of and act as 
a reservoir for resistance gene cassettes in the hospital environment. 
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CHAPTER 3: POLYMERASE CHAIN REACTION ASSAY TO DETERMINE 
THE PRESENCE OF INTEGRON-ASSOCIATED ANTIBIOTIC RESISTANCE 
GENES 
3.A. INTRODUCTION 
To study the contents of the variable regions of integrons, Levesque eta/. 
(1995) designed primers directed at the 5'- and 3'-conserved regions of class 
1-type integrons for use in polymerase chain reaction (PCR) assays. Using 
these primers (5'-CS and 3'-CS, respectively), they identified integron-related 
antibiotic resistance genes in 75% of aminoglycoside resistant strains of 
Enterobacteriacea (including Klebsiella pneumoniae, Enterobacter cloacae, 
Serratia marcescens, Salmonella typhimurium, Escherichia coli, and Proteus 
mirabilis) and Pseudomonas aeruginosa. They obtained amplification 
products of -1 kb to -3.5kb. The larger products encoded as many as 4 
antibiotic resistance genes (Table 3.1.). 
Table 3.1.: PCR amplification products obtained by Levesque eta/. (1995) using the 5'-
CS and 3' -CS primers 
(adapted from Levesque et at., 1995) 
Bacterial strain Length of product (bp) Gene order in variable region 
K.pneumoniae 1000 ant(3 · ')-Ia 
E. cloacae 1600 ant(2'l-la- ant(3'')-la 
S.marcescens I 1600 ant(2")-la- oxa2 
S.marcescens II 1600 dfrl- ant(3")-la 
S. typhimurium 2000 aac(6'l-lb- ant(3")-la 
E. coli 3000 aac(3)-la- orfE- ORF- ant(3")-la 
P.mirabilis 3500 aac(3)-la- orfE- ant(3")-lb - em/A 
In another study, Vila eta/. (1997) used the same primers to amplify a PCR 
product of -1.5kb from genomic DNA isolated from Acinetobacter (strain 
Ab41 ). DNA sequencing of the product showed that the integron contains an 
ant(2")-la (aminoglycoside adenylyltransferase) gene followed by a novel 
OXA-derived P-lactamase gene. 
The 36 Acinetobacter isolates (23 from GSH and 13 from UH) which were 
positive for the presence of the integrase gene in hybridisation studies 
[Chapter 2] were subjected to a polymerase chain reaction (PCR) assay using 
the primers described by Levesque eta/. (1995). 
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3.8. MATERIALS AND METHODS 
3.8.1. Isolation of DNA 
Genomic DNA was isolated as described [section 2.8.4]. Alternatively, DNA 
was prepared as follows: a bacterial colony was suspended in 1 00~-tl distilled 
water. To release the genomic DNA, the supension was boiled vigorously for 
10-15 minutes. Cellular debris was removed by centrifugation in a microfuge 
(Eppendorf Centrifuge 5415C) for 2 minutes at 14000rpm. Five microlitres of 
the lysate was used in the PCR (Grim berg eta/., 1989). 
3.8.2. PCR primers 
The sequences of the primers directed against the 5'- and 3'-conserved 
sequences of type 1 integrons were obtained from R.Seward and K.J. Towner 
(Department of Microbiology and PHLS Laboratory, University Hospital, 
Queen's Medical Centre, Nottingham) and have been described by Levesque 
eta/. (1995). The 5'-CS primer, 5'-GGCATCCAAGCAGCAAG-3' 
(corresponding to nucleotides 1190 to 1206 in the sequence published by 
Bissonnette and Roy, 1992), and the 3'-CS primer, 5'-
AAGCAGACTTGACCTGA-3' (nucleotides 1342 to 1326 in the same 
sequence), flank the variable region which contains the gene cassettes 
(fig.3.1.). 
1047 
CGGTTCGTAAGCTGTAATGCAAGTAGCGTATGCGCTCACGCAACTGGTCCAGAACCTTGACCGAACGCAG 
CGGTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTGTTATGACTGTTTTTTTGTACAGTCTATGCCTCGG 
5'-CS PRIMER (5'-3') 
GCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGC 
5'-conserved segment ~ I I ~ 3'-conserved segment 
AGCAGGGCAGTCGCCCTAAAACAAAGTTAGATGCACTAAGCACATAATTGCTCACAGCCAAACTATCAGG 
3'-CS PRIMER (3'-5') 
TCAAGTCTGCTTTTATTATTTTTAAGCGTGCATAATAAGCCCTACACAAATTGGGAGATATATCATGAAA 
GGCTGGCTTTTTCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGG 
1471 
Fig. 3.1.: The 5'-CS and 3'-CS primers. 
Sequence taken from Bissounette and Roy (1992) showing the 5'-CS and 3'-CS primers in bold and 
underlined (// indicates the junction between the 5'- and 3' -conserved segments) 
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3.8;3. PCR Assay 
The polymerase chain reaction (PCR) is the primer-directed enzymatic 
ampli1fication of DNA using a thermostable DNA polymerase isolated from 
Thermus aquaticus, called Taq DNA polymerase (Saiki eta/., 1988). The 
reaction involves cycles of template denaturation, primer annealing, and DNA 
strand extension by the polymerase (Saiki et a/., 1988).. Thermostable DNA 
polymerase is used since it is not denatured or inactivated at the high 
temperatures required to denature the double-stranded template (Saiki eta/., 
1988). Fig. 3.2. illustrates the principles of PCR 
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{5
'-lcATGGTAGACCGTTAGAcJ 3 , 
DOUBLE-STRANDED * * * * * * * * * * * * * * * * * * 
TEMPLATE 3 '-IGTACCATCTGGCAATCTGj-5 ' 
+ 5 '-ICATI_3 . + r-ICTGI- 5 ' 
FWD PRIMER 
dATP 
dGTP dTIP 
dCTP 
REV PRIMER 
ICTGI 
*** lCATGGTAGACCGTTAGACi 
dATP ~ 
dGTP dTIP 
dCTP GGCAATICTGI 
****** *** ICATGGTAGACCGTTAGACI 
+ + dNTPs 
Taq 
DNA POLYMERASE 
Template 
denaturation 
IGTACCATCTGGCAATCTGI 
Primer 
annealing 
lGTACCATCTGGCAATCTGi 
*** !CAT I 
Strand 
extension 
IGTACCATCTGGCAATCTGI 
********* ICATIGGTAGA dATP 
~dGTP_ dTIP 
~ dCTP 
25-35 CYCLES 
Fig. 3.2: Schematic diagram of the polymerase chain reaction (PCR) 
(adapted from Boehringer Mannheim PCR Applications Manual) 
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The initial reaction components and thermocycle profile were those 
recommended by Seward and Towner and consisted of a 25).!1 amplification 
mix with 1x Taq DNA polymerase buffer (Boehringer Mannheim; Mannheim, 
Germany) containing 1.5mM MgCI2, 0.2mM of each dNTP (Boehringer 
Mannheim; Mannheim, Germany), 1 U Taq DNA polymerase (Boehringer 
Mannheim; Mannheim, Germany) and 2.5pmol of each primer. DNA obtained 
using the crude boiling method of preparation was utilised as template 
(Grimberg et. a/., 1989). The thermocycle profile consisted of three steps: 1 
minute of denaturation at 94°C, 1 minute of annealing at 55°C, and 5 minutes 
of extension at 72°C; for 35 cycles. The reactions were performed in a Perkin 
Elmer (California, USA) Model 24600 PCR machine. Inconsistent results were 
obtained using these parameters making it necessary to optimise both the 
reaction components and the thermocycle profile. 
Amplification products were analysed by electrophoresis [section 2.8.3]. Five 
to ten microlitres of gel tracking dye were added to the PCR products and 
20).!1 of this mix was loaded onto the gels. 
3.C. RESULTS 
3.C.1. Optimisation of the PCR assay 
Using the conditions recommended by Seward and Towner, the assay was 
not reproducible and often yielded multiple products. The reaction 
components and thermal cycle were optimised. The optimisation strategy is 
summarised in Table 3.2. 
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Table 3.2.:· PCR assay optimisation strategy 
Total Primer MgCl2 
volume cone cone 
(Jll) (pmol) (mM) 
A 2S 2.S l.S 
B so s l.S 
so s 1. 7S 
so s 2.0 
so s 2.25 
so 5 2.5 
c so 5 2.25 
so 5 2.25 
so s 2.25 
D 50 5 2.25 
A - Recommended cond1t1ons 
B MgCl~ and dNTP titrations 
C Annealing temperature changes 
0 Conditions used in the PCR assays 
Genomic template = SOOng 
DNTP cone 
(mM) 
0.2 
0.2,0.3,0.4 
0.2,0.3,0.4 
0.2,0.3,0.4 
0.2,0.3,0.4 
0.2,0.3,0.4 
0.2 
0.2 
0.2 
0.2 
Taq Pol Template Thermo cycle 
pol. buffer Denat Anneal Extension Cycles 
(U) (T°C/min) 
1 1X Crude 94/1 SS/1 72/S 3S 
1 1X Crude 94/1 SS/1 72/1 3S 
1 1X Crude 94/1 SS/1 72/1 3S 
1 1X Crude 94/1 SS/1 72/1 3S 
1 1X Crude 94/1 S5/1 72/1 3S 
1 1X Crude 94/1 55/1 72/1 3S 
1 1X Crude 94/1 57.5/1 72/1 3S 
1 1X Crude 94/1 60/1 72/1 35 
1 1X Crude 94/1 62/1 72/1 35 
1 1X Genomic 94/1 60/1 72/1 35 
Template obtained from A.baumannii strain CW20, using the "boiling 
method," was used for optimisation reactions. Empirical changes were to 
double the reaction volume and increase the primer concentration to 5pmol 
for each primer. These changes did not have an effect on the results. MgCb 
and dNTP titrations were performed to determine the optimum concentration 
of these components. The extension time was reduced to 1 minute in order to 
speed up the amplification and to test whether a 5 minute extension period 
was necessary- reducing the time did not affect the results. The MgCb was 
titrated across the following concentrations: 1.5mM, 1.75mM, 2mM, 2.25mM, 
and 2.5mM. For each of these MgCb concentrations, dNTP concentrations of 
0.1 mM, 0.2mM, and 0.3mM were used. As can be seen in Fig. 3.3., although 
amplicons were obtained for all MgCI2 and dNTP concentrations, the highest 
yield was at concentrations of 2.25mM MgCI2 and 0.2mM dNTPs (lane 10). 
The annealing temperature was raised to increase the specificity of the 
primers. Temperatures of 57.5°C, 60°C and 62°C were tested. The highest 
yield was obtained at 60°C (Fig. 3.4., lane 2). Although the optimisation was 
performed using DNA prepared by the "boiling method", when the PCR was 
performed on clinical isolates using a crude template, amplicons were not 
obtained. Genomic DNA was therefore used as a template iin test assays. 
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1 2 3 4 5 
Lane 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
1 5 
[MgC1 2 ] 
111M 
1.5 
1. 75 
2 . 0 
2 . 25 
2 . 5 
1 . 5 
1 . 75 
2 . 0 
2 . 25 
2 . 5 
1.5 
1 . 75 
2 .0 
2 . 25 
2 . 5 
[ dNTP) 
111M 
0 . 1 
0 . 1 
0 . 1 
0 .1 
0 . 1 
0. 2 
0 . 2 
0 . 2 
0 . 2 
0 . 2 
0 . 3 
0. 3 
0. 3 
0 .3 
0 . 3 
Lane 16 = molecular weight marker VI 
Lane 17 = dH ~O negative contro l 
[MgC1 1 ]=1 . 5mM; [dNTP)=0 . 2mM 
7 8 10 11 12 13 14 1 7 
Fig. 3.3.: Optimisation of the PCR assay: MgCI2 and dNTP titrations. 
PCR was performed in 50!-!1 volumes containing 5pmol of each primer, 1 U of Taq DNA 
polymerase, 1X polymerase buffer, and 5f.t l of crude template (A.baumannii CW20 genomic 
DNA). The MgCI2 and dNTP concentrations were varied as indicated. The thermocycle 
involved 35 cycles of denaturation at 94°C for 1 min , annealing at 55°C for 1 min , and extension 
at 72°C for 1 min . Products were electrophoresed on a 1% agarose gel at 80V for 1 hour. See 
Appendix B for sizes of the bands from molecular weight marker VI. 
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Fig. 3.4.: Optimisation of the PCR assay: annealing temperature 
Lane 1, 57.5°C; lane 2, 60°C; lane 3, 62°C; lane 4, molecular weight marker VI ; and lane 5, 
dH20 at 60°C. PCR was performed in 50~-tl volumes containing 5pmol of each primer, 2.25mM 
MgCI2, 0.2mM dNTPs, 1 U Taq DNA polymerase, 1X polymerase buffer, 5~-tl crude template 
(A.baumannii CW20 genomic DNA). The thermocycle consisted of 35 cyces of denaturation at 
94°C for 1 min , annealing at 57.5°C, 60°C,or 62°C for 1 min, and extension at 72°C for 1 min. 
Products were electrophoresed on a 1% agarose gel at 80V for 1 hour. See Appendix B for 
sizes of the bands of molecular weight marker VI. 
On completion of optimisation, assay conditions and the thermocycler profile 
were as follows: 50f.ll volumes containing 1x BioTaq ™ Buffer (Bioline; 
London, UK) without MgCb, 1 U BioTaq TM DNA polymerase (Bioline, London, 
UK), 5pmol of each primer, 0.2mM deoxynucleoside triphosphate mix 
(Boehringer Mannheim; Mannheim, Germany), 2.25mM MgCb (Bioline; 
London, UK) and 500ng of genomic DNA. The reaction profile consisted of 5 
minutes of initial denaturation at 95°C followed by 1 minute of denaturation at 
94°C, 1 minute of annealing at 60°C, and 1 minute of extension at 72°C for 35 
cycles . 
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3.C.2. PCR assay 
Assays were carried out on the strains which gave a signal with the int1 
probe. Using primers directed at the 5'- and 3'-conserved sequences of 
integrons, a product of the correct size (0.7kb) was obtained from the control 
strain A.baumannii CW20 (Fig 3.5.A; Table 2.2 .). Of the 36 isolates positive 
for the presence of the integrase gene (Table 2.2) , 24 (67%) yielded PCR 
products. 
A product of 0. 7kb was obtained from 10/23 and 12/13 of the acinetobacters 
from GSH and UH, respectively, indicating the presence of a single cassette 
in the variable region. A product of 2kb was obtained from 1 GSH strain 
(fig.3.5.A., lane 12); suggesting that th is acinetobacter has an integron 
carrying at least 2 gene cassettes. Two isolates, one from GSH and one from 
UH, yielded 2 amplicons. The isolate from GSH (fig .3.5.A. , lane 13), yielded a 
2kb and a 3.5kb product, suggesting that this strain contains 2 integrons; one 
with 2 gene cassettes and one with 3. The isolate from UH (fig.3.5.B., lane 
12) yielded a 0.65kb product in addition to its 0.7kb product, suggesting that it 
contains 2 integrons with one gene cassette in each . 
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A. Lane Sample 
1 lkb ladder 
2 Gl 
3 G2 
4 G3 
5 G4 
6 G5 
7 G6 
8 Gl2 
9 Gl5 
10 G20 
11 G21 
12 G3 7 
13 G39 
14 CW20 
15 MW VI 
16 DH5a 
17 dH20 
B. Lane Sample 
1 81 
2 82 
3 83 
4 84 
5 86 
6 8 8 
7 89 
8 810 
9 811 
10 812 
11 813" 
12 814 
13 MW VI 
14 lkb ladder 
15 DH5a 
16 dH20 
Fig.3.5.: PCR products obtained from the genomic DNA of the clinical A.baumannii 
isolates. (A) Isolates from GSH; (B) Isolates from UH 
The products were electrophoresed on 1% agarose gels at 80V for 1.5 hours. PCR was 
performed in 50~1 volumes containing 5pmol of each primer, 2.25mM MgCI2, 0.2mM dNTPs, 
1 U Taq DNA polymerase, 1 X polymerase buffer and 500ng genomic DNA. The thermocycle 
profile consisted of 35 cycles denaturation at 94°C for 1 min, annealing at 60°C for 1 min, and 
extension at 72°C for 1 min . See Appendix B for the sizes of the bands of molecular weight 
marker VI and 1 kb ladder. 
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3.0. DISCUSSION 
Twenty-four of the 36 (67%) of the Acinetobacter isolates shown to contain 
int1 by hybridisation studies, yielded amplification products using primers 
directed at the 5'- and 3'-conserved regions of class 1-type integrons (see 
also Table 2.2.). A single product of 0.7kb was obtained from 22/36 strains, 
suggesting that these acinetobacters contain integrons with one cassette in 
the variable region. One of the strains which yielded a 0.7kb product also 
yielded a 0.65kb product, suggesting that this strain contains 2 integrons. A 
product of 2.0kb was obtained from 1 strain, suggesting the contents of the 
variable region of this integron consist of at least 2 cassettes. Two products 
(2.0kb and 3.5kb) were obtained from 1 strain, suggesting that this 
acinetobacter contains at least 2 integrons. 
No PCR products were obtained with the DNA from 12 acinetobacters which 
had hybridised to the int1 probe. Interestingly, of these 12 isolates, G26, G28, 
and G30, isolated in 1997, have the same resistance profile as G20 (also 
isolated in 1997). However, G20 did yield a PCR product. A number of 
reasons could account for this result. Firstly, the {solates may contain an I nO-
like integron. lnO lacks a variable region, and the 5'-conserved region is 
contiguous with the 3'-conserved region in this integron (Bissonnette and 
Roy, 1992). A second and more likely possibility is that the variable regions of 
these integrons contain a number of cassettes, resulting in variable regions 
too large to be amplified using the PCR assay described in this study. A final 
reason could be that the isolates contain only a portion of the integrase gene 
- hence the positive hybridisation signal with the int1 probe - but lack other 
conserved integron-related sequences (see Chapter 6). 
In a recent study of the molecular epidemiology of aminoglycoside resistance 
in Acinetobacter, Seward et a/. ( 1998) used the 5' -CS primer in combination 
with various other primers specific for aminoglycoside resistance genes 
(including aac(6')-la, aac(6')-lb, aac(3)-la, aac(3)-lla, ant(3' ')-Ia, ant(3")-lb, 
and ant(2")-la), in a PCR analysis to determine the association of these 
resistance genes with class 1-type integrons. They found that 6 of the 24 
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(25%) Acinetobacter isolates carried an integron-associated aac(3)-la and 3 
of these isolates also carried an integron-associated ant(3")-la. No integron-
associated products were detected using the ~;>'-CS primer with any of the 
other primers (specific for aac(6')-la, aac(6')-lb, aac(3)-lla, ant(3")-lb, and 
ant(2")-la). 
Class 2-or Tn 7-type integrons have been described in Acinetobacter strains 
from Chile (Amyes and Young, 1996). The investigators studied the genetic 
basis of high level trimethoprim resistance of 30 isolates. Initial hybridisation 
studies on total cellular DNA from 13 isolates, using a probe for dfrla 
(encoding a dihydrofolate reductase which mediates resistance to 
trimethoprim), indicated the presence of this gene in each isolate. 
Subsequent hybridisation experiments using probes for int2 and the 
transposition gene (tnsE) from Tn 7 suggested that dfr was part of a Tn 7-like 
transposon in these isolates. To confirm the genetic surroundings of the dfrla 
and to extend the analysis to the remaining strains, all 30 isolates were 
subjected to PCR using primers directed at the N-terminal sequences of dfr/a 
and the Tn7 int. Twenty-seven (90%) of the isolates yielded the expected 
700bp product indicative of a dfrla in a classic Tn7 integron structure 
(Sundstrom eta/., 1991). A second PCR product of about 2.5kb was found in 
11 of the isolates (usually in conjunction with the smaller 700bp product but 
on 4 occasions the 2.5kb amplicon was the sole product), but it was not 
consistently obtained. Subcloning and partial sequence analysis of the -2.5kb 
product revealed the presence of 3 gene cassettes inserted between the 
integrase gene and the dfrla -sat, ant(2")-la, and cat gene cassettes 
(encoding streptothricin resistance, aminoglycoside resistance, and 
chloramphenicol resistance, respectively). Interestingly, although previous 
investigators have observed that the Tn7-related integrase gene (int2) is 
interrupted by a termination codon and is thus non-functional, the results 
described here suggest the presence of a Tn7-related integron which is active 
in the integration of resistance gene cassettes. Another feasible explanation 
for these observations is that the strains may contain a Tn21 (lnt1) integrase 
which was responsible for the recombination of cassettes into the Tn 7-like 
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structure - Tn21 integrase has been shown to function in trans to effect such 
insertions and deletions. However, no signal was obtained with the DNA from 
the isolates when they were hybridised with probes specific for Tn21 
integrase and the authors concluded that the integrase of the transposon 
described in their study may be active. This assumption may be incorrect. 
Segal and Elisha (1997) described an ant(2")-la gene cassette recombined 
at a secondary site in a plasmid (pRAY) isolated from Acinetobacter strain 
SUN. They suggest that the gene cassette might have been inserted into 
pRAY by integrase encoded by an integron on a plasmid, resident long 
enough for such events to occur, before being lost from strain SUN. 
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CHAPTER 4: CHARACTERIZATION OF THE 0. 7kb AMPLICONS 
4.A. INTRODUCTION 
Using primers for the amplfication of the variable region of type 1 integrons, a 
PCR product of 0. ?kb was obtained from the DNA of 22 isolates. As a first 
step to the characterisation of these products, one of the 0. ?kb am pi icons 
obtained from an A.baumannii strain, designated CAR, was cloned and 
sequenced. 
4.8. MATERIALS AND METHODS 
4.8.1. Bacterial isolates and plasmids 
E. coli LKIII (lacr, /acZL1M15, lacY) (Zabeau and Stanley, 1982) and E. coli 
DH5a. were used as recipients in transformation experiments, while pUC19 
(Norrander eta/., 1983) was used as a vector. 
4.8.2. Isolation of plasmid DNA 
4.8.2.a. Small-scale extraction 
Plasmid DNA was extracted from putative E. coli DH5a. transformants using a 
protocol based on those of lsh-Horwicz and Burke (1981) and Sam brook et 
a/. (1989). Six to eighteen white colonies were inoculated, separately, into 5ml 
of 2X YT broth containing 501-!g/ml of ampicillin (Ranbaxy; South Africa) and 
grown, with vigorous shaking, at 37°C overnight. One and a half millilitres of 
each culture was decanted into microfuge tubes and the cells were harvested 
at 14000rpm for 5 minutes in a microfuge (Eppendorf Centrifuge 5415C). Cell 
pellets were resuspended in 0.2ml of Solution I (25mM Tris-HCI pH 8.0, 
50mM EDTA, 1%w/v Glucose; Appendix A). The glucose in Solution I 
weakens the cell walls and the EDTA chelates Mg2+ ions making them 
unavailable to degradative enzymes (Ausubel eta/., 1987). After 
resuspension, 0.4ml of Solution II (0.2N NaOH, 1% w/v SDS; Appendix A) 
was added, the tubes shaken to ensure thorough mixing, and held on ice for 
5 minutes. This is a denaturation step: the SDS denatures bacterial proteins 
causing the cells to lyse and release their contents, while the NaOH 
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denatures both chromosomal and plasmid DNA (Ausubel eta/., 1987). Pre-
cooled Solution Ill (5M potassium acetate, 3M glacial acetic acid; Appendix A) 
-0.3ml- was added and the tubes were kept on ice for ~1 0 minutes. This step 
neutralises the preparation and selectively renatures the plasmid DNA. The 
chromosomal DNA, bacterial proteins, and SDS are complexed with the 
potassium and precipitate (Ausubel eta/., 1987). The precipitates were 
pelleted by centrifugation in a microfuge (Eppendorf Centrifuge 5415C) at 
14000rpm for 10 minutes and the plasmid DNA in the recovered supernatants 
was purified further by phenol-chloroform-isoamylalcohol precipitation [section 
2 .. B.5.b] and then concentrated by precipitation with 100% ethanol, washed in 
70% ethanol, dried at 37°C for 10-15 minutes, and resuspended in 50f.ll TE 
buffer (Appendix A). 
4.8.2.b. Large-scale extraction 
A large-scale extraction of plasmid DNA was performed on certain of the 
E. coli transformants using a method based on those described by lsh-
Horwicz and Burke (1981) and Sambrook eta/. (1989). A single colony was 
inoculated into 200m I of 2X YT broth containing 20f.lg/ml of trimethoprim 
(Roche; Mannheim, Germany) and allowed to grow at 37°C for ±18 hours. 
The cells were then harvested by centrifugation (5000rpm) at 4°C in a 
Beckman Model J2-21 Centrifuge for 5 minutes. Plasmid DNA was extracted 
using the same procedure and reagents as the small-scale plasmid extraction 
in section 4.B.2.a., except that the volumes of the reagents were increased 
proportionally. After lysis, cell debris and chromosomal DNA was removed by 
centrifugation at 1 OOOOrpm in a Beckman Centrifuge for 1 0 minutes and the 
clear lysate was recovered to a fresh tube. Plasmid DNA was precipitated by 
adding 0.6 volumes of isopropanol, incubating at RT for 10 minutes, and 
centrifugation at 1 OOOOrpm as described. After discarding the supernatant, 
the plasmid DNA pellet was washed in 70% ethanol, drained thoroughly, 
allowed to air dry, and resuspended in 7.5ml of TE buffer. 
Plasmid DNA was further purified by CsCI-EtBr gradient centrifugation 
(Sambrook et al., 1989). This method depends on differences between the 
amounts of EtBr that can be bound to linear and closed circular DNA. EtBr 
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unwinds DNA helices by intercalating between the bases (1 EtBr molecule for 
every 2 base pairs) (Cantor and Schimmel, 1980). Unwinding leads to an 
increase in the length of linear DNA molecules and to the introduction of 
compensatory superhelical turns in closed circular plasmid DNA. The density 
of the superhelical turns eventually becomes so great that further intercalation 
of EtBr molecules is not possible. Linear molecules, however, bind dye until 
saturation is reached. Due to this differential binding of dye, the buoyant 
densities of the linear and closed circular DNA molecules are different and 
they can be separated in CsCI gradients containing saturating amounts of 
EtBr. 
In the protocol used (Sambrook et al., 1989), 8.3g of CsCI was dissolved in 
the 7.5ml DNA solution. A volume (0.8ml) of 10mg/ml EtBrwas added, the 
solution was mixed and centrifuged at 1 OOOOrpm as before. The supernatant 
was recovered and the refractive index was adjusted to 1.390 using a 
refractometer (ABBE; London, UK). Two Vti65 tubes (13X51 mm) were filled 
with the solution, the tubes were sealed and centrifuged at 60000rpm at 20°C 
for ?hours in a Beckman L-70 Ultracentrifuge. 
With visualisation under UV (310nm), 1 major plasmid band and a minor band 
(residual chromosomal DNA) was seen. The tops of the sealed tubes were 
cut off, the bottom of the tube was pierced with a needle, and the flow of the 
tube contents was controlled with a finger. The excess solution below the 
plasmid band was allowed to drip out and the plasmid was collected in a 2ml 
microfuge tube. The remaining solution was discarded. The EtBr was 
removed by extracting (3X) with salt-saturated isopropanol (Appendix A)- the 
isopropanol containing the EtBr was discarded after each extraction. Two 
volumes of dH20 were added and the solution was mixed. A volume of 
isopropanol, equivalent to the new total volume, was added, mixed, the 
solution incubated at RT for 10 minutes, and centrif~ged for 15 minutes in a 
microfuge (Eppendorf Centrifuge 5415C) at 14000rpm. The DNA pellet was 
washed in 70% ethanol, allowed to dry at 37°C, and resuspended in a 
suitable volume of TE buffer. The concentration of the DNA was determined 
by fluorescent quantitation (section 2.B.4). 
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4.8.3. DNA-DNA hybridisation studies 
4.8.3.a. Preparation of probe 
An internal 300bp EcoRV fragment of the dfrV/1 gene (Fig. 4.1.) was used as 
a specific probe. After restriction enzyme digestion, the 300bp EcoRV 
fragment was purified [section 2.B.5.b.] and labelled [section 2.B.5.c.]. 
EcoRV 
TTGAAAATTT CATTGATTTC TGCAACGTCA GAAAATGGCG TAATCGGTAA TGGCCCTGAT~ 6o 
ATCCCATGGT CAGCAAAAGG TGAGCAGTTA CTCTTTAAAG CGCTCACATA TAATCAGTGG 12o 
CTCCTTGTTG GAAGGAAAAC ATTTGACTCT ATGGGTGTTC TTCCAAATCG AAAATATGCA 1ao 
GTAGTGTCGA GGAAAGGAAT TTCAAGCTCA AATGAAAATG TATTAGTCTT TCCTTCAATA 240 
GAAATCGCTT TGCAAGAACT ATCGAAAATT ACAGATCATT TATATGTCTC TGGTGGCGGT 3oo 
CAAATCTACA ATAGTCTTAT TGAAAAAGCA GATATAATTC ATTTGTCTAC TGTTCACGTT 360 
EcoRV 
GAGGTTGAAG GTGAT~ATCAA TTTTCCTAAA ATTCCAGAGA ATTTCAATTT GGTTTTTGAG 420 
CAGTTTTTTT TGTCTAATAT AAATTACACA TATCAGATTT GGAAAAAAGG CTAAC 475 
Fig.4.1.: DNA sequence of the dfrV/1 gene showing the internal300bp EcoRV probe 
fragment (blocked off) 
(Towner and Carter, 1990) 
4.8.3.b. DNA transfer 
DNA was transferred from agarose gels to Hybond TM -N+ membranes, using a 
mono-directional transfer based on the method of Smith and Summers 
(1980). Before the transfer was performed, the gel was soaked twice in 2-3 
gel volumes of 0.25M HCI (Appendix A) for 15 minutes at RT. This partially 
hydrolyses the DNA by acid depurination and causes double-stranded 
breaks, allowing larger fragments of DNA to transfer more efficiently. The gel 
was then soaked twice in 2-3 gel volumes of 1.5M NaCI, 0.5M NaOH 
(Appendix A) at RT for 15 minutes to denature the DNA. Finally, it was 
neutralised by soaking it once in 2-3 gel volumes of 0.5M Tris pH 7.2, 1.5M 
NaCI, 1mM EDTA (Appendix A) at RT for 30 minutes. Between each step and 
after neutralisation the gel was rinsed with water. 
On completion of the pre-transfer treatment, DNA was transferred from the 
gel to a membrane. The gel was placed face down on a piece of glass on a 
flat surface. A piece of Hybond TM -N+ membrane was cut to size and layered 
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carefully onto the gel, ensuring that no air bubbles were trapped beneath it. 
Three pieces of Whatmans No. 1 filter paper were soaked in the 
neutralisation solution and layered on the HybondTM_N+. About 50mm of dry 
paper towel was placed on filter paper, followed by a piece of perspex and a 
brick to compress the sandwich. Transfer was allowed to continue for 4.5 
hours. The different materials were removed and the Hybond TM -N+ membrane 
was peeled off. After the DNA had been fixed to the membrane by UV cross-
linking at 254nm in a UV Cross-linker (Hoefer Scientific Instruments; 
California, USA) for 30 seconds, it was hybridised to the dfrV/1 probe [section 
4.B.3.a]. 
DNA-DNA hybridisations, post-hybridisation washes and signal detection 
were performed as described in section 2.B.5.c. 
4.8.4. Cloning experiments 
4.8.4.a. Amplification product 
The amplification product was cloned using the DNA blunting kit from 
Amersham International (Buckinghamshire, UK) following the protocol 
supplied by the manufacturer. 
Preparation of pUC19 vector 
For cloning the amplication product, pUC19 vector DNA was digested with 
Smal (CCC-1.-GGG), which cleaves the plasmid within the multiple cloning site 
(Appendix C) to generate a linear plasmid with blunt ends. Two micrograms of 
pUC19 DNA were digested with 20U of Smal (Boehringer Mannheim; 
Mannheim, Germany) in 1X buffer A (Boehringer Mannheim; Mannheim, 
Germany) in a total volume of 20).!1 (adjusted with dH20) at 25°C for 1 hour. 
The linearized plasmid DNA was purified and precipitated as in section 
2.B.5.b. The DNA was resuspended in 20).!1 of dH20 to give a final 
concentration of 1 OOng/ul. 
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Preparation of insert 
The amplification product was purified by electrophoresis on a 1% agarose 
gel at 80V for ±1 hour, excised and extracted with phenol [section 2.B.5.b] 
and the DNA was quantitated [section 2.8.4.]. 
Taq DNA polymerase has template-independent terminal transferase activity 
which adds dATP residues to the 3' -ends of amplification products (Haqqi, 
1992). For this reason, it was necessary to remove the dATP residues 
(blunting) from the amplicon before it could be cloned into pUC19 digested 
with Smal. The blunting reaction was performed using a DNA blunting kit 
(Amersham International; Buckinghamshire, UK) following the protocol 
supplied by the manufacturer. Eight microlitres of the purified product (500-
SOOng) was mixed with 1J.LI of the 1 OX blunting buffer and incubated at 70°C 
for 5 minutes. Thereafter 1J.LI of T4 DNA polymerase was added. T4 DNA 
polymerase has 5'-3' polymerase activity (blunts the DNA by adding 
complimentary bases to an overhang) and 3'-5' exonuclease activity (blunts 
the DNA by removing the overhang). For blunting the amplification product 
the exonuclease activity was utilised. The reaction was mixed by gentle 
· pipetting, incubated at 37°C for 5 minutes, vortexed to deactivate the 
polymerase, and placed on ice for immediate use in the ligation reaction. 
4.8.4.b. Enriched cloning 
Preparation of pUC19 vector 
pUC19 vector DNA was prepared as in section 4.8.4.a., except that 20U of 
BamHI and 20U of Hindi II were used for the restriction endonuclease 
digestion. Both these endonucleases cleave within the multiple cloning site 
(Appendix C) and generate a linear plasmid with 5'-overhangs ("sticky" ends). 
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Identification and preparation of insert for enriched cloning 
Approximately 1 01-1g of genomic DNA [section 2.8.4] was digested with either 
BamHI + EcoRI, BamHI + Hindlll, BamHI + Sphl, EcoRI + Hindlll, EcoRI + 
Xbal, or Hindlll + Xbal (all Boehringer Mannheim; Mannheim, Germany) and 
electrophoresed on a 1% agarose gel at 60V for 4 hours [section 2.8.3.]. The 
DNA was then transferred to a Hybond-N+ membrane as described [section 
4.8.3.b.] and hybridised with the dfrV/1 probe [section 2.8.5.c.]. 
4.8.5. Ligations 
Ligation involves the formation of new bonds between phosphate residues 
located at the 5'-termini of double-stranded DNA and adjacent 3'-hydroxyl 
moieties (Sambrook et al., 1989). 
The blunted amplification product was ligated to Smal-digested pUC 19 using 
a DNA blunting kit (Amersham International; Buckinghamshire, UK). The 
protocol supplied with the kit was followed: 500-800ng of the blunted 
amplification product was mixed with 1 DOng of Smal-digested pUC 19 in a 
microfuge tube. Ligation solution A (4X volumes), which is the reaction buffer, 
and an equal volume of ligation solution B, containing T4 DNA ligase, which 
catalyses ligation (Sgaramella and Ehrlich, 1978) were added and mixed 
gently but thoroughly. The ligation reaction was allowed to continue at 16°C 
overnight. 
The restriction fragments identified for enriched cloning [section 4.8.4.b.] 
were ligated to appropriately digested pUC19 using a DNA ligation kit from 
Amersham International (Buckinghamshire, UK). The manufacturers's 
protocol was followed and was similar to the ligation reaction for the DNA 
blunting kit. The ligation was allowed to proceed at 16°C for about 4 hours. 
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4.8.6. Transformation studies 
4.8.6.a. Preparation of competent E.coli cells 
In 1970, Mandel and Higa showed that bacteria treated with ice-cold solutions 
of CaCI2 and then heated briefly could be transfected with bacteriophage 'A 
DNA. Most current methods of bacterial transformation are based on these 
observations. The treatment induces a transient state of "competence" in the 
recipient bacteria during which they can take up DNA from various sources 
(Mandel and Higa, 1970; Sambrook et al., 1989). 
E. coli DH5a cells were made competent by a CaCI2-shock procedure based 
on the method described by Dagert and Ehrlich (1979). A single colony of the 
bacterium was inoculated into 5ml of 2X YT broth (Appendix A) and grown at 
37°C overnight with shaking. This starter culture was diluted 1/100 in 1 OOml of 
2X YT broth and cultured to early logarithmic phase, corresponding to an 
optical density (OD) of ±0.3. The cells were harvested by centrifugation in a 
Beckman Model J2-21 Centrifuge for 5 minutes at 4°C and were kept at 4°C 
during all subsequent procedures. Cells were resuspended in 50ml of ice-cold 
0.1 M CaCI2 (Appendix A) and kept on ice for 1 hour. They were harvested as 
before and resuspended in 1Om I of ice-cold 0.1 M CaCI2, thereby inducing the 
transient state of competence. Ice-cold, sterile glycerol was added to the cells 
to a final concentration of 10% (v/v), mixed and held on ice for 30 minutes. 
Aliquots of the competent cells were stored at -70°C until required in 
transformation experiments. 
4.8.6.b. Transformation studies and screening for putative 
recombinants 
Transformation studies were carried out using a modification of the protocols 
of Cohen eta/. (1972) and Dagert and Ehrlich (1979). Twenty microlitres of 
the ligation mix [section 4.8.5.] was added to 1 OOJ.LI of competent E. coli DH5a 
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cells and kept on ice for ~30 minutes to enable the DNA to bind to the cell 
surface. To facilitate the uptake of DNA by the bacterial cells (ie. 
transformation) the transformation mix was heat-shocked at 42°C for 90 
seconds. To allow for the expression of the resistance markers carried by the 
vectors and/or the insert (ampicillin resistance In pUC19, Appendix C), 0.9ml 
2X YT was added to the transformed cells and they were incubated at 37°C 
for 1 hour. The transformations were plated onto appropriate selective media 
and incubated at 37°C overnight. 
When selecting for recombinants containing the amplification product, 200fll 
of the transformation mix was plated on 2X YT agar (Appendix A) containing 
50flg/ml of ampicillin (Ranbaxy; South Africa), 1 OOflg/ml of IPTG (Appendix 
A), and 200flg/ml of X-gal (Appendix A). Ampicillin was added to ensure the 
growth of only those bacteria that had been transformed with pUC19. X-gal 
was included as a colour indicator of ~-galactosidase (~-gal) activity, which is 
induced by IPTG. pUC vectors carry the amino-terminal (a-peptide) of ~-gal. 
When this plasmid is introduced into bacteria containing the carboxy-terminal 
(eg. DH5a), the two portions can associate (a-complementation) to form an 
active enzyme. X-gal is hydrolysed by ~-gal and releases a blue, non-
diffusable dye, giving rise to blue colonies on media containing X-gal. On the 
other hand, if the sequence encoding the a-peptide is interrupted by cloning 
into the multiple cloning site (MCS, Appendix C), a-complementation cannot 
occur and colonies grown on similar media will be white. Thus, putative 
recombinants will appear as white colonies on media containing X-gal, IPTG 
and ampicillin. 
Positive selection was used to isolate transformants resulting from the· 
enriched cloning experiment by plating the transformation mixes on media 
containing trimethoprim (30flg/ml). 
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4.8.6.c. Ligation and transformation controls 
. ; ~ 
Controls were included in all ligation and transformation experiments. They 
are summarised in Table 4.1. 
Table.4.1.: Ligation and transformation controls 
CONTROL 
Ligation 
pUC19 
digestion 
Transformation 
efficiency of 
competent cells 
Contamination 
Of competent 
Cells 
RATIONALE 
To determine whether ligase was 
functioning, pUC19 was digested 
with Smai and religated 
Linear DNA is not taken up by 
E.coli, so linearised vector was 
used to determine if pUC19 had 
been digested completely 
Determined by transforming the 
competent cells with circular, 
undigested pUC19 
To ensure that the competent 
cells are not contaminated with 
pUC19, heat-shocked cells were 
plated onto selective media 
without transforming them. 
4.8.7. DNA Sequencing 
4.8.7.a. DNA sequencing protocol 
EXPECTED RESULT 
Numerous blue colonies 
are expected if ligase 
is functioning 
zero blue colonies 
indicate complete 
digestion; a few = 
near-complete 
digestion; numerous 
indicate very 
Little or no digestion 
Numerous blue colonies 
indicate a high efficiency 
of transformation 
zero colonies indicate that 
there is no contamination; 
any blue colonies indicate 
contamination with pUC19 
DNA sequencing data were generated by the dideoxy chain termination 
method (Sanger eta/., 1977) using either a T? Sequencing Kit (Pharmacia 
Biochemicals; Uppsala, Sweden), the SequiTherm EXCEL II DNA 
Sequencing Kit (Epicentre Technologies; Wisconsin, USA), or rapid 
automated flourescence in an automatic DNA sequencer (373A, Applied 
Biosystems; Perkin Elmer; California, USA). The latter was performed in the 
Department of Chemical Pathology, University of Cape Town. The dideoxy 
chain termination method of sequencing (Sanger, eta/., 1977) is illustrated in 
Fig. 4.2. 
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Template: 3' CATGGTCGACGA 5' 
5' GTACCAGCTGCT 3' 
Primer: 5' GT 3' 
Template denaturation 
Primer annealing 
DNA polymerase 
dATP*+ddATP 
dCTP 
dATP* 
dCTP 
dGTP+ddGTP 
dTTP 
dATP* 
dCTP+ddCTP 
dGTP dGTP 
dTTP 
l 
GTA 
GTACCA 
l 
A 
-
-
dTTP 
chain eloigation and tirmination 
GTACCAG 
GTACCAGCTG 
GTAC 
GTACC 
GTACCAGC 
GTACCAGCTGC 
Separate~by denaturint PAGE 
G c 
-
-
-
-
~r -
-
Sequence read: 
5' ACC AGC TGC T 3' 
dATP* 
dCTP * indicates 
35 S-label 
dGTP 
dTTP+ddTTP 
l 
GTACCAGCT 
GTACCAGCTGCT 
l 
T 
-
-
Fig. 4.2.: Schematic diagram 
of dideoxy chain termination 
sequencing. 
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The rationale behind the dideoxy chain termination method is as follows (Fig. 
4.2.): DNA polymerase incorporates dNTPs into growing DNA chains through 
phosphodiester bonds at the 3'-end of the chain. One of the dNTPs is 
labelled to produce a signal which is captured on autoradiographic film. The 
termination mixes contain dideoxynucleotides (ddNTPs) which differ from 
dNTPs in that they lack a 3'-hydroxyl group. Once they have been 
incorporated into the growing DNA chain the absence of the 3'-hydroxyl group 
prevents the formation of a further phosphodiester bond with the succeeding 
dNTP and chain elongation terminates. There is thus a termination 
corresponding to each base in the sequence and when the reactions are 
electrophoresed on a denaturing polyacrylamide gel, there will be a band 
corresponding to each termination. The sequence of the new strand can be 
"read" directly from an autoradiograph of the gel - it will be complementary to 
that of the template DNA. 
DNA sequencing using the T? Sequencing Kit (Pharmacia Biochemicals; 
Uppsala, Sweden) was performed according to the manufacturer's 
instructions: Approximately 2)lg of double-stranded DNA template [prepared 
in section 4.8.2.b] (in a total volume of 16)-LI) was denatured in 4)ll 2M NaOH 
(Appendix A) at RT for 10 minutes. Six microlitres 3M sodium acetate 
(Appendix A) was added to stop denaturation and prevent renaturation 
(Sambrook et al., 1989). The volume was made up to 40)-LI with dH20 and the 
single-stranded DNA was precipitated on dry ice for 15 minutes by the 
addition of 3 volumes of 100% ethanol. The DNA was collected by 
centrifugation at 14000rpm for 10 minutes in a microfuge (Eppendorf 
Centrifuge 5415C). The DNA pellet was washed in 70% ethanol, dried at 
37°C for 10-15 minutes, and resuspended in 1 O)ll of dH20. 
Two to ten picomoles of primer (2)ll) and 2)ll of annealing buffer were added 
to the denatured template. The microfuge tube was vortexed, centrifuged 
briefly, and incubated at 60°C for 10 minutes to allow the primer to anneal to 
the template. The tube was left at RT for ;?:1 0 minutes and centrifuged briefly 
to collect the contents at the bottom of the tube. 
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Three microlitres of labelling mix (containing dCTP, dGTP, and dTTP but not 
dATP), 11-11 of 35S-Iabelled dATP, and 21-11 ofT? DNA polymerase (diluted 1 in 
5 with the enzyme dilution buffer) were added to the tube containing the 
annealed primer and template. The components were mixed by gentle 
pipetting and the contents were collected at the bottom of the tube by brief 
centrifugation. The labelling and chain elongation was allowed to proceed at 
RT for 5 minutes. Thereafter, 4.51-11 of the labelling reaction was transferred to 
each of the four termination mixes (prewarmed to 37°C) containing 2.51-11 of 
the ddATP-mix, ddCTP-mix, ddGTP-mix, or ddTTP-mix. The components 
were mixed by gentle pipetting and the termination reactions were incubated 
at 37°C for 5 minutes. The reactions were stopped by the addition of 5!-LI of 
stop solution and the contents were collected at the bottom of the tubes by 
brief centrifugation. The reactions were stored at -20°C until required. Stop 
solution contains EDTA which chelates Mg2+ ions thereby inhibiting the 
polymerase enzyme. It also contains bromophenol blue which served as a 
tracking dye during electrophoresis. 
Alternatively, DNA sequencing was performed using the SequiTherm EXCEL 
II DNA Sequencing Kit (Epicentre Technologies; Wisconsin, USA), which is 
based on the same principal as the T? Sequencing Kit. Sequencing was 
carried out according to the manufacturer's protocol: the premix consisted of 
51-11 5X sequencing buffer, 11-11 prelabelling mix, 5-1 Opmoles primer, 51-LCi of [a-
35S]-dATP, 500-1 OOOng DNA template, 11-11 DNA polymerase and deionised 
water to a total volume of 171-11. The tube containing the premix was heated at 
95°C for 5-10 minutes to denature the template DNA The tube was then 
placed at RT and primer annealing and incorporation of the labelled 
nucleotide was allowed to continue for 20-30 minutes. Two microlitres of each 
termination mix (C, A, T, and G) were added to 4 appropriately labelled tubes. 
After annealing and labelling/chain elongation, 41-11 of the premix were added 
to each of the 4 tubes containing the termination mixes and termination 
reactions were carried out at 65°C for 2-5 minutes. The reactions were 
stopped with 31-11 stop/loading buffer. 
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4.8.7.b. Denaturing polyacrylamide gel electrophoresis 
Sequencing reactions were electrophoresed on denaturing polyacrylamide 
gels based on a method described by Sambrook eta/. (1989). 
The apparatus consisted of two glass plates of differing lengths (cleaned with 
detergent and 70% ethanol and dried with acetone), two spacers made of 
thin, flexible plastic, a strip of filter paper, clamps, a shark's tooth comb, and 
electrophoresis equipment. The apparatus was assembled as illustrated in 
Fig. 4.3. 
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Spacers 
\iII W Shark's tooth comb 
Wells where samples are loaded 
(C, A, T, G) 
Gel front 
Electrophoresis tanks 
Filter paper 
Fig. 4.3: Schematic diagram of sequencing apparatus 
(adapted from Sambrook, eta/., 1989) 
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Six percent polyacrylamide was prepared as follows (Appendix A): 50% 
acrylamide, 2.5% bis-acrylamide (6ml), 10X NNB (5ml), dH20 (21ml), and 
urea (24g) were mixed and dissolved. The polymerisation process was 
initiated by the addition of 200J.!I 20% ammonium persulphate (APS, Appendix 
A) and 40J.!I of TEMED. The polyacrylamide was immediately poured between 
the two glass plates (see Fig.4.3.) and allowed to polymerise completely. 
In preparation for loading and electrophoresis of samples, the gel was 
clamped to the electrophoresis apparatus (Fig.4.3.). 1x NNB buffer was 
added to the upper and lower tanks. The shark's tooth comb was removed 
and reinserted with the teeth just touching the gel surface to form the wells. In 
order to help maintain the denatured state of the DNA samples, the gel was 
prewarmed for approximately 30 minutes at 35-40W prior to electrophoresis 
of the samples. DNA in the sequencing reactions was denatured by heating at 
80°C for 2 minutes, during which time excess urea was washed out of the 
wells with 1XNNB using a syringe. The latter was carried out since excess 
urea masks the signal generated by 35S, causing the bands to become 
diffuse. Three to four microlitres of each reaction was loaded, in separate 
wells, in the sequence CATG, and electrophoresed at a constant power of 
40W. The length of time of electrophoresis was 2-4 hours and was monitored 
by tracking the rate of migration of the dye in the stop solution. When the 
gels were electrophoresed for 4hours, 1 OOml 3M sodium acetate was added 
to the bottom tank (to give a final concentration of 1M sodium acetate) after 
2hours. This was to create a buffer gradient to improve resolution of the larger 
DNA bands. 
After electrophoresis, the apparatus was dismantled and the plates were 
carefully separated. The gel was removed from the glass plate by placing a 
sheet of Whatman 3MM filter paper on top of it, applying gentle pressure over 
the surface to ensure the gel attached to the filter paper, and then carefully 
peeling the filter paper, holding the gel, from the plate. The gel was covered 
with cling film and dried for 1.5-2 hours under vacuum on a Slab Gel Drier 
(Model SE1160; Hoefer Scientific Instruments; California, USA). After drying, 
the cling film removed and the gel was exposed to X-ray film (Hyperfilm MP, 
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Amersham Life Science; Buckinghamshire, UK) for 16-24 hours at RT. The 
autoradiograph was then developed. 
4.8. 7 .c. Computer analysis of sequencing data 
The DNA sequences were analysed using the Basic Local Alignment Search 
Tool, BLAST, (Altschul eta/., 1997) and Genepro version 6.1 (Riverside 
Scientific). 
4.C. RESULTS 
4.C.1.Characterisation of the amplification product from strain CAR 
The 0. 7kb amplicon from strain CAR was sequenced directly using the 5' -CS 
primer. Of the 426bp of data generated, the first 68 nucleotides were identical 
to integron-related sequences (Fig. 4.4.A.). The remaining 358bp were 
identical to the dfrV/1 gene encoding dihydrofolate reductase type VII (Fig. 
4.4.B.). The amplicon was cloned into pUC19 and introduced into E.coli 
DH5a; the recombinant plasmid was designated pG5DR. 
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1 PCR product from strain CAR (bases 1-68) 
2 Integrase-related region (Bissonnette and Roy, 1992) 
2 TGTTATGACT GTTTTTTTGG GGTACAGTCT ATGCCTCGGG CATCCAAGCA GCAAGCGCGT 1080 
5 . -CS PRIMER 
1 GG AGCAGCAACG ATGTTACGCA GCAGGGCAGT 32 
** ********** ********** ********** 
2 TACGCCGTGG GTCGATGTTT GATGTTATGG AGCAGCAACG ATGTTACGCA GCAGGGCAGT 1140 
1 CGCCCTAAAA CAAAGTTAGC CATTACGGGG GTTGAA 68 
********** ********** ********** ****** 
2 CGCCCTAAAA CAAAGTTAGC CATTACGGGG GTTGAA 1158 
Fig.4.4.A.: Comparison of the integrase-related region of the PCR product from strain 
CAR with the corresponding region described for int1 (Bissonnette and Roy, 1992) 
The first 68 bases of the PCR product from strain CAR generated by direct sequencing with 
the s· -CS primer are compared to the corresponding region for int1 (Bissonnette and Roy, 
1992). Identical nucleotides are indicated with an asterisk (*). The s· -CS primer annealing site 
is indicated in bold and underlined. 
1 PCR product from strain CAR (bases 69 - 426) 
2 dfrVII from E. coli (Sundstrom et al., 1993) 
1 TTGAAAATTT CATTGATTTC TGCAACGTCA GAAAATGGCG TAATCGGTAA TGGCCCTGAT 60 
********** ********** ********** ********** ********** ********** 
2 TTGAAAATTT CATTGATTTC TGCAACGTCA GAAAATGGCG TAATCGGTAA TGGCCCTGAT 60 
~d.£r start 
1 ATCCCATGGT CAGCAAAAGG TGAGCAGTTA CTCTTTAAAG CGCTCACATA TAATCAGTGG 120 
********** ********** ********** ********** ********** ********** 
2 ATCCCATGGT CAGCAAAAGG TGAGCAGTTA CTCTTTAAAG CGCTCACATA TAATCAGTGG 120 
1 CTCCTTGTTG GAAGGAAAAC ATTTGACTCT ATGGGTGTTC TTCCAAATCG AAAATATGCA 180 
********** ********** ********** ********** ********** ********** 
2 CTCCTTGTTG GAAGGAAAAC ATTTGACTCT ATGGGTGTTC TTCCAAATCG AAAATATGCA 180 
1 GTAGTGTCGA GGAAAGGAAT TTCAAGCTCA AATGAAAATG TATTAGTCTT TCCTTCAATA 240 
********** ********** ********** ********** ********** ********** 
2 GTAGTGTCGA GGAAAGGAAT TTCAAGCTCA AATGAAAATG TATTAGTCTT TCCTTCAATA 240 
1 GAAATCGCTT TGCAAGAACT ATCGAAAATT ACAGATCATT TATATGTCTC TGGTGGCGGT 300 
********** ********** ********** ********** ********** ********** 
2 GAAATCGCTT TGCAAGAACT ATCGAAAATT ACAGATCATT TATATGTCTC TGGTGGCGGT 300 
1 CAAATCTACA ATAGTCTTAT TGAAAAAGCA GATATAATTC ATTTGTCTAC TGTTCACG 358 
********** ********** ********** ********** ********** ******** 
2 CAAATCTACA ATAGTCTTAT TGAAAAAGCA GATATAATTC ATTTGTCTAC TGTTCACGTT 360 
2 GAGGTTGAAG GTGATATCAA TTTTCCTAAA ATTCCAGAGA ATTTCAATTTG GTTTTTGAG 420 
2 CAGTTTTTTT TGTCTAATAT AAATTACACA TATCAGATTT GGAAAAAAGGCT AAC 475 
Fig.4.4.8. Comparison of the dfrV/1 region of the PCR product from A.baumannii strain 
CAR with the corresponding region of the published dfrV/1 gene (Sundstrom eta/., 
1993) 
The remaining 358bp of the PCR product from strain CAR generated by direct sequencing 
with the s· -CS primer are compared to the dfrV/1 gene described by Sundstrom et at. (1993). 
Identical nucleotides are indicated with an asterisk (*). The dfrV/1 start codon is shown in bold. 
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To further characterize the regions abutting dfrV/1, the structural gene and its 
flanking sequences were cloned. To identify the DNA fragment carrying dfrV/1, 
genomic DNA from strain CAR was digested with BamHI + EcoRI, BamHI + 
Hindi!!, BamHI + Sphl, EcoRI +Hindi!!, EcoRI + Xbal, or Hindi!!+ Xbal, 
electrophoresed, transferred to a Hybond™-N+ membrane, and hybridised 
with the dfrV/1 probe (Fig. 4.5.). A 2kb BamHI/Hindlll fragment, which 
hybridised to the probe, was cloned into pUC19 and expressed in E.coli. The 
recombinant plasmid was designated pDS100 and conferred resistance to 
trimethoprim. 
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A. 1 6 7 8 2 3 4 5 B. 
, 1 1 2 3 4 5 6 7 I 8 I 
Fig. 4.5. Identification of the DNA fragment from A.baumannii strain CAR carrying the dfrV/1 gene 
(A) Digests of genomic DNA from strain CAR. Lane 1, BamHI/EcoRI digest; lane 2, BamHI/Hindlll digest; lane 3, BamHI/Sphl digest; lane 4, 
EcoRI/Hindlll digest; lane 5, EcoRI/Xbal digest, lane 6, Hindiii/Xbal digest; lane 7, 1kb ladder (Appendix 8) , lane 8, undigested pGSDR plasmid 
DNA. Electrophoresis was on a 1% agarose gel at 60V for 4 hours. (B) Autoradiograph of the Southern blot of the DNA shown in (A) hybridised to 
the 300bp dfrV/1 probe. Autoradiography was overnight. The 2kb BamHI/Hindlll fragment is indicated with an arrow. 
Bant·U 
4.C.2. Nucleotide sequence analysis of dfrV/1 and its flanking sequence 
The DNA sequencing strategy is shown in Fig.4.6. The DNA sequence of the 
2kb insert is shown in fig.4.7. and was confirmed on both strands. 
Hind Ill 
---7~qacEtA --7 
100bp 
Fig. 4.6.: DNA sequencing strategy for the 2kb SamHI/Hindlll fragment carrying the 
dfrV/1 gene from A.baumannii strain CAR 
The arrows below the bar indicate the direction and extent of the sequenced regions. The 
location of the dfrVII, int1, and qacEM genes are indicated by arrows above the bar. 
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BamHI 
GGATCCATCAGGCAACGACGGGCTGCTGCCGGCCATCAGCGGACGCAGGGAGGACTTTCC 60 
GCAACCGGCCGTTCGATGCGGCACCGATGGCCTTCGCGCAGGGGTAGTGAATCCGCCAGG 120 
ATTGACTTGCGCTGCCCTACCTCTCACTAGTGAGGGGCGGCAGCGCATCAAGCGGTGAGC 180 
intl stop 
GCACTCCGGCACCGCCAACTTTCAGCACATGCGTGTAAATCATCGTCGTAGAGACGTCGG 240 
AATGGCCGAGCAGATCCTGCACGGTTCGAATGTCGTAACCGCTGCGGAGCAAGGCCGTCG 300 
CGAACGAGTGGCGGAGGGTGTGCGGTGTGGCGGGCTTCGTGATGCCTGCTTGTTCTACGG 360 
CACGTTTGAAGGCGCGCTGAAAGGTCTGGTCATACATGTGATGGCGACGCACGACACCGC 420 
TCCGTGGATCGGTCGAATGCGTGTGCTGCGCAAAAACCCAGAACCACGGCCAGGAATGCC 480 
CGGCGCGCGGATACTTCCGCTCAAGGGCGTCGGGAAGCGCAACGCCGCTGCGGCCCTCGG 540 
CCTGGTCCTTCAGCCACCATGCCCGTGCACGCGACAGCTGCTCGCGCAGGCTGGGTGCCA 600 
AGCTCTCGGGTAACATCAAGGCCCGATCCTTGGAGCCCTTGCCCTCCCGCACGATGATCG 660 
TGCCGTGATCGAAATCCAGATCCTTGACCCGCAGTTGCAAACCCTCACTGATCCGCATGC 720 
CCGTTCCATACAGAAGCTGGGCGAACAAACGATGCTCGCCTTCCAGAAAACCGAGGATGC 780 
GAACCACTTCATCCGGGGTCAGCACCACCGGCAAGCGCCGCGACGGCCGAGGTCTTCCGA 840 
TCTCCTGAAGCCAGGGCAGATCCGTGCACAGCACCTTGCCGTAGAAGAACAGCAAGGCCG 900 
CCAATGCCTGACGATGCGTGGAGACCGAAACCTTGCGCTCGTTCGCCAGCCAGGACAGAA 960 
ATGCCTCGACTTCGCTGCTGCCCAAGGTTGCCGGGTGACGCACACCGTGGAAACGGATGA 1020 
AGGCACGAACCCAGTGGACATAAGCCTGTTCGGTTCGTAAGCTGTAATGCAAGTAGCGTA lOBO 
-35 -10 
G 
TGCGCTCACGCAACTGGTCCAGAACCTTGACCGAACGCAACGGTGGTAACGGCGCAGTGG 1140 
CGGTTTTCATGGCTTGTTATGACTGTTTTTTTGTACAGTCTATGCCTCGGGCATCCAAGC 1200 
<c-intl start 
AGCAAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGC 1260 
AGCAGGGCAGTCGCCCTAAAACAAAGTTAGCCATTACGGGGGTTGAATTGAAAATTTCAT 1320 
attl --RBS----- ~K I S L 
d£rVII start 
TGATTTCTGCAACGTCAGAAAATGGCGTAATCGGTAATGGCCCTGATATCCCATGGTCAG 1380 
I S A T S E N G V I G N G P D I P W S A 
CAAAAGGTGAGCAGTTACTCTTTAAAGCGCTCACATATAATCAGTGGCTCCTTGTTGGAA 1440 
K G E Q L L F K A L T Y N Q W L L V G R 
GGAAAACATTTGACTCTATGGGTGTTCTTCCAAATCGAAAATATGCAGTAGTGTCGAGGA 1500 
K T F D S M G V L P N R K Y A V V S R K 
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AAGGAATTTCAAGCTCAAATGAAAATGTATTAGTCTTTCCTTCAATAGAAATCGCTTTGC 1560 
G I S S S N E N V L V F P S I E I A L Q 
AAGAACTATCGAAAATTACAGATCATTTATATGTCTCTGGTGGCGGTCAAATCTACAATA 1620 
E L S K I T D H L Y V S G G G Q I Y N S 
GTCTTATTGAAAAAGCAGATATAATTCATTTGTCTACTGTTCACGTTGAGGTTGAAGGTG 1680 
LIEKADLIHLSTVHVEVEGD 
ATATCAATTTTCCTAAAATTCCAGAGAATTTCAATTTGGTTTTTGAGCAGTTTTTTTTGT 1740 
I N F P K I P E N F N L V F E Q F F L S 
CTAATATAAATTACACATATCAGATTTGGAAAAAAGGCTAACAAGTCGTTCCAGCACCAG 1800 
N I N Y T Y Q I W K K G dfrVII stop 
TCGCTGCGCTCCTTGGACAGTTTTTTAAGTCGCGGTTTTATGGTTTTGCTGCGCAAAAGT 1860 
c 
ATTCCATAAAACCACAACTTAAAAACTGCCGCTGAACTCGGCGTTAGATTGCACTAAGCA 1920 
core site 
CATAATTGCTCACAGCCAAACTATCAGGTCAAGTCTGCTTTTATTATTTTTAAGCGTGCA 1980 
TAATAAGCCCTACACAAATTGGGAGATATATCATGAAAGGCTGGCTTTTTCTTGTTATCG 2040 
~ qacELll start 
Hindi II 
CAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGC 2100 
TT 2102 
Fig.4.7.: DNA sequence analysis of the 2kb BamHI/Hindlll fragment carrying the dfrV/1 
gene from A.baumannii strain CAR 
The BamHI and Hindlll sites at the ends of the insert are indicated in bold. Dots above the 
sequence correspond to every 10 nucleotides. The first 1307 bases of sequence are 99.9% 
homologous to the int1 gene (and its flanking regions) as described for Tn5086 (Sundstrom et 
a/., 1993). The G~A transition is indicated by a G above the sequence. The int1 start and 
stop codons, the recombination site, attl, and the ribosomal binding site (RBS) are indicated in 
bold. The -35 and -10 sites of the weak PANT promoter are underlined. Bases 1308 to 1781 
are identical to the dfrV/1 gene from Tn5086 (Sunstrom et a/., 1993). The start and stop 
codons are indicated in bold and the derived amino acid sequence is indicated below the 
nucleotide sequence. The 59-bpe associated with the dfrV/1 is identical to the one from 
Tn5086 except for the c~ T transition indicated in bold (Sunstrom eta/., 1993) - the core site 
of the 59-bpe is indicated in bold. The sequence of the qacE11 gene (start codon in bold) 
downstream of the dfrV/1 gene is identical to the published sequence (Sundstrom eta/., 1993). 
The arrows indicate the direction in which the genes are transcribed. Single letter 
abbreviations for the amino acid residues are as follows: C, Cys; D, Asp; E, Glu; F, Phe, G, 
Gly; I, lie, K, Lys; M, Met; P, Pro, R, Arg, S, Ser; T, Thr; and V, Val. 
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The pDS1 00 insert was 2102 nucleotides in length (fig.4.7.). The first 1307 
bases were 99.9% homologous to the int1 gene and the regions flanking the 
gene as described for Tn5086 (nucleotides 1 to 714; Sundstrom eta/., 1988; 
and nucleotides 1 to 593; Sundstrom eta/., 1993). A transition of G~A 
accounts for the difference in homology. This transition does not change the 
amino acid sequence but results in the preferred TTG for leucine in 
Acinetobacter (White et a/., 1991). The first 136 nucleotides are the region 
upstream of the int1 stop codon and the nucleotides from position 1151 to 
1307 (fig.4. 7) are downstream of the int1 start codon. The downstream region 
includes the integron-associated attl recombination site (position 1286 to 
1292; fig.4.7.) and the ribosomal binding site (position 1295 to 1303; fig.4.7.). 
The weak PANT promoter, TGGACA(-35)N17TAAGCT(-10) (Collis and Hall, 
1995) was identified at positions 1035-1040 and 1058-1063 (fig.4.7.). The 
promoter (P2) TTGTTA(-35)N17 TACAGT(-1 0), usually associated with PANT 
was not present (Collis and Hall, 1995). The pDS1 00 sequence lacks the 
three G-residues between nucleotides 1173 and 1174 (fig.4.7.), which alter 
the space between the hexamers of P2 to 17, creating an alternative 
promoter. In this respect, pDS1 00 resembles the Tn21-like integron on 
Tn5086 (Sundstrom eta/., 1993). 
The next 602 bases (position 1308 to 1909; fig.4.7.) are identical to dfrV/1 and 
its 59-be (nucleotides 594 to 1194; Sundstrom eta/., 1988). Following the 59-
be are 193 bases of sequence which are identical to the region upstream of 
the qacE11 gene (position 1910 to 2011; fig.4.7.) and to the first 90 bases of 
the qacEL11 gene itself (position 2012 to 2102; fig.4.7.) described by 
Sundstrom eta/. (1988; nucleotides 1194 to 1387). 
4.C.3. Characterisation of the remaining 0.7kb amplification products 
To determine whether any of the other 0.7 amplicons obtained from the 
acinetobacters are related to dfrV/1 sequences, hybridisation studies were 
performed using the dfrV/1 probe. Towner and Carter (1990), showed that the 
EcoRV fragment is specific for dfrtype VII genes. A signal was obtained from 
the amplicon obtained from strain CAR, but not with that from strain CW20, 
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indicating that the 0.7kb product from this strain is not dfrV/1-related. Seward 
and Towner have not identified the structural gene from the integron of strain 
CW20 (personal communication). All (22) of the 0. 7kb amplicons hybridised 
to the probe suggesting that, like strain CAR, these isolates contain a 
trimethoprim resistance gene. Fig.4.8. shows the ·result of the hybridisation. 
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1 2 3 4 5 6 7 8 9 1) 11 12 13 14 15 17 
A.1. 
A. Lane Sample 
1 lkb ladder 
2 Gl 
3 G2 
4 G3 
5 G4 
6 G5 
7 G6 
8 Gl2 
9 Gl5 
10 G20 
11 G21 
12 G37 
13 G39 
14 CW20 
15 MW VI 
16 DH5a 
17 dHzO 
A.2. 1 2 3 4 ,. 6 7 8 9 10 1112 13 141516 17 :> 
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Fig. 4.8.A.: PCR products obtained from the A.baumannii clinical isolates, using the 5'-
CS and 3'-CS primers, hybridised to the dfrV/1 probe. 
(A.1.) PCR products obtained from the GSH isolates. PCR was performed in 50J..tl volumes 
containing 5pmol of each primer, 2.25mM MgCI2, 0.2mM dNTPs, 1 U Taq DNA polymerase, 
1X polymerase buffer, and 500ng genomic DNA. The thermocycle profile consisted of 35 
cycles denaturation at 94°C for 1 min , annealing at 60°C for 1 min, and extension at 72°C for 
1 min. Products were electrophoresed on a 1% agarose gel at 80V for 1.5 hours. (A.2.) The 
autoradiograph of the blot of the PCR products shown in (A.1.) and (B.1.) hybridised to the 
dfrV/1 probe. Autoradiography was for 40min. The sizes of the bands of the molecular weight 
markers can be seen in Appendix B. 
Fig. 4.8.8: PCR products obtained from the A.baumannii clinical isolates, using the 5' -
CS and 3' -CS primers, hybridised to the dfrV/1 probe. 
(8.1.) PCR products obtained from the UH isolates. PCR was performed in 50J..tl volumes 
containing 5pmol of each primer, 2.25mM MgCI2, 0.2mM dNTPs, 1 U Taq DNA polymerase, 
1X polymerase buffer, and 500ng genomic DNA. The thermocycle profile consisted of 35 
cycles denaturation at 94°C for 1 min , annealing at 60°C for 1 min , and extension at 72°C for 
1 min. Products were electrophoresed on a 1% agarose gel at 80V for 1.5 hours. (8.2.) The 
autoradiograph of the blot of the PCR products shown in (A.1 .) and (B. 1.) hybrid ised to the 
dfrV/1 probe. Autoradiography was for 40min . The sizes of the bands of the molecular weight 
markers can be seen in Append ix B. 
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8.1. 
B. Lane Sample 
1 B1 
2 B2 
3 B3 
4 B4 
5 B6 
6 B8 
7 B9 
8 B10 
9 Bll 
10 B12 
11 B13 
12 B14 
13 MW VI 
14 1kb ladder 
15 DH5a 
16 dHzO 
8.2. 
1 2 3 4 5 6 7 8 9 10 11 12'C 1415 16 
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4.C.4. Location of the dfrV/1 gene 
~ 
To determine whether the integron dfrV/1 genes are located on plasm ids, 
plasmid DNA was extracted from the 22 clinical isolates and hybridised with 
the dfrV/1 probe. A signal was obtained from pDS100, the source of the 
probe, but no signal was obtained with the plasmid DNA from any of the 
isolates, suggesting that the integron-associated trimethoprim resistance 
gene is in the chromosomes of the clinical isolates (data not shown). 
4.0. DISCUSSION 
DNA sequencing of the 0.7kb amplicon from A.baumannii strain CAR showed 
that it contained an integron dfrV/1. The dfrV/1 gene encodes dihydrofolate 
reductase type VII which mediates resistance to trimethoprim. Hybridisation 
studies showed that all the 0. 7kb am pi icons obtained from the acinetobacters 
contained dhfrV/1 sequences, suggesting that 22/57 isolates carry integron-
associated trimethoprim resistance. 
Trimethoprim is structurally analogous to DHFR and acts as a competitive 
inhibitor of bacterial DHFR, preventing the formation of the essential cofactor, 
tetrahydrofolate. Dihydrofolate reductase (DHFR) is an enzyme which 
catalyses the reduction of dihydrofolate to tetrahydrofolate. Trimethoprim 
resistance in Gram negative bacteria is mediated by the synthesis of 
additional DHFR enzymes insusceptible to the antibiotic. The genes encoding 
these DHFRs are plasmid-mediated and have mutations which give rise to 
the resistance. Thus far, 16 different types of DHFRs have been described. 
Two major families, which encode high-level trimethoprim resistance, have 
been identified based on amino acid sequence identity. Family 1 consists of 
types Ia, lb, V, VI, and VII; while family 2 is made up of types lla, lib, and lie. 
The remainder -types lila, lllb, lllc, VIII, IX, X, and XII- have not been 
classified into either family because they have a much lower amino acid 
sequence identity, to each other and to the other types. 
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There are two reports of plasmid-mediated high-level trimethoprim resistance 
in Acinetobacter (Goldstein eta/., 1983; Chirnside eta/., 1985). The 
biochemical mechanism of resistance in the Acinetobacter described by 
Goldstein eta/. (1983) was not determined, but hybridisation studies showed 
that it was not a dfrla gene, nor was it Tn 7-related. In the other study 
(Chirnside eta/., 1985) the gene was not characterised at all. In France 
(Amyes and Young, 1996) and Chile (Amyes and Young, 1996) high-level 
trimethoprim resistance is common in Acinetobacter spp. responsible for 
nosocomial infections. 
The most widespread DHFR is type Ia (Steen and Skold, 1985). This is 
mainly attributed to its location on Tn 7. Tn 7 is able to insert into a wide range 
of different plasm ids at a low frequency and into a specific site on the 
chromosomes of a range of bacteria at a high frequency. Interestingly, in a 
survey of trimethoprim resistance in South African isolates of Gram-negative 
aerobic bacteria, Wylie and Koornhof (1989) showed a low prevalence of 
DHFR type Ia. A more recent study showed that 74.2% of Gram-negative, 
aerobic faecal flora, isolated from rural and urban populations in South Africa, 
was resistant to trimethoprim (Shanahan eta/., 1993). Further studies on 
those isolates showed that the resistance was carried on self-transmissible 
plasmids in 54.9% of the strains (Adrian eta/., 1995a). The majority of 
plasmids (30%) encoded type lb resistance and only 3% carried type VII. An 
investigation of. the non-transferable trimethoprim resistance showed the 
DHFR type VII was the most prevalent in this group (17.4%) (Adrian eta/., 
1995b). Furthermore, as described in our study, hybridisation experiments 
showed that the dfrV/1 genes have chromosomal loci, and similar studies 
demonstrated the presence of class 1-type integrase in these strains. The 
authors concluded that the dfrV/1 genes are probably located on integrons. 
Further analysis of the sequences flanking the dfrV/1 from strain CAR showed 
that the structural gene is part of a cassette bounded by an att1 site 
(GTTAGCC) and a 59 base element! attC site identical to that associated with 
dfrV/1 in Tn5086 (Sundstrom eta/., 1993). Analysis of the sequence upstream 
of the structural gene identified the weak PANT promoter, 
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TGGACA(-35)N17TAAGCT(-10) (Collis and Hall, 1995). However, the 
promoter (P2) TTGTTA(-35)N17TACAGT(-10), usually associated with PANT is 
not present (Collis and Hall, 1995). The sequence from strain CAR lacks the 
three G-residues between nucleotides 1173 and 1174 (fig.4.7.), which alter 
the space between the hexamers of P2 to 17, creating an alternative 
promoter. In this respect, the integron identified in this study is similar to 
Tn5086, a Tn21-like integron (Sundstrom eta/., 1993). This integron also 
contains a dfrV/1 cassette which is regulated by a weak PANT· 
A number of trimethoprim resistance determinants have been identified on 
gene cassettes associated with either Tn7- or Tn21-like integrons (Sundstrom 
and Skold, 1990). The genes encoding the enzymes in families 1 and 2, and 
dfrX/1, have been identified on gene cassettes (Sundstrom and Skold, 1990). 
That these genes are present on mobile elements has undoubtedly 
contributed to the spread of trimethoprim resistance. 
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CHAPTER 5: CHARACTERISATION OF THE 2K8 AMPLIFICATION 
PRODUCTS 
5.A. INTRODUCTION 
The DNA from two of the Acinetobacter isolates, strains G37 and G39, 
yielded amplification products of 2kb using the 5'- and 3' -CS primers 
[Chapter 3]. These amplicons were cloned and partially sequenced. 
5.8. MATERIALS AND METHODS 
5.8.1. Cloning experiments 
Amplification products were purified as described [section 4.8.4.a] and cloned 
using the pGEM®-T Easy Vector System (Promega; Madison, USA). An 
alternative to removing the gratuitous dATP residue (added to the ends of 
PCR products by the template-independent terminal transferase activity of 
Taq polymerase) is to clone the product into a "T-tailed" vector, such as 
pGEM®-T Easy. This vector is prepared by digesting pGEM®-SZf(+) 
(Promega; Madison, USA) with EcoRV and adding a 3'-dTTP residue to both 
ends (Appendix D). PCR products can thus be ligated directly onto the vector 
without blunting. The ligation was performed following the manufacturer's 
protocol: 1j..tl T4 DNA ligase buffer, SOng pGEM®-T Easy vector, 500-BOOng 
PCR product, and 3U T4 DNA ligase were mixed in a microfuge tube in total 
volume of 1 Oj..tl. The reaction was incubated at 4°C overnight. The ligation 
reactions were introduced into competent E. coli DHScx. cells as described 
[section 4.8.6.b]. Putative transformants were screened by blue-white colony 
selection [section 4.8.6.b]. Plasmid DNA was extracted from putative 
transformants [section 4.8.2.a], digested with EcoR1 (which cuts on either 
side of the cloning site; Appendix D), and electrophoresed on a 1% agarose 
gel [section 2.8.3.]. 
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5.8.2. DNA sequencing 
5.8.2.a. Template preparation 
DNA sequencing template was prepared using the High Pure Plasmid 
Isolation Kit (Boehringer Mannheim; Mannheim, Germany) following the 
manufacturer's protocol. The transformants were cultured in 5ml 2XYT 
containing 50)lg/ml of ampicillin (Ranbaxy; South Africa) at 37°C overnight. 
The cells (1.5ml) were harvested by centrifugation in a microfuge (Eppendorf 
Centrifuge 5415C) at 14000rpm for 5 minutes and lysed according to the 
alkaline method [section 4.8.2.a] while simultaneously removing RNA with 
RNAse A The cell pellet was resuspended in 250).!1 suspension buffer and 
lysed with 250)lllysis buffer for 5 minutes at RT. The lysate was neutralised 
with 350).!1 binding buffer on ice for 5 minutes. Chromosomal DNA and cellular 
debris were pelleted by centrifugation (Eppendorf Centrifuge 5415C) at 
14000rpm for 10 minutes. The clear lysate was pi petted into the High Pure 
filter tube and centrifuged (Eppendorf Centrifuge 5415C) for 1 minute at 
14000rpm. Plasmid DNA bound to the glass fibre fleece in the filter tube and 
the flow-through was discarded. Plasmid DNA was washed with 700).!1 wash 
buffer II by centrifugation as before and eluted with 1 OO)ll elution buffer. 
5.8.2.b. DNA sequencing 
DNA sequencing was performed using the SequiTherm EXCEL II DNA 
Sequencing Kit (Epicentre Technologies; Wisconsin, USA)[section 4.8.7.a]. 
The universal M13 forward and reverse primers were used. DNA sequencing 
data were analysed as before [section 4.8.7.c] and using CLUSTALX version 
1. 7 4 (Thompson et. a/., 1997). 
S.C. RESULTS 
5.C.1. A.baumannii strain G37 
The PCR product from strain G37 was cloned into pGEM®-T and the 
recombinant plasmid was designated pG37C. The nucleotide sequence 
obtained from the two primers is shown in fig 5.1. 
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A. 
GGCATCCAAG CAGCAAGCGC GTTACGCCGT GGGTCGATGT TTGATGTTAT GGAGCAGCAA 60 
5'-CS PRIMER 
CGATGTTACG CAGCAGCAAC GATGTTACGC AGCAGGGCAG TCGCCCTAAA ACAAAGTTAG 120 
A A A 
GCCGCATGGA CACAACGCAG GTCGCATTGA TACTCCAATT TCTAGCTGCG GCAGATGAGC 180 
~ ant (2' ') -Ia start 
GAAATCTGCC GTCTGGATCG GTGGGGGCTG GGCGATCGAT GCACGGCTAG GGCGTGTA 238 
B. 
AAGCAGACTT GACCTGATAG TTTGGCTGTG AGCAATTATG TGCTTAGTGC ATCTAACGCA 60 
3' -CS PRIMER inverse core 
TAGTTGAGCG GCGGGCGCAG CCTCCACTTC AACGCGGAGT TAGGCATCAA GTGCCTGGGC 120 
core 
GCCGGTCGAT GCACTTTCGC ACGTCGTGCT CAACGCAAGA TTCTCTAATC GTTGCTTTGG 180 
CATATCGAAC GAACGAACGC AGCCGGTCTC TTCGACGCGG CATTGCTAGG TCGTCGTCCT 240 
CGTACCAGGT ACGC 254 
Fig. 5.1.: DNA sequence analysis of the pG37C insert generated with the M13 
universal forward and reverse primers 
(A) Forward sequence. The sequence from position 1 to 115 were identical to sequences 
related to the 5'-conserved region of class 1-type integrons (Bissonnette and Roy, 1992), 
except for the overlapping direct repeat of bases 58 to 76 (underlined and in bold). The 5'-CS 
primer is indicated in bold. The remaining 123 bases had 97.6% homology to the 
corresponding portion of the ant(2 · ')-Ia described by Cameron eta/. ( 1986) and 98.4% 
homology to the ant(2'')-la described by Segal and Elisha (1997). The nucleotide changes are 
indicated above the sequence. The sequence from Cameron eta/. (1990) contains an A at 
positions 144, 154 and 159, while the sequence from Segal and Elisha (1997) contains an A 
at positions 154 and 159. The start codon of the ant(2' ')-Ia is shown in bold. 
(B) Reverse sequence. The first 53 bases were identical to sequences related to the 3'-
conserved region class 1-type integrons (Bissonnette and Roy, 1992).The 3'-CS primer is 
indicated in bold. Nucleotides 51 to 104 constitute a putative, atypical 59-be. The core and 
inverse core sites are underlined. The remaining 201 bases showed no significant homology 
to any sequences in the GenBank DNA database. 
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DNA sequencing using the universal M13 forward primer yielded 238 bp of 
data (fig 5.1.A.). The first 115 nucleotides were identical to sequences related 
to 5'-conserved region of class 1-type integrons (nucleotides 1190 to 1285; 
Bissonnette and Roy, 1992), except for an overlapping direct repeat of bases 
53-76 from position 72-95 (fig. 5.1.A.). The remaining 123 nucleotides have 
I 
97.6% homology to the published ant(2")-la sequence (nucleotides 1288 to 
1412; Cameron eta/., 1986), which includes the recombination/att/ site 
upstream (position 123 to 129) of the start codon. A transition from A~G at 
position 144 and transversions from A~ T at positions 154 and 159 result in 
the incorporation of alanine instead of threonine, leucine instead of histidine 
and phenylalanine instead of isoleucine, respectively. The A~G transition 
and the A~ T transversion at position 159 result in the preferred GCA for 
alanine and TTT for phenylalanine in Acinetobacter, respectively (White eta/., 
1991 ). The A~ T transversion at position 154 results in a CTC for leucine 
which is recognised in Acinetobacter (White eta/., 1991 ). Comparison of the 
123 bases with the ant(2")-/a sequence from another Acinetobacter 
(A.baumannii strain SUN) yielded an homology of 98.4% (nucleotides 638 to 
761; Segal and Elisha, 1997). This region also includes the upstream attl site. 
The A~ T transversions at positions 154 and 159 account for the difference in 
homology in this case. 
The universal reverse primer yielded 254 nucleotides (fig. 5.1.B.). The first 53 
bases were identical to integron-related sequences (nucleotides 1342 to 
1290; Bissonnette and Roy, 1992) from the 3'-conserved region of class 1-
type integrons and included the 3'-CS primer sequence. Although a putative 
59 base element! attC site is present (nucleotides 51 to 104; fig. 5.1.B.), a 
comparison of the remaining 201 bases with the sequences in the GenBank 
DNA and protein database yielded no significant homologies. Alignment of 
the putative 59 base element (59-be) from pG37C with the 59-bes from 40 
other gene cassettes and with the 59-be consensus shows that it has little 
homology to any of them (fig. 5.2.). The 59-be from strain G37 was most 
similar to the 59-be contiguous with an open reading frame, orfA (Recchia 
and Hall, 1995) and to the putative 59-be from pG39SC [section 5.C.2.]. 
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The 59-bes are the cassette-associated recombination sites [section 2.A.]. 
Although they are not highly conserved and vary in length, they are identified 
by their location (downstream of gene cassettes) and the relationship of over 
20 bp at their outer ends to consensus sequences that are imperfect inverted 
repeats of one another (Hallet a/., 1991; Collis and Hall, 1992b). The most 
conserved features are the ?bp core site at the right hand end of the element 
and the inverse core site at the left hand end (Hallet a/., 1991; Collis and 
Hall, 1992b). The core site has the consensus sequence GTTAGGC or 
GTTRRRY and the inverse core site has the consensus sequence GCCTAAC 
or RYYYAAC (Hall eta/., 1991; Collis and Hall, 1992b). Recombination 
occurs between the G and the first T of the 7bp core site (Hall eta/., 1991 ). 
The putative 59-be from pG37C has a core site homologous to the·consensus 
core. However, the inverse core site is not entirely complementary to the core. 
The imperfect inverted repeats at the ends of the element do not complement 
each other as well as those described for other 59-bes. The sequence is also 
shorter (54 bp) than previously identified 59-bes which range in size from 57 
to 141bp (Recchia and Hall, 1995). 
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lL --t ~ 2L 2R --t ~ lR 
consensus GYCTAACAATTCGNTCAAGCCGACSSCNM NNSSCGCCGCTTANCTCNGGCGTTAGCG 
or fA GCCTAACCGGTCGTTCGAGCGGACTGCCC 12 GGTCAGCCGCTCAACTTCAACGTTAGGC 
G37 ATCTAACGCAT-AGTTGAGCGGCGGGCGC 0 AGCCTCCACTTCAACGCGGA-GTTAGCG 
G39 ATCTAACGCTTGAGTTAAGCCGCGCCGGC 0 AACGTCCG-TTGAACGAATT-GTTAGAC 
cmlA GCCCAACAAATCGCTGCAGCCGACCCAAA 13 TTCGGTCGGCTGAGCTCAGGCGTTGGGC 
catB2 GCCTAACAATACGCTACACACGGACAAAT 16 AATTTGCCGGTGAGCGT-GGCGTTAGGC 
blarMP TTCTAACAAGTCGTTGCAGCACGCCACTA 71 AAACTGCCGCTGAACTT-AGCGTTAGAA 
qacE ATCTAACAAGTCGTTGCAGCACCGCTCCA 85 AAACTGCCGCTGAACTC-GGCGTTAGAT 
dfrA7 GGCTAACAAGTCGTTCCAGCACCAGTCGC 78 AAACCGCCGCTGAACTC-GGCGTTACGC 
dfrB1 GCCCAACTTGTCGCTCCAGCGGACGGC-- 3 -GCCGCCCGCTGAGCTAATTCGTTGGGC 
dfrB3 GCCCAACTGGTCGCTCCAGCGGACGGC-- 3 -GCCGCCCGCTGAGCTAGAGCGTTGGGC 
dfrB2 GCCTAACAATTCGCTCCAGCGGACGGC-- 3 -GCCGCCCGCTGAGCTTTATCGTTAGGC 
oxa7 GGCTAACAATTCGCTGCAGGCGCGACGGC 7 GGCCGCGGCCTGAGCTCAAACGTTAGCC 
aac (6') -IIb GCCTAACTTTTCGCTCCAACGGACGCTTG 40 CAACCGCCGCTGACCTCCGGAGTTAGGC 
orfD CTCTAACATTTCGGTCAAGCCGACCCGCA 3 TGCGGTCGGCTTACCTCGCCCGTTAGTA 
orfF TTCTAACATTTCGGTCAAGCCGACCCGCA 3 TGCGGTCGGCTTACCTCGCCCGTTAGCA 
orfE GTCTAACTCTGCGGTCAAGCGGACCCGCA 3 TGCGGGCCGCTTACCTTGGCCGTTAGTC 
aac(6')-Ia GCCTAACCCTTCCATCGAGGGGATGCCCA 15 TGTGCACCCCTCATGTCAAACGTTAGGC 
aac(6')-Ib GCCTAACCCTTCCATCGAGGGGGACGTCC 13 TTGGCCGCCCTCATGTCAAACGTTAGGC 
dfrA12 GGCTAACCATTCCGTCAACGGGACGCCAA 33 CCGGCTCTCGTTACGTCCAACGTTAGCC 
oxa2 GCCCAACCCGGCAGTCAACTCGGACGCTG 14 GCAGCGCCGGTTACTTC-AACGTTGGGC 
oxa3 GCCCAACCCGGCAGTCAACTCGGACGCAG 14 GACAGCCCGGTTACTTC-TACGTTGGGC 
oxal GCCCAACCCTTCAATCAAGTCGGGACGGC 33 TCGGCGCCCCTTATTTCAAACGTTGGGC 
oxa9 GCATAACCCTGCGCTCGAGCGGACCTCGC 12 GCGAGTCCGCTCACCTTGAACGTTATGC 
catB3 GTCTAACAATTCAATCAAGCCGATGCCGC 3 GCGGCACGGCTTATTTCAGGCGTTAGAC 
catB5 GTCTAACAATTCATTCAAGCCGACGCCGC 3 GCGGCACGGCTTAATTCTGGCGTTAGAC 
aac ( 6') -II a GCCTAACAACTCATTCAAGCCGACGCCGC 3 GCGGCGCGGCTTAATTCAGGCGTTAGGC 
sat GCCTAACAATTCATTCAAGCCGACACCGC 3 GCGGCGCGGCTTAATTCAGGAGTTAGGC 
ant (2") -Ia GCCTAACAATTCGTCCAAGCCGACGCCGC 3 GCGGCGCGGCTTAACTCAGGTGTTAGGC 
ant (3") -Ia GTCTAACAATTCGTTCAAGCCGACGCCGC 3 GCGGCGCGGCTTAACTCAAGCGTTAAAC 
ant(3' ')-Ib GTCTAACAATTCGTTCAAGCCGACGCCGC 3 GCGGCGCGGCTTACCTTGGCCGTTAAAC 
ant(3")-II GTCTAACAATTCGTTCAAGCCGACCGCGC 3 GCGCGGCGGCTTAACTCCGGCGTTAGAC 
ant ( 3' ' ) -VII GCCTAACAATTCGTTCAAGCCGAACTTGC 55 GCAAGTCGGCTTAACTCAGGCGTTAGGC 
aac(3)-Ia ACCTAACAATTCGTTCAAGCCGAGATCGG 52 GCGCTCCGGCTTAACTCAGGCGTTAGGT 
blaP1 GGCTAACAAGGCCATCAAGTTGACGGCTT 55 AAGCCGCAACTTATGGC-GGCGTTAGCC 
blaP2 GGCTAACAAGGCCATCAAGTTGACGGCTT 55 AAGCCGCAACTTATGGC-GGCGTTAGCC 
oxa10 GGCTAACAAGTCGCTCAAGGTCGCTCCCT 54 TGCCTGCCCCTTAGCTCCAACGTTAGCC 
oxa5 GGCTAACAAGGCGCTCAAGGCTCGGTTCG 50 TAGCCGCCCCTTAGCTT-TGCGTTAGCC 
dfrA5 GGTTAACAAAGCTATGCAATTGACGGTAA 31 TTACCGCAATTGATAAC-GGCGTTAACC 
dfrA14 GGTTAACAAAGCTATGCAATCGACGGCAA 30 TTTCCGCGATTGATAGC-GACGTTAACC 
orfC CCTTAACAAGTTTCGGCAAGGGACGCTCC 4 GTCGCGCCCCTGCTAAA-AGCGTTAAGG 
dfrA1 GGTTAACAAGTGGCAGCAACGGATTCGCA 39 TGCGATCCGCTGTGCCA-GGCGTTAACC 
lL --t ~ 2L 2R --t ~ lR 
consensus GYCTAACAATTCGNTCAAGCCGACSSCNM NNSSCGCCGCTTANCTCNGGCGTTAGCG 
Fig. 5.2. Alignment of 59 base elements. 
The sequences of the outer ends from 41 59-bp elements are aligned. Putative lnt1 binding domains at 
the LH (1 Land 2L) and RH (1 R and 2R) ends are indicated by arrows and are underlined. Numbers 
indicate the number of bases in the central region of each element. The 59-bp element from pG37C is 
second in the list. Adapted from Stokes eta/. (1997). Sources of the cassettes can be found in Recchia 
and Hall (1995). R, purine; Y, pyrimidine, M, A or C; S, .Cor G; N, A, C, G, T. · 
5.C.2. A.baumannii strain G39 
The 2kb amplicon from strain G39 was also cloned into pGEM®-T. The 
recombinant plasmid was designated pG39SC. The nucleotide sequence 
obtained from the two primers are shown in fig.5.3. 
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A. 
AAGCAGACTT GACCTGATAG TTTGGCTGTG AGCAATTATG TGCTTAGTGC ATCTAACGCT 60 
3'-cs PRIMER inverse core 
TGAGTTAAGC CGCGCCGCGA AGCGGCGTCG GCTTGAACGA ATTGTTAGAC ATTATTTGCC 120 
core ant(3'')-Ia stop 
GACTACCTTG GTGATCTCGC CTTTCACGTA GTGAACAAAT TCTTCCAACT GATCTGCGCG 180 
CGAGGCCAAG CGATCTTCTT CTTGTCCAAG ATAAGCCTGT CTAGCTTCAA GTATGACGGG 240 
CTGATACTGG GCCGGCAGGC GCTCCATTGC CCAGTCGG 278 
B. 
GAATTCACTA GTGATTAAAA CCGATATGAA CGTACGCACT TGCACTGAAT CTGACGTCGC 60 
inverted repeat ~ orfX start 
CTCTATCGCA GTCGTATTTA CTGAGTCTAT TCATGTACTT GGAGCGTCTC ACTATGAGGC 120 
TTCGCAAAGG AATGCGTGGG CACCGCGTCC CGCAGATATA GAGGCTTGGT CAGCTCGCTT 180 
ATCTGGCCTA CAGACTCTTC TAGCAATTGA GGGAGATGCG GTTATCGGGT TCATCTCTTA 240 
CGAGCTTAGC GGCCACATCG AGTTTCTTTA CAC 273 
Fig. 5.3.: DNA sequence analysis of the pG39SC insert generated with the M13 
universal forward and reverse primers 
(A) Forward sequence. The sequence from position 1 to 53 was identical to 3'-conserved 
region of class 1-type integrons (Bissonnette and Roy, 1992). The 3' -CS primer is indicated in 
bold. Nucleotides 51 to 105 constitute a putative, atypical 59-be. The core and inverse core 
sites are underlined. The remaining 147 nucleotides (105 to 252) are identical to the 3'-end of 
the ant(3")-/a described by Hollingshead and Vapnek (1985), including the first base after the 
stop codon. The stop codon is indicated in bold. 
(B) Reverse sequence. The first 16 bases of the sequence contained a 14bp inverted repeat 
(underlined). The 5'-CS primer was absent and there was no sequence homologous to the 5'-
conserved region of class 1-type integrons as expected. Adjacent to this region (position 17 to 
273) was a portion of a putative gene cassette, orfX, including the 9 bases upstream of the 
cassette start site. The orfX start codon is indicated in bold. 
DNA sequencing using the universal forward primer yielded 252 bp of data 
(fig 5.3.A). In this case, it was the first 53 nucleotides of the forward sequence 
which were identical to sequences from the 3'-conserved region (nucleotides 
1342 to 1290; Bissonnette and Roy, 1992) of class 1-type integrons; including 
the 3'-CS primer sequence. Nucleotides 51 to 105 (fig. 5.3.A.) constitute a 
putative 59-be. The remaining 14 7 nucleotides (position 106 to 252) are 
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identical to the last 147 bases of the published ant(3")-la (nucleotides 1022 
to 1191; Hollingshead and Vapnek; 1985), including the first base after the 
stop codon. 
The putative 59-be is not homologous to the 59-bes previously described for 
the ant(3")-Ja (fig 5.2.). It was most homologous to the putative 59-be from 
pG37C [section 5.C.1]. It too has the core site, and an inverse core site which 
is not entirely complementary to the core. The imperfect IRs at the ends are 
also less complementary than those described for other 59-bes. It is 57 bases 
long. 
The 273bp of data (fig.5.3.B) generated with the universal reverse primer did 
not contain the 5'-CS primer nor any portion homologous to the 5'-conserved 
region of class 1-type integrons. The first 16 nucleotides of sequence 
contained, instead, an inverted repeat sequence, TCACTAGTGA (bases 5 to 
14). This region was adjacent to sequence identical to a portion of a putative 
gene cassette, orfX, including the nine bases upstream of the cassette start 
codon (nucleotides 1504 to 1760; Tosini eta/., 1998). Like the orfXfrom 
pG39SC, the original orfX was upstream of an ant(3' ')-Ia gene cassette. The 
original gene, however, was third in array of 4 cassettes, the first two being 
aac(6')-lb and aac(3)-Ja. 
5.0. DISCUSSION 
The hybridisation studies and PCR experiments [Chapter 2 and 3, 
respectively], together with the DNA sequencing data in this chapter, suggest 
that A.baumannii strain G37 carries an ant(2")-la gene cassette and a 
putative cassette in the variable region of a class 1-type integron. The 
ant(2")-la was most similar to the ant(2")-la from another Acinetobacter 
(strain SUN). Based on the results of this study it is not possible to make any 
conclusions as to the probable function, if any, of the putative cassette. 
The sequenced portion of the 5'-conserved region of this integron is unlike 
the corresponding region in other class 1-type integrons in that it has 2 
overlapping direct repeat sequences. This region is downstream of the 
integrase gene in an area where repeat sequences are not uncommon 
(Mercier, 1990). 
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The origin and function of the repeat sequence are unknown but, 
interestingly, the equivalent region of the original integron carrying the orfX 
gene cassette (Tosini eta/., 1998) has the same overlapping repeats. These 
unpublished results are in the form of a GenBank database report (accession 
no. AJ009820) and describe an integron isolated from a plasmid in 
Salmonella typhimurium. The DNA sequencing data for a portion of the 
integrase gene and for the 4 gene cassettes in the variable region (aac(6')-/b, 
aac(3)-la, orf)(, and ant(3")-la) are presented. The portion of the integrase 
gene which was sequenced was 96.7% and 73% homologous to the same 
portion of the int1 gene at the DNA and amino acid level, respectively 
(Mercier eta/., 1990). 
It is possible that the integron in A.baumannii strain G37 has a similar 
integrase gene and was introduced via a plasmid from Salmonella. 
The ant(2")-la encodes ANT(2"), an aminoglycoside adenyltransferase, 
which mediates resistance to gentamicin, tobramycin, dibekacin, sisomicin, 
and kanamycin. ANT(2") is widespread among all Gram-negative bacteria 
(Shaw eta/., 1993). The distribution of aminoglycoside modifying enzymes in 
clinical isolates of Acinetobacter spp. was investigated by Shaw eta/. (1991; 
1993). In the first survey, there was only a 1.4% incidence of ANT(2") in the 
isolates tested. However, this increased to 15.5% in 1993. Murray and 
Moellering (1980) were the first to identify ANT(2") in Acinetobacter and their 
results suggested that the gene for the enzyme was plasmid-mediated. Elisha 
and Steyn (1991 a) identified the gene encoding ANT(2") on a plasmid in a 
clinical strain of Acinetobacter by hybridisation, but Northern blot analysis of 
RNA transcripts showed that the gene was not expressed. The most recent 
report of ANT(2") activity in Acinetobacterwas by Segal and Elisha (1997). 
They describe an ant(2")-la gene cassette integrated at a secondary site on 
a plasmid in a clinical isolate of Acinetobacter. The only other report of an 
ant(2")-la gene cassette on an integron in Acinetobacter is by Vila eta/. 
(1997). The ant(2")-la is the first cassette in the variable region, followed by a 
gene encoding an OXA-derived P-lactamase. 
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The putative cassette from strain G37 had an atypical 59-be. It had a core 
site homologous to the consensus core. The inverse core site, however, was 
not fully complementary to the core. The imperfect inverted repeats at the 
ends were less complementary than expected and the element was shorter 
than previously described 59-bes. Whether this 59-be is active in 
recombination cannot be determined based on these results. 
The hybridisation, PCR and DNA sequencing studies performed on 
A.baumannii strain G39 suggest that it carries a class 1-type integron with two 
gene cassettes in its variable region. The 3'-end of the variable region has an 
ant(3")-/a gene cassette which, like strain G37, has an atypical 59-be. 
The ant(3")-la encodes ANT(3"), another aminoglycoside adenyltransferase, 
which mediates resistance to streptomycin and spectinomycin (Hollingshead 
and Vapnek, 1985). The ant(3' ')-Ia has been identified in association with 
several transposons and is widespread among Gram-negative bacteria (Shaw 
eta/., 1993). Various investigators have reported the presence of the enzyme 
in Acinetobacter (Shannon eta/., 1978; Murray and Moellering, 1980; Devaud 
eta/., 1982; Goldstein eta/., 1983; and Vila eta/., 1993). In the study by 
Devaud eta/. (1982), the enzyme was found to be transposon-mediated. 
The 5' -end of the variable region of pG39SC has a putative gene cassette, 
orfX. In the original description of this cassette (Tosini eta/., 1998), it was 
also on an integron and was associated with an ant(3")-la gene cassette. 
The sequence upstream of orfX in pG39SC did not contain integrase-related 
sequences, nor the sequence of the 5'-CS primer as was expected. Instead, 
it had a 14bp inverted repeat sequence. The amplification product cloned into 
pG39SC must have been generated from only the 3'-CS primer or the 
product was somehow altered during the cloning or sequencing procedure so 
that the expected sequence on the 5'-end was deleted. There is no adequate 
explanation for how either of these events may have occurred. If the 2kb 
product from strain G39 is not the full amplicon, the variable region may 
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contain further cassettes, however, the regiorJ upstream of orfX should then 
have contained a 59-be. 
Further analysis, including sequencing the inserts in pG37C and pG39SC on 
both strands to avoid errors due to compressions or secondary structure, is 
necessary to determine the full structure of the integrons in strains G37 and 
G39, respectively. 
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CHAPTER 6: PARTIAL CHARACTERIZATION OF INTEGRASE-RELATED 
SEQUENCES FROM A MULTI-RESISTANT CLINICAL ISOLATE OF 
A.baumannii, STRAIN PAU 
6.A. INTRODUCTION 
Hybridisation studies performed previously in our laboratory demonstrated 
that a multi-resistant clinical isolate of A.baumannii designated strain PAU, 
carries a 6.5kb Hind Ill fragment with homology to the int1 integrase gene. The 
6.5kb fragment was characterized further. 
6.8. MATERIALS AND METHODS 
6.8.1. Bacterial isolates and plasmids 
A.baumannii strain PAU was isolated from the leg stump of an amputee in 
1992 by the Clinical Microbiology Laboratory, GSH. The isolate was shown to 
be resistant to amoxicillin, trimethoprim, gentamicin, cotrimoxazole, 
piperacillin, and kanamycin [section 2.B.2.] 
6.8.2. Cloning experiments 
6.8.2.a. Cloning the 6.5kb Hind Ill fragment from A.baumannii strain PAU 
Approximately 1 Ollg of genomic DNA from strain PAU (extracted as in section 
2.B.4.) and 1!-lg of pUC19 DNA were digested with 20U of Hindlll (Boehringer 
Mannheim; Mannheim, Germany) in 1X buffer B (Boehringer Mannheim; 
Mannheim, Germany) at 37°C for 2 hours. The DNA in both digests was 
purified by extraction with phenol and precipitation with 4M LiCI and 100% 
ethanol [section 2.B.5.b]. Ligation [section 4.B.5.] and transformation [section 
4.B.6.] have been described. The transformations were plated on selective 
media containing 51-lg/ml of gentamicin (lntramed; Port Elizabeth, South 
Africa) since it was proposed that the observed gentamicin resistance of 
strain PAU could be linked to the integrase-associated sequence on the 6.5kb 
Hind Ill fragment. Plates were incubated at 37°C overnight. 
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Putative transformants, capable of growth on the gentamicin-containing agar, 
were screened as in section 4.B.6.b. The recombinant plasmid containing the 
6.5kb Hindlll fragment was designated pSKIF100. 
6.8.2.b. Subcloning the 6.5kb Hindlll fragment 
Digests (BamHI/Hindlll, BamHI/Sphl, Sphl, Pstl, and Xbal) of pSKIF100 were 
electrophoresed on 1% agarose and transferred to Hybond ™ -N+ membrane 
as in section 4.B.3.b. The int1 probe [section 2.B.5.b] was then hybridised to. 
this DNA [section 2.B.5.c.] A 1.3kb Sphl fragment which hybridised to the 
probe was cloned into the Sphl site of the pUC19 multiple cloning site as 
described in sections 4.8.5 and 4.8.6. 
pSKIF100 was digested with Sa/1 and a 2kb fragment was cloned into pUC19 
as described for the 6.5kb Hind Ill fragment [section 6.B.2.a]. Transformants 
were selected on 2X YT agar containing 5J.!g/ml of gentamicin (lntramed). 
6.8.3. DNA sequencing 
DNA sequencing data were generated by the dideoxy chain termination 
method (Sanger et a/., 1977) using either a T? Sequencing Kit (Pharmacia 
Biochemicals; Uppsala, Sweden), the SequiTherm EXCEL II DNA 
Sequencing Kit (Epicentre Technologies; Wisconsin, USA), or rapid 
automated fluorescence in an automated DNA sequencer (373A, Applied 
Biosystems; Perkin Elmer; California, USA). The latter was performed in the 
Department of Chemical Pathology, UCT. The protocols for the sequencing 
reactions were the same as in sections 4.8.7. 
S.C. RESULTS 
6.C.1. Cloning experiments 
The 6.5kb Hindlll fragment carrying integrase-related sequences from 
A.baumannii strain PAU was cloned into the Hind Ill site of pUC19 and 
conferred gentamicin resistance on E. coli DH5a. The recombinant plasmid 
was designated pSKIF1 00. 
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The two fragments which were subcloned from pSKIF1 00 were: 
1) a 1 .3kb Sphl fragment carrying integron-related sequences and 
2) a 2kb Sa/1 fragment conferring gentamicin-resistance on its host E. coli. 
The recombinant plasm ids were designated pOINT1 00 and pGmR1 00, 
respectively. 
6.C.2. DNA sequencing 
The sequencing strategy employed to obtain the sequence of the 6.5kb 
pSKIF insert is illustrated in Fig. 6.1. DNA sequencing data was generated for 
6059 nucleotides of the 6.5kb insert. Fig. 6.2. shows the sequence of the 
insert with all relevant feature indicated. The sequence was confirmed on 
both strands. 
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Hind Ill 5'-END san 
~-Ac. sequ--_,. ~---aac(3)-l/a -------?> ~oRF~ 
1001>p 
3'-END 
Sphl Hind Ill Sphl 
"------ Ac. sequ ---~ 1Stl5-~ ------,) ~----int1 --- :» ~ tnpMIR ----~ 
Fig. 6.1.: DNA sequencing strategy for the 6.5kb Hindlll pSKIF100 Insert derived from A.baumann/1 strain PAU 
The arrows below the bar indicate the direction and extent of the sequenced regions. The location of the different regions of the fragment are indicated above the bar. 
Hindi II c 
1 AAGCTTATAG CTAACACCGC AATCAATTTT TTCACTCGTC TAGGGTCTGT CAAGCGCGTA 
61 TTTTCAAGAT TAAACCCGCG TCCTTTGAGA CAACTGAATA AGGTTTCAAT TTCCCAGCGT 
121 AATGCATAAT CCTGAATAGC ATTGGCATTA AACTGAGGAG AAACGACGAG TAAAAGCTCT 
181 CCATTTTCTA ACTGTAGTGC ACTTATATAT AGTTTCACCC GACCAACCAA AATCCGTCGT 
241 TTACGACATT CAATTTGACC AACTTTAAGA TGGCGAAATA AATCACTAAT TTTATGATTC 
301 TTTCCTAAAT GATTGGTGAC AATGAAGTTT TTTTAACACG AATGCAGAAG TTGATGTCTT 
361 GGTTCAATTA ACCATGTAAA CCACTGCTCA CCGATAAACT CTCTGTCTGC GAACACATTC 
TT A 
421 ACAATACGGT CTTTACCAAA AATGGCTATA AAGCG-GGAAT CAAAGCAATG CGCTCTTTCG 
481 TATCTGAATT TCCACGTTTA TTAAGCAATG TCCAAAGGAT AGGTATCGCT ATTCCACGAT 
541 AAACGATTGC GAGCATCAGG ATATTAATAT TTCGTTTTCC CCATTTCCAA TTGGTTCTAT 
601 CTAAAGTCAG TTGCACTTGG TCGAATGAAA ACATATTGAA AATCAACTGA GAAATTTGAC 
661 GATAATCAAA ATACTGACCT GCAAAGAAGC GCTGCATACG TCGATAAAAT GATTGTGGTA 
721 AGCACTTGAT GGGCAAGGCT TTAGATGCAG AAGAAAGATT ACATGTTTGC TTTAAAATAA 
781 TCACAAGCAT GATGAGCGCA AAGCACTTTA AATGTGACTT GTTCCATTTT AGAGATTTGT 
841 TTAAGATAAG ATATAACTCA TTGAGATGTG TCATAGTATT CGTCGTTAGA AAACAATTAT 
901 TATGACATTA TTTCAATGAG TTATCTATTT TTGTCGTGTA CAGAGAAATG GCTTTTATAA 
~ 
RA3849 homology 
~ 
IS1133 homology 
961 TCCACGCCGA AGACATTCAA CACTCGGCTG GAAATCGCCG GTGGCATTTG AGAAAAAAGC 
T 
1021 CGCTTAAAAT GAGAGATAGA CCGGAACACA ACCGGTGCAA GACCAAAACG CTTGGCCAAA 
IS1133 inverted repeat 
1081 AAGCCACCAA CGGCGACGGT CCTCCACCTC GGTCAAGCAG CGAGAGGTAG AGTGATATCT 
CAP 
1141 CGATAGGTAT AGTGTTTTGC AGTTTAGAGG AGATATCGCG ATGCATACGC GGAAGGCAAT 
-10 -RES-- ~ aac(3)-IIa start 
1201 AACGGAGGCA ATTCGAAAAC TCGGAGTCCA AACCGGTGAC CTGTTGATGG TGCATGCCTC 
1261 ACTTAAAGCG ATTGGTCCGG TCGAAGGAGG AGCGGAGACG GTCGTTGCCG CGTTACGCTC 
1321 CGCGGTTGGG CCGACTGGCA CTGTGATGGG ATACGCGTCG TGGGACCGAT CACCCTACGA 
1381 GGAGACTCTG AATGGCGCTC GGTTGGATGA CAAAGCCCGC CGTACCTGGC CGCCGTTCGA 
1441 TCCCGCAACG GCCGGGACTT ACCGTGGGTT CGGCCTGCTG AATCAATTTC TGGTTCAAGC 
1501 CCCCGGCGCG CGGCGCAGCG CGCACCCCGA TGCATCGATG GTCGCGGTTG GTCCGCTAGC 
G 
1561 TGAAACGCTG ACGGAGCCTC ACGAACTCGG TCACGCCTTG GGGAAAGGGT CGCCCGTCGA 
1621 GCGGTTCGTC CGCCTTGGCG GGAAGGCCCT GCTGTTGGGT GCGCCGCTAA ACTCCGTTAC 
1681 CGCATTGCAC TACGCCGAGG CGGTTGCGGA TATCCCCAAC AAACGATGGG TGACGTATGA 
1741 GATGCCGATG CTTGGAAGAA ACGGTGAAGT CGCCTGGAAA ACGGCATCAG AATACGATTC 
1801 AAACGGCATT CTCGATTGCT TTGCTATCGA AGGAAAGCCG GATGCGGTCG AAACTATAGC 
1861 AAATGCTTAC GTGAAGCTCG GTCGCCATCG AGAAGGTGTC GTGGGCTTTG CTCAGTGCTA 
1921 CCTGTTCGAC GCGCAGGACA TCGTGACGTT CGGCGTCACC TATCTTGAGA AGCACTTCGG 
1981 AGCCACTCCG ATCGTGCCAG CACACGAAGC CGCCCAGCGC TCTTGCGAGC CTTCCGGTTA 
aac(3)-IIa stop 
2041 GAGGCCGTCG ACAATGATAA TCTGGATCAA CGGACCTTTC GGCGCCGGAA AGACGACTCT 
Sal! ~ 
ORF start 
2101 CGCTGAGCGG CTGCGCGATC GGCGTCCGAA ATCGCTGATC TTTGACCCTG AGGAAATCGG 
2161 GTTCGTGGTG AAAGAAACGG TCCCCATACC AGCGAGCGGA GACTATCAGG ATCTCCCCTT 
2221 GTGGAGGGGA CTTACGATCG CTGCGGTCAG CGAGATTCGC AGGAATTACT CGCAGGACAT 
2281 CATCATCCCA ATGACGCTCG TGTACCCGGA CTATCAGAGG TGGCTCGGGA A 
99 
Fig.6.2.A. DNA sequence analysis of the 5'-end of pSKIF100 (2331 bases) 
The first 929 nucleotides are 99.6% homologous to intergenic Acinetobacter sequence from 
Acinetobacter strain RA3849. The difference in homology was due to transversions at 
positions 44 and 456, a transition at position 470 and a deletion at position 455 (indicated in 
bold above the sequence). The sequence from position 946 to 1065 is 99.2% homologous to 
the right hand side of IS 1133. A transversion of T ~A at position 1062 within the 27 -bp 
inverted repeat accounts for the difference in homology. The transversion is indicated in bold 
above the sequence and the 27-bp IR is underlined. The aac(3)-lla structural gene (position 
1181 to 2041) is identical to the aac(3)-lla described by Elisha (1991) and Elisha and Steyn 
(1991). This sequence differs from the original aac(3)-l/a (VIiegenthart et a/., 1989) by a 
transition of G~A (position 1604; indicated in bold above the sequence).The upstream 
regulatory region of the aac(3)-lla includes a ribosomal binding site (RBS; in bold), a -10 
promoter sequence (underlined) and a CAP protein binding site (underlined). There is no 
sequence corresponding to the -35 consensus. Downstream of the aac(3)-l/a is a region 
encoding an open reading frame (ORF) of unknown function (start codon indicated in bold). 
This ORF was described by Allmansberger eta/. (1985) on an R-plasmid, pWP116a. The 
ORF does not have a promoter but it is lkely that a polycistronic messenger is transcribed 
from the aacC2 promoter (AIImansberger eta/., 1985). The Hindlll and Sa/1 sites are shown in 
bold. 
The 5'-end of pSKIF100 was sequenced for 2331 bases (fig.6.2.A.), then 
there is a break in data, and the sequence continues to the 3'-end for 3728 
bases (fig.6.2.B.). The first 929 nucleotides on the 5'-end (fig.6.2.A.) are 
99.6% homologous to sequence generated for Acinetobacter sp. strain 
RA3849 (Schembri eta/., 1995). Transversions of C-;G and T -;G at 
nucleotides 44 and 456, respectively, a transition of A-;G at nucleotide 470, 
and a deletion of aT at nucleotide 455 account for the difference in 
homology. The sequence from RA3849 is intergenic DNA flanking an 
acetoacetyl-GoA reductase gene (phaB). 
The DNA sequence from position 930 to 2052 (fig.6.2.A.) is identical to 
sequence of an aac(3)-lla and its upstream flanking region from an isolate of 
A.baumannii, strain SAK (Elisha, 1991; Elisha and Steyn, 1991 a). The 
sequence from position 1181 to 2041 (fig.6.2.A.) in pSKIF100 contains the 
aac(3)-lla structural gene (nucleotides 252 to 111 0; Elisha, 1991 ). The 
sequence from strain SAK showed a 99.9% homology with the sequence for 
the aac(3)-lla originally described by Vliegenthart eta/. (1989), the only 
difference being a transition of G-;A at position 1604, which results in the 
incorporation of lysine rather than glutamic acid. Nucleotide sequence 
comparisons showed that the aac(3)-lla was equivalent to the aac(3)-lla 
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described by Allmansberger eta/. (1985). As with the aac(3)-lla from strain 
SAK, the region upstream (position 1100 to 1180; fig.6.2.A.) of the aac(3)-l/a 
from pSKIF1 00 contains the regulatory region. This region contains a 
ribosomal binding site (AGGAG) and there is a -10 region (TATAGT) but no 
sequence corresponding to the E. coli -35 consensus sequence, TTGACAT. 
However, 12 bp from the -10 region, there is a sequence (AGTGA) similar to 
the consensus sequence described for cAMP/CAP controlled promoters (De 
Crombrugghe eta!., 1984; Elisha, 1991; Elisha and Steyn, 1991 a). It has 
been suggested (McClure, 1985) that an activator protein often controls 
promoters with poor homology to the consensus sequence in the -35 region. 
CAP is one such protein, which binds to cAMP to form an active complex. 
Upstream of the pSKIF1 00 regulatory region (position 946 to 1 065; fig.6.2.A.) 
is a region which is 99.2% homologous to portion of an insertion sequence, 
IS1133 (nucleotides 4772 to 4891; Chiou and Jones, 1993). IS1133 was 
identified as part of Tn5393, a Tn3-type transposon (Chiou and Jones, 1993). 
It is a 1.2kb insertion element with 27bp inverted repeats (IRs) and 3bp 
duplicates and its nucleotide sequence shared a 45% identity with IS3 (Chiou 
and Jones, 1993). The area of homology is in the last 120 nucleotides of 
IS 1133 and includes the right-hand IR (fig.6.2.A.1.). The difference in 
homology is due to a transversion ofT ~A (position 1 062; fig.6.2.A; 
fig.6.2.A.1.), which is within theIR. The 3bp duplicate (TAG) is absent in 
pSKIF1 00. The regions flanking the partial IS element (positions 1 to 946 and 
1066 to 1 099; fig.6.2.A.) in pSKIF1 00 are not homologous to any portion of 
Tn5393. Interestingly, Elisha (1991) showed that the sequence corresponding 
to position 930 to 1024 (fig.6.2.A.) in pSKIF1 00 (nucleotides 1 to 155; Elisha, 
1991) had a 54.8% identity with the right end of IS981 (an element isolated 
from Lactococcus /actis and related to IS2 and IS3) and felt that this may 
imply that the aac(3)-lla was carried on a transposon in strain SAK. The 
homology to IS 1133 in strain PAU may imply the same about its aac(3)-lla. 
101 
Sequence 1 
Sequence 2 
IS1133 from pSKIFlOO (position 946 to 1065; fig.6.2.A.) 
IS1133 from Chiou and Jones (1993) 
Sequence 2 TGGACTTGCCTCGGTTTCGTTCCGGTCTTTTTGAGAGCATTATTTGTTATCAAGGAGACC 60 
Sequence 2 ATATATGTCATTAAAGCATAGTGATGAATTTAAGCGTGATGCAGTTCGCATAGCACTCAC 120 
Sequence 2 TAGTGGCTTAACACGCCGTCAAGTTGCGTCAGATTTAAGTATTGGGCTTTCCACGCTTGG 180 
Sequence 2 GAAATGGATCGCATCAATTTCCGATGAAACTAAAATTCCTACCCAAGACACTGATCTTCT 240 
Sequence 2 GCGTGAGAATGAACGTTTACGCAAAGAGAACCGTATCCTTCGGGAGGAGAGGGAGATATT 300 
Sequence 2 AAAAAAGGCAGCAATATTTTTCGCAGTACAAAAGCTGTGAGATTTCAGTTTATTACGGAT 360 
Sequence 2 TACCGTGGCTCTCTCTCACGTTCACGCATATGTCGTTTGATGGGCGTAACAGATCGTGGT 420 
Sequence 2 TTACGTGCATGGAAACGCCGTCCTCCATCACTGCGCCAGCGTCGTGATCTTATACTTCTA 480 
Sequence 2 GCGCATATACGTGAGCAGCATCGGTTGTGTTTGGGGAGCTATGGTAGGCCGCGTATGACA 540 
Sequence 2 GAAGAGTTGAAAGCGCTGGGCCTGCAGGTTGGGCAGCGTCGGGTTGGACGTTTGATGCGC 600 
Sequence 2 CAGAATAACATTACAGTTGTTCGAACGCGTAAATTCAAACGGACAACGGATAGTCATCAT 660 
Sequence 2 ACCTTCAACATTGCACCGAACCTATTAAAACAAGACTTTAGCGCAAGCGCACCCAACCAG 720 
Sequence 2 AAATGGGCAGGCGATATCACTTATGTTTGGACCAGAGAAGGATGGGTCTATCTTGCTGTT 780 
Sequence 2 ATCCTTGACCTGTATTCCCGTCGCGTGATTGGCTGGGCAACAGGTGATCGATTAAAGCAG 840 
Sequence 2 GATCTTGCATTAAGGGCACTGAATATGGCGTTGGCTTTACGCAAACCACCACCGGGTTGT 900 
Sequence 2 ATTCAACACACAGACCGTGGGAGCCAATATTGCGCTCATGAATATCAAAAGCTACTGCTC 960 
Sequence 2 AAACATCAATTGCTGCCGTCCATGAGCGGGAAAGGCAATTGTTTTGATAACTCCGCAGTA 1020 
Sequence 2 GAAAGCTTCTTTAAATCATTAAAGGCTGAGTTGATTTGGCGCAGACACTGGCAAACAAGG 1080 
Sequence 1 AAATGGCTTTTATAATCCACGCCGAAGA 973 
**************************** 
Sequence 2 CGAGATATTGAGATTGCAATCTTCGAATATATAAATGGCTTTTATAATCCACGCCGAAGA 1140 
Sequence 1 CATTCAACACTCGGCTGGAAATCGCCGGTGGCATTTGAGAAAAAAGCCGCTTAAAATGAG 1033 
************************************************************ 
Sequence 2 CATTCAACACTCGGCTGGAAATCGCCGGTGGCATTTGAGAAAAAAGCCGCTTAAAATGAG 1200 
Sequence 1 AGATAGACCGGAACACAACCGGTGCAAGACCA 1065 
**************************** *** 
Sequence 2 AGATAGACCGGAACACAACCGGTGCAAGTCCA 1232 
Fig.6.2.A.1. Comparison of the IS1133 region of pSKIF100 with the published IS1133 
sequence 
The sequence from position 946 to 1065 (fig.6.2.A.1.) was compared to the full IS1133 
sequence (Chiou and Jones, 1993). The homology is 99.2% and is at the right hand end of the 
IS1133 sequence. The T ~A transversion accounts for the difference in homology. An 
asterisk (*) indicates an identical base. The 27 -bp inverted repeats are underlined. 
The remaining 279 bases of the sequencing data from pSKIF1 00 (position 
2053 to 2.331; fig.6.2.A.) are identical to an open reading frame (nucleotides 
1059 to 1336; Allmansberger eta/., 1985) which resides on three related R-
plasmids, pWP14a, pWP116a and pWP113a, downstream of an aac(3)-lla. 
These plasmids were isolated from various strains of Serratia marcescens 
and Klebsiella pneumonia. As in the three R-plasmids, the open reading 
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frame (ORF) on pSKIF1 00 started at the 12th bp downstream from the stop 
codon of the aac(3)-lla and a suitable ribosomal binding site was found 9 bp 
upstream from the start codon. The ORF is not preceded by a promoter and, 
as in the three R-plasmids, there is no stop codon within the ORF. The 
homology between pWP116a and the two other R-plasmids ended inside the 
ORF (nucleotide 1321; Allmansberger eta/., 1985). The corresponding region 
in pSKIF100 (position 2316 to 2331; fig.6.2.A.) is homologous to pWP116a 
and not pWP14a or pWP113a (fig.6.2.A.2.). The authors felt that although no 
attempts had been made to test for the expression of a protein from it, it was 
likely that a polycistronic messenger transcribed from the aac(3)-lla promoter 
was translated from the ORF. The function of a possible gene product 
expressed from this ORF was not determined (AIImansberger eta/., 1985). 
Also of note is that pWP14a and pWP116a, but not pWP113a, have an IS140 
element upstream of their aac(3)-lla genes (AIImansberger eta/., 1985). In 
pWP116a, the element is inverted relative to its orientation in pWP14a. IS140 
bears palindromic -35 sequences at both ends, inside its 14bp IRs. It is, 
however, an IS26- and IS 15-related element and bears no similarity to IS 1133 
or IS3 (AIImansberger eta/., 1985). 
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Sequence 1 
Sequence 2 
al., 1985) 
pSKIFlOO ORF (position 2053 to 2331; fig.6.2.A) 
pWP116a ORF (position 1047 to 1336; Allmansberger et 
Sequence 1 2053 AGGCCGTCGACAATGATAATCTGGATCAACGGAC 2086 
********************************** 
Sequence 2 1047 AGGCCGTCGACAATGATAATCTGGATCAACGGAC 1080 
~ ORF start 
Sequence 1 CTTTCGGCGCCGGAAAGACGACTCTCGCTGAGCGGCTGCGCGATCGGCGTCCGAAATCGC 214 6 
************************************************************ 
Sequence 2 CTTTCGGCGCCGGAAAGACGACTCTCGCTGAGCGGCTGCGCGATCGGCGTCCGAAATCGC 1140 
Sequence 1 TGATCTTTGACCCTGAGGAAATCGGGTTCGTGGTGAAAGAAACGGTCCCCATACCAGCGA 2206 
************************************************************ 
Sequence 2 TGATCTTTGACCCTGAGGAAATCGGGTTCGTGGTGAAAGAAACGGTCCCCATACCAGCGA 1200 
Sequence 1 GCGGAGACTATCAGGATCTCCCCTTGTGGAGGGGACTTACGATCGCTGCGGTCAGCGAGA 2266 
************************************************************ 
Sequence 2 GCGGAGACTATCAGGATCTCCCCTTGTGGAGGGGACTTACGATCGCTGCGGTCAGCGAGA 1260 
Sequence 1 TTCGCAGGAATTACTCGCAGGACATCATCATCCCAATGACGCTCGTGTACCCGGACTATC 2326 
************************************************************ 
Sequence 2 TTCGCAGGAATTACTCGCAGGACATCATCATCCCAATGACGCTCGTGTACCCGGACTATC 1320 
Sequence 1 AGAGGTGGCTCGGGAA 2331 
**************** 
Sequence 2 AGAGGTGGCTCGGGAA 1336 
Fig.6.2.A.2. Comparison of the ORF from pSKIF1 00 with the ORF from pWP116a 
The sequence from position 2053 to 2331 (fig.6.2.A.) of pSKIF100 was compared to the ORF 
from pWP116a (AIImansberger eta/., 1985). The sequence from pSKIF100 was identical to 
the published sequence. The start codon of the ORF is shown in bold. 
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Ac. sequence 
~ 
1 GGGTCATCCC TGAGCTGAGT CCACAGCGGC TAGCTGAGAT TAGGTGAATC 
51 TCGAGACCAT CCAAATACTA GGAGCAGTCA CCCTCTTTTG GAGCTGACCA 
101 AAGCCGTGAG CTGCTGTGAC AATTGGCAGC TCATAGAGTC AGTCTATCAG 
151 GCCAGGAGCT CGCAGTAACC GTACGTACTA CAGGAGACTC AAAGACGGTT 
201 AGAGGACTGG CGTAGACTAG CATTCAGGGG AGAGTAGTTC CCATCAAGGA 
251 CTATCAGAGG CGAGCGACCA TAGCCCTGGC AAAGAAAGTG GATGCTTGGG 
301 CTGAAAGGAA GTCGTAAGCC GTACCGCCTG ACGGTCGGTT TACGTGACGC 
351 GAATGGCGAC TTCCGTTTCG GAAGAAGCAC CACCGCGGCA TAGAGACGCC 
401 AGCTGCCGAA GCCTCCGCCT TGAAGGGACA CGAACCGTCG ACCCGCAAGT 
451 TGGTGTACTA AGTGATTGAA ATCCAGACGC TCAGGCAAGC GGGGTGTCGG 
501 CTGTAGCGTG ACGTTAAATT ATAGAACCTA AAGCTCCATA TGCTAAATGG 
551 TATCAAGGGG CCAAATAGCG GCGGCTACAG TCGCCGCCTT TAACGGATAA 
601 CAACCCGCAA CGACTTTCGA GCCTGATTGG CTTCGCACGG CCTAGACACC 
651 AGGGTTGCAC ATATTTCCAG CATACAATTA CACTATAGCT GGATCAAGCC 
701 CAAGGTGCAC GCCGTACTAC GACGCACTTG ATCTAAAGTT GGCCCTTATC 
751 TCATTGAGAC GGATAAAGAA ACTCCTCGCA AAGCTCGATT TGTGGCTTCA 
801 GCATCGCGGT TCGGCGGTGG ACCGCCGTGG TCATCGGCTT CATCGGAGTG 
851 CTTCTAGTGG TCAAGCCGGG CTATCTGCCG TTCCAATTGG GTCATTTGGC 
901 TGCCATCGGC ACCGGGCTGG CCACGGACGC GGCAATCATC ATCCTCAGGC 
951 GCGTCGGCGG AAAGGTGAAG ACCACCAGCA TGCTGGGCAT CAGTGCCGGC 
Sphi 
1001 GCTTGCAGCG CGCTGAGGCA CGACATATGA AGGCGTAGCT GGAAACCCCG 
1051 TCAGCCAAAA TTGGCGACAG GGTCTAGATC CCTTATTTTA AAGCGCGGAC 
1101 CGACCCATAG TCGCTATTGG AGTGTCTCAA GCCGCAGTGG TAGAAACGGC 
1151 CGAGGCTCCT CAAATGATGG AGATGTCAGC AACAGATGGT CACGCTTTCC 
1201 TTATCGCTGG CAGATTTTAT GGACCACCTC ACCAACACGG TGGAAGTTTT 
1251 GCCAGCAGAT CGCTTGTGCA AAACATAGCA ATCTTGTCTA TGCGGTGATT 
1301 GGGCAGCCGG TGCGAAGATC TCATCAACGA AATCCGGGAT CTGATCTTTA 
1351 CGCATTTCAT CCGGCACTGT TGCAAATAGT CGGTGGTGAT AAACTTATCA 
~ IS15-LIII IR 
Ac. sequence 
1401 TCCCCTTTTG CTGATGGAGC TGCACATGAA CCCATTCAAA GGCCGGCATT 
1451 TTCAGCGTGA CATCATTCTG TGGGCCGTAC GCTGGTACTG CAAATACGGC 
1501 ATCAGTTACC GTGAGCTGCA GGAGATGCTG GCTGAACGCG GAGTGAATGT 
1551 CGATCACTCC ACGATTTACC GCTGGGTTCA GCGTTATGCG CCTGAAATGG 
1601 AAAAACGGCT GCGCTGGTAC TGGCGTAACC CTTCCGATCT TTGCCCGTGG 
1651 CACATGGATG AAACCTACGT GAAGGTCAAT GGCCGCTGGG CGTATCTGTA 
1701 CCGGGCCGTC GACAGCCGGG GCCGCACTGT CGATTTTTAT CTCTCCTCCC 
1751 GTCGTAACAG CAAAGCTGCA TACCGGTTTC TGGGTAAAAT CCTCAACAAC 
1801 GTGAAGAAGT GGCAGATCCC GCGATTCATC AACACGGATA AAGCGCCCGC 
1851 CTATGGTCGC GCGCTTGCTC TGCTCAAACG CGAAGGCCGG TGCCCGTCTG 
1901 ACGTTGAACA CCGACAGATT AAGTACCGGA ACAACGTGAT TGAATGCGAT 
1951 CATGGCAAAC TGAAACGGAT AATCGGCGCC ACGCTGGGAT TTAAATCCAT 
2001 GAAGACGGCT TACGCCACCA TCAAAGGTAT TGAGGTGATG CGTGCACTAC 
2051 GCAAAGGCCA GGCCTCAGCA TTTTATTATG GTGATCCCCT GGGCGAAATG 
2101 CGCCTGGTAA GCAGAGTTTT TGAAAGGTAA GGCCTTTGAA TAAGACAAAA 
2151 GGCTGCCTCA TCGCTAACTT TGCAACAGTG CCCTTCAGGA GATCGGAAGA 
!815-LIII IR ~ 
truncated intl 
2201 CCTCGGCCGT CGCGGCGCTT GCCGGTGGTG CTGACCCCGG ATGAAGTGGT 
2251 TCGCATCCTC GGTTTTCTGG AAGGCGAGCA TCGTTTGTTC GCCCAGCTTC 
2301 TGTATGGAAC GGGCATGCGG ATCAGTGAGG GTTTGCAACT GCGGGTCAAG 
Sphi 
2351 GATCTGGATT TCGATCACGG CACGATCATC GTGCGGGAGG GCAAGGGCTC 
2401 CAAGGATCGG GCCTTGATGT TACCCGAGAG CTTGGCACCC AGCCTGCGCG 
2451 AGCACGTGTC GCGTGCACGG GCATGGTGGC TGAAGGACCA GGCCGAGGGC 
2501 CGCAGCGGCG TTGCGCTTCC CGACGCCCTT GAGCGGAAGT ATCCGCGCGC 
2551 CGGGCATTCC TGGCCGTGGT TCTGGGTTTT TGCGCAGCAC ACGCATTCGA 
2601 CCGATCCACG GAGCGGTGTC GTGCGTCGCC ATCACATGTA TGACCAGACC 
2651 TTTCAGCGCG CCTTCAAACG TGCCGTAGAA CAAGCAGGCA TCACGAAGCC 
105 
2701 CGCCACACCG CACACCCTCC GCCACTCGTT CGCGACGGCC TTGCTCCGCA 
2751 GCGGTTACGA CATTCGAACC GTGCAGGATC TGCTCGGCCA TTCCGACGTC 
2801 TCTACGACGA TGATTTACAC GCATGTGCTG AAAGTTGGCG GTGCCGGAGT 
2851 GCGCTCACCG CTTGATGCGC TGCCGCCCCT CACTAGTGAG AGGTAGGGCA 
intl stop 
2901 GCGCAAGTCA ATCCTGGCGG ATTCACTACC CCTGCGCGAA GGCCATCGGT 
2951 GCCGCATCGA ACGGCCGGTT GCGGAAAGTC CTCCCTGCGT CCGCTGATGG 
3001 CCGGCAGCAG CCCGTCGTTG CCTGATGGGG ATCCAACCCC TCCGCTGCTA 
3051 TAGTGCAGTC GGCTTCTGAC GTTCAGTGCA GCCGTCTTCT GAAAACGACA 
25-bp Brown's repeat 
3101 ATGGAGGTGG TAGCCGAGGG TGTGGAAACA CCCGACTGCC TTGCGTGGTT 
~ 
tnpM start 
3151 GCGGCAGGCG GGTTGCGACA CGGTGCAGGG TTTCCTGTTC GCCAGGCCGA 
3201 TGCCGGCGGC GGCCTTCGTC GGCTTCGTCA ACCAATGGAG GAACACCACC 
3251 ATGAACGCCA ATGAACCGAG CACCAGTTGC TGCGTGTGCT GCAAGGAAAT 
3301 CCCGCTCGAT GCCGCCTTCA CGCCGGAAGG GGCCGAGTAC GTGGAGCATT 
3351 TCTGCGGGCT GGAGTGCTAT CAGCGCTTCC AGGCGCGGGC CAGCACTGCG 
3401 ACCGAAACCA GCGTCAAACC GGACGCTTGT GATTCGCCGC CGTCAGGTTG 
tnpM stop 
3451 AGGCATACCC TAACCTGATG TCAGATGCCA TGTGTAAATT GCGTCAGGAT 
3501 AGGATTGAAT TTTGAATTTA TTGACATATC TCGTTGAAGG TCATAGAGTC 
3551 TTCCCTGACA TTTTGCAGGG AATTCCATGA CTGGACAGCG CATTGGGTAT 
~ 
tnpR start 
3601 ATCAGGGTCA GCACCTTCGA CCAGAACCCG GAACGGCAAC TGGAAGGCGT 
3651 CAAGGTTGAT CGCGCTTTTA GCGACAAGGC ATCCGGCAAG GATGTCAAGC 
3701 GTCCGCAACT GGAAGCGCTG ATAAGCTT 
Hindi II 
Fig.6.2.B. DNA sequence analysis of the 3'-end of pSKIF100 (3728 bases) 
The first 1362 bases (between the arrows) of data have no significant homology to any 
sequences in the GenBank DNA and protein database. This region is most likely 
Acinetobacter intergenic sequence. Position 1363 to 2182 encompass an insertion sequence, 
IS 15-LIII. The 14-bp inverted repeats marking the boundary of the IS are underlined. 
Downstream of IS 15-LIII is a truncated int1. In addition to truncating the int1, IS 15-LIII has 
deleted the variable region and 3'-conserved region of the integron. The 5'-outer boundary of 
the int1, the 25-bp Brown's repeat (underlined) and the int1 stop codon (in bold) are indicated. 
The remaining sequence consists of a the Tn21-related tnpM gene (start and stop codon in 
bold) and the first 152 bases of the tnpR gene (start codon in bold). The Sphl and Hindi! I sites 
are shown in bold. 
The 3'-end of pSKIF100 consists of 3728 bases of data (fig.6.2.B.) and 
begins with 1362 nucleotides which have no significant homology to any 
sequences in GenBank (DNA and protein). This sequence is most likely 
Acinetobacter intergenic sequence. 
The intergenic region is followed by 820 bases (position 1363 to 2182; 
fig.6.2.B.) which are identical to an insertion sequence, IS15-LIII (Trieu-Cuot 
and Courvalin, 1984). The insertion of the IS15-Llll element has truncated a 
Tn21/int1 integrase gene and deleted the region which presumably contained 
the variable region and 3'-conserved segment of Tn21-like integrons [section 
2.A.]. IS 15-Llll is one of the genetic variants of IS 15-Ll (Labigne-Roussel and 
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Courvalin, 1983). IS15 is formed by the insertion of IS15-Lll into 1815-Llll, an 
event which is accompanied by the duplication of 8bp of the target sequence. 
The next 741 nucleotides (position 2183 to 2923; fig.6.2.B.) are 100% 
homologous to the last 715 nucleotides of the int1 and the 13 bases 
downstream of the gene (nucleotides 850 to 111; Bissonnette and Roy, 
1992). 
The region downstream of the int1 contains the 5' -outer boundary of the 
integron, the 25-bp Brown's repeat (position 3076 to 31 00; fig.6.2.B.). The 
remaining 628 bases are identical to the tnpM gene (position 3101 to 3451; 
fig.6.2.B.) -encoding a Tn21 modulator.protein- and its downstream flanking 
sequence (position 3451 to 3576; fig.6.2.B.), and the first 152 nucleotides of 
the tnpR gene (position 3577 to 3728; fig.6.2.B.)-encoding a Tn21 resolvase 
protein (nucleotides 178 to 653 and 654 to 805, respectively; Hyde and Tu, 
1985). 
6.0. DISCUSSION 
The pSKIF1 00 insert cloned from A.baumannii strain PAU has an interesting 
genetic organisation. Hybridisation studies showed that the fragment carried 
sequences homologous to the integrase gene and it was hypothesised that 
the fragment carried an integron. Partial DNA sequence analysis revealed 
that this was not the case. The insert did carry an integrase gene, but a 
truncated one. The gene is interrupted at its 5'-end by an insertion sequence, 
1815-Llll. The IS15-Llll not only truncated the int1, it also deleted the variable 
region and 3'-CS of the integron. The truncated integrase gene is upstream 
of the genes encoding the Tn21 modulator protein (tnpM) and resolvase 
protein (tnpR). Upstream of the insertion sequence and Tn21-related genes, 
on the 5' side of pSKIF1 00, is an aac(3)-/la encoding an AAC(3)-II 
aminoglycoside resistance gene. This gene is flanked by a portion of an 
insertion sequence, IS 1133 (on the 5' -end) and an ORF, the product of which 
has not been identified (on the 3'-end). 
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Aminoglycoside 3-acetyltransferase (AAC(3)-II) is characterised by resistance 
to gentamicin, tobramycin, dibekacin, netilmicin, 2'-N-ethylnetilmicin, 6'-N-
ethylnetilmicin, and sisomicin (Shaw eta/., 1993). It has been previously 
designated AAC(3)-III, but DNA sequence analysis showed that the genes 
encoding AAC(3)-II and AAC(3)-III were identical (AIImansberger eta/., 1985; 
Vleigenthart eta/., 1989). Although common in Gram-negative bacteria, 
AAC(3)-II occurs with varying frequency in different genera. In Acinetobacter it 
occurs with a 21.3% frequency (Shaw eta/., 1993). The aac(3)-lla -also 
designated aacC2, aacC3, aacC5, and aac(3)-Vb- is one of 3 genes found 
to encode AAC(3)-II (VIiegenthart eta/., 1989) and is the most common, 
being present in 84.8% of isolates expressing the enzyme (Shaw eta/., 
1993).The DNA sequences of the other genes, aac(3)-llb and aac(3)-llc, are 
72% and 97% identical to that of the aac(3)-lla (Shaw eta/., 1993). 
The aac(3)-lla and its upstream flanking region described in this study are 
identical to the aac(3)-l/a described by Elisha (1991 ). The transition at 
nucleotide 1604 of a G to an A results in the incorporation of lysine rather 
than glutamic acid. The region immediately upstream of the aac(3)-lla 
encompasses the regulatory region, which includes a -10 region, but there is 
no sequence corresponding to the E. coli -35 consensus sequence. However, 
as with strain SAK (Elisha, 1991; Elisha and Steyn, 1991 a), there is a region 
similar to the consensus sequence for cAMP/CAP controlled promoters (De 
Crombrugghe eta/., 1984 ). Studies to prove conclusively that the aac(3)-lla 
from strain SAK had a catabolite sensitive promoter were not performed and 
the necessity for control associated with the availability of energy sources was 
not explained (Elisha, 1991; Elisha and Steyn (1991 a). Elisha (1991) 
hypothesised that the reason may be related to the origins of Acinetobacter 
as a common soil org~nism in an ecological niche where special metabolic 
demands are placed on it. The aac(3)-lla on pSKIF1 00 is expressed but 
whether it is affected by catabolite repression when in strain PAU was not 
investigated. 
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On the 5' -end of the regulatory region of the aac(3)-lla is a portion of IS 1133, 
encompassing the right hand IR of the element. This insertion sequence was 
originally identified as part of Tn5393, a Tn3-type transposon, isolated in the 
Gram-negative plant bacterium, Erwinia amylovora. Tn5393 carries two 
streptomycin resistance genes, strA and strB. 
There is an ORF on the 3'-end of the aac(3)-l/a from strain PAU. In the 
original description of this ORF, it was shown to be downstream of an aac(3)-
l/a (AIImansberger eta/., 1985). The function of a possible gene product from 
this ORF has not been elucidated (AIImansberger eta/., 1985). The ORF 
lacks a promoter but it does have a suitable ribosomal binding site and the 
authors postulate that a possible gene product may be translated from a 
polycistronic messenger transcribed from the aac(3)-lla promoter. Two of the 
plasmids on which the ORF was originally identified, pWP14a and pWP116a, 
had an IS140 element upstream of their aac(3)-lla. IS140, however, is not 
related to IS 1133. 
Because the insert was only partially sequenced, downstream of the ORF 
there is a gap in the data. The sequence resumes with more than a kilobase 
of data which has no significant homology to any sequences in the GenBank 
DNA or protein database, nor any ORFs, and is more than likely 
Acinetobacter intergenic sequence of unknown function. 
Inserted between this intergenic sequence and a truncated integrase gene is 
a second insertion sequence, IS15-L1ll. Transposable elements -insertion 
sequences and transposons - are discrete segments of DNA which are able 
to insert into various sites of prokaryotic and eukaryotic genomes, in the 
absence of sequence homology (Kleckner, 1981 ). The integration event is 
usually accompanied by the duplication of a short sequence of the target DNA 
(Kleckner, 1981) and the process of transposition probably results from the 
action of a Tn/IS-encoded transposase. Tn 1525 is a transposable element in 
which a kanamycin resistance determinant is flanked by two copies of an 
insertion sequence, IS 15, in direct orientation (Labigne-Roussel eta/., 1983). 
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IS 15 is widely spread among enterobacteria (Labigne-Roussel and Courvalin, 
1983) and is capable of independent transposition. It is 1648bp long with 
14bp inverted repeats at its termini (Trieu-Cuot and Courvalin, 1984). It 
results from the transposition, in direct orientation, of a smaller insertion 
sequence, IS 15-Ll, into itself. This event is accompanied by the duplication of 
8bp in the target DNA (Trieu-Cuot and Courvalin, 1984). The parentaiiS15-Ll 
consists of two large overlapping ORFs located on opposite strands and, 
because of this, IS15 possesses 4 large ORFs (Trieu-Cuot and Courvalin, 
1984). The two 820bp IS elements which make up IS15 have been 
designated IS 15-Lll and IS 15-Llll (Trieu-Cuot and Courvalin, 1984). They differ 
by only four point substitutions (at positions 57, 207, 208, and 362; Trieu-Cuot 
and Courvalin, 1984) and are considered to be two genetic variants of IS15-Ll 
(Labigne-Roussel and Courvalin, 1983). The transition from IS15 to IS15-Ll 
was observed in vivo (Labigne-Roussel and Courvalin, 1983) and the reverse 
was also shown to be possible (Trieu-Cuot and Courvalin, 1984). 
Trieu-Cuot and Courvalin (1984) showed that IS15-Ll is not related to IS1, 
IS2, IS3, IS4, IS5, IS50, and IS903, but is closely related, structurally, to IS26 
(lida eta/., 1982; Mollet eta/., 1983), IS140 (Brau and Pierpersberg, 1983) 
and IS46 (Trieu-Cuot and Courvalin, 1984). IS26 is generated by homologous 
recombination between IS 15-Lll and IS 15-Llll (Trieu-Cuot and Courvalin, 
1984). IS15-Lll and -Llll, IS26, IS140, and IS46 are variants of the same 
genetic mobile element, IS15-Ll (Trieu-Cuot and Courvalin, 1984). IS15 and 
IS 15-Ll have been detected in a variety of plasm ids of various incompatibility 
groups and have been described as the two interconvertible forms of a 
ubiquitous transposable module (Trieu-Cuot and Courvalin, 1984). The 
presence of IS15-Ll was revealed in a multi-resistant plasmid piP1031 from a 
clinical isolate of A. calcoaceticus strain BM2500 (Goldstein eta/., 1983). 
The remaining sequences are homologous to Tn21-related sequences 
including a portion of the gene encoding a Tn21-like integrase (int1), the gene 
encoding the modulator protein (TnpM), and a portion of the gene encoding 
the resolvase protein (TnpR). 
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In summary, partial sequence analysis of the 6.5kb Hind Ill fragment from 
strain PAU reveals an interesting "slice" of the genome. It consists of an 
aminoglycoside resistance gene, aac(3)-lla, downstream of a partial insertion 
sequence, IS 1133. Upstream of the aac(3)-l/a is an ORF, expressing a 
product of unknown function. On the other end of the fragment is another 
insertion sequence, IS15-LIII, which has deleted all but a portion of a Tn21-
like integron. The 3'-end of the integrase gene is all that remains. The 
truncated integrase gene is upstream of the Tn21-associated tnpM and tnpR 
genes, the products (modulator protein and resolvase, respectively) of which 
are involved in transposition. The sequence upstream of the IS15-LIII element 
appears to be constitute a non-coding, intergenic region. It is that unlikely that 
the aacC2 gene originally constituted a part of the variable region of the 
integron deleted by IS15-LIII, since it is transcribed from the other strand. It is 
more likely that the aac(3)-lla was acquired during a transposition event 
involving IS1133 or the transposon on which it originally resided. Since 
IS 1133 was originally identified in a transposon from a plant bacterium, the 
acquisition could have occurred far back in the history of strain PAU. 
However, this hypothesis is questioned by the fact that the IS 1133 element is 
interrupted by Acinetobacter intergenic sequence. One would expect the 
reverse to occur: that the insertion of the IS element and its associated 
sequence would interrupt intergenic sequence. Another possibility is that the 
aac(3)-lla was introduced into strain PAU during an infection by a plasmid 
similar to pWP116a. 
The results presented in this chapter highlight the limitations of hybridisation 
experiments. In this case, hybridisation with the int1 probe suggested that the 
fragment carried an integrase gene and it could have been assumed that 
strain PAU contained an integron. However, further studies showed that only 
a portion of the integrase gene was present. 
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CHAPTER 7: SUMMARY 
The incidence of integrons in 57 clinical isolates of Acinetobacter from two 
South African hospitals, Groote Schuur Hospital (GSH), Cape Town and 
Universitas Hospital (UH), Bloemfontein, was investigated by hybridisation 
with a specific probe and PCR. Hybridisation studies with the int1 probe 
indicate that 53.5% of the GSH isolates and 92.9% of the UH isolates (63.2% 
overall; 36/57) contain integrase related sequences. However, only 24 of the 
36 (67%) isolates yielded amplification products using primers directed at the 
5'- and 3'-conserved regions of class 1-type integrons. A single product of 
0. 7kb was obtained from 22/36 strains, suggesting that these acinetobacters 
contain integrons with one cassette in the variable region. One of these 
strains also yielded a 0.65kb product, suggesting that this strain contains 2 
integrons. A product of 2.0kb was obtained from 1 strain, suggesting that the 
variable region of this integron consists of at least 2 cassettes. Two products 
(2.0kb and 3.5kb) were obtained from another strain, suggesting that this 
acinetobacter contains at least 2 integrons. No PCR products were obtained 
with the DNA from 12 acinetobacters which had hybridised to the int1 probe. 
This may be due to various reasons: firstly, the isolates may contain an !nO-
like integron. lnO lacks a variable region, and the 5'-conserved region is 
contiguous with the 3'-conserved region in this integron (Bissonnette and 
Roy, 1992). A second and more likely possibility is that the variable regions of 
these integrons contain a number of cassettes, resulting in variable regions 
too large to be amplified using the PCR assay described in this study. A final 
reason could be that the isolates contain only a portion of the integrase gene 
- hence the positive hybridisation signal with the int1 probe - but lack other 
conserved integron-related sequences [see Chapter 6]. 
The 0. 7kb amplicon from A.baumannii strain CAR contained an integron 
dfrV/1 which encodes dihydrofolate reductase type· VII (mediates resistance 
to trimethoprim). Hybridisation studies showed that all the 0. 7kb amplicons 
obtained from the acinetobacters contained dfrV/1 sequences, suggesting that 
22/57 isolates carry integron-associated trimethoprim resistance. 
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Further analysis of the sequences flanking the dfrV/1 from strain CAR showed 
that the structural gene is part of a cassette bounded by an att1 site and a 59 
be/ attC site identical to that associated with dfrV/1 in Tn5086 (Sundstrom et 
a/., 1993). The dfrV/1 is transcribed from the weak PANT promoter, TGGACA(-
35)N17TAAGCT(-10) (Collis and Hall, 1995). The promoter (P2) TTGTTA(-
35)N17TACAGT(-10), usually associated with PANT is not present (Collis and 
Hall, 1995) since strain CAR lacks the three G-residues which alter the space 
between the hexamers of P2 to 17, creating an alternative promoter. The 
integron in this study is similar to Tn5086, a Tn21-like integron (Sundstrom et 
a/., 1993). 
The 2kb amplicons from A.baumannii strain G37 and A.baumannii strain G39 
were cloned and partially sequenced. DNA sequencing data suggest that 
A.baumannii strain G37 carries an ant(2' ')-Ia gene cassette and a putative 
cassette in the variable region of a class 1-type integron. The ant(2' ')-Ia was 
most similar to the ant(2")-la from another Acinetobacter (strain SUN). Based 
on the results of this study it is not possible to make any conclusions as to the 
probable function, if any, of the putative cassette. The 5'-conserved region of 
this integron is unlike the corresponding region in other class 1-type integrons 
in that it has 2 overlapping direct repeat sequences. This region is 
downstream of the integrase gene in an area where repeat sequences are not 
uncommon (Mercier, 1990). While the origin and function of the repeat 
sequence are unknown it is interesting to note that the equivalent region of 
the original integron carrying the orfX gene cassette has the same 
overlapping repeats (Tosini eta/., 1998). The putative cassette from strain 
G37 has an atypical 59-be. Although the core site is homologous to the 
consensus core, the inverse core site is not fully complementary to the core. 
In addition, the imperfect inverted repeats at the ends were less 
complementary than expected and the element was shorter than previously 
described 59-bes. Whether this 59-be is active in recombination cannot be 
determined based on these results. 
The hybridisation, PCR and DNA sequencing data for A.baumannii strain G39 
suggest that it carries a class 1-type integron with two gene cassettes in its 
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variable region. The 3'-end of the variable region has an ant(3")-/a gene 
cassette with an atypical 59-be (core site, non-complementary inverse core 
site, poorly complementary imperfect inverted repeats at the end). The 5'-end 
of the variable region has a putative gene cassette, orfX. In the original 
description of this cassette (Tosini eta/., 1998), it was also on an integron and 
was associated with an ant(3")-la gene cassette. The integrase-related 
sequences and the sequence of the 5'-CS primer were not identified 
upstream of orfX in strain G39. Instead, there was a 14bp inverted repeat 
sequence. This suggests that the amplification product cloned into pG39SC 
must have been generated from the 3'-CS primer alone or that the product 
was altered during the cloning or sequencing procedure so that the sequence 
on the 5'-end was deleted. There is no adequate explanation for how either of 
these events may have occurred. If the 2kb product from strain G39 is not the 
full amplicon, the variable region may contain further cassettes. The region 
upstream of orfX should then have contained a 59-be. Further analysis is 
necessary to determine the full structure of the integron in strain G39. 
A 6.5kb Hind Ill fragment from A.baumannii strain PAU hybridised to the int1 
probe. This fragment was cloned into pUC19 to give pSKIF100 and the insert 
was partially sequenced. Since the hybridisation studies showed that the 
fragment carried sequences homologous to the integrase gene, it was 
hypothesised that the fragment carried an integron. Partial DNA sequence 
analysis revealed that this hypothesis was incorrect. On the 3'-end of 
pSKIF1 00, the insert did have an integrase gene, but it was truncated due to 
the insertion of IS 15-L111. The IS 15-L111 not only truncated the int1 gene, it also 
deleted the variable region and 3'-CS of the integron. The truncated integrase 
gene is upstream of the genes encoding the Tn21 modulator protein (tnpM) 
and resolvase protein (tnpR). The 5' side of pSKIF1 00, carries an aac(3)-lla 
encoding an AAC(3)-II aminoglycoside resistance gene which is flanked by a 
portion of IS1133 (on the 5'-end) and an ORF, the product of which has not 
been identified (on the 3'-end). 
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This study has demonstrated that integrons are prevalent in the Acinetobacter 
isolates from the two hospitals, particularly those from Universitas Hospital. 
The integrons no doubt play a role in the dissemination and acquisition of 
resistance genes within the bacterial population in the hospitals. 
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APPENDIX A: MEDIA, BUFFERS, and SOLUTIONS 
A.1. Media 
Note: volumes were adjusted with distilled water unless otherwise indicated. 
2XYT 
Broth (11): 16g Tryptone 
1 Og Yeast extract 
5g NaCI 
Autoclave 
Agar: 1 OOml 2X YT broth 
1.5g Agarose 
Autoclave 
A.2. Buffers and Solutions 
Note: all volumes were adjusted with distilled water unless otherwise 
indicated and all buffers/solutions were made up volumetrically. 
50% Acrylamide, 2.5% Bis (500ml) 
250g Acrylamide 
12.5g Bis 
1 OOml Distilled water 
Filter and store at 4°C in an amber bottle. 
10% APS (1Om I) 
1g APS 
Aliquot and store at -20° C. 
1M CaCb (1 OOml) 
14.7g CaCI2.2H20 
Autoclave and store at 4°C. 
Chloroform-lsoamylalcohol 
Mix in a ratio of 24:1. 
CTAB/NaCI 
Dissolve 4.1g NaCI in 80ml dH20 and slowly add 10g 
CTAB. Heat at 65°C to dissolve and adjust the volume 
to 1 OOml. 
Store at RT for no longer than 6 months. 
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Denaturation solution (11) 
300ml 5M NaCI 
50ml 1 ON NaOH 
ECL hybridisation solution (100ml) 
1 OOml ECL hybridisation buffer 
2.9g NaCI 
5g blocking agent 
Mix at RT for 1 hour on a magnetic stirrer and then heat to 42°C for 1 hour. 
Store aliquots at -20°C. 
ECL wash buffer (11) 
360g urea 
4g SDS 
5mi20X sse 
Store at 4°C for up to 3 months. 
0.5M EDTA (500ml) 
Dissolve 93.05g EDTA in 400ml dH20 by stirring 
vigorously. Adjust the pH to 8.0 with NaOH pellets 
(-1 Og). 
Autoclave. 
Ethidium Bromide solution (1Om I) 
0.1g Ethidium bromide 
Gel tracking dye (1Om I) 
25mg Bromophenol blue 
4g Sucrose 
0.4ml 0.5M EDTA (pH 8.0). 
1M HCI (11) 
86.2ml HCI 
200mg/ml IPTG (1Om I) 
2g IPTG 
Freeze 150,ul aliquots at -20°C. 
Isopropanol, salt saturated 
Mix isopropanol with Y4 volume 5M NaCI. A white precipitate forms and two 
phases appear. Use the top phase. 
4M LiCI (100ml) 
16.96g LiCI 
Autoclave. 
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Neutralization solution (11) 
500ml 1M Tris (pH 7.2) 
300ml 5M NaCI 
2ml 0.5M EDTA 
10X NNB (11) 
162g Tris base 
27.5g Boric acid 
9.3g EDTA 
Phenol 
To 500g of commercial crystallized phenol, add the following: 
0.6g 8-Hydroxyquinolone 
7.5ml 2M NaOH 
130ml dH20 
6ml1 M Tris (pH 7.6) 
Leave overnight to liquefy or at 40°C until the solution is clear. 
Aliquot and store at -20°C. 
Phenol-chloroform-isoamylalcohol 
Mix the 3 components in a ratio of 25:24:1. 
SM Potassium acetate (100ml) 
49.1 g Potassium acetate 
Store at 4°C. 
10% SDS (100ml) 
10g SDS. 
, Heat to about 80°C to dissolve. Add a few drops of HCI to adjust pH to 7.2 
3M Sodium acetate (500ml) 
204.05g sodium acetate in 400ml dH20. Dissolve and adjust to desired pH 
with glacial acetic acid. Make up to 500ml. 
SM Sodium Chloride/NaCI (1 OOml) 
29.22g NaCI 
Autoclave. 
10N Sodium Hydroxide/NaOH (100ml) 
40g NaOH 
Store in a plastic container. 
Solution I (1 OOml) 
2.5ml 1M Tris-CI (pH 8.0) 
10ml 0.5M EDTA (pH 8.0) 
5ml 20%w/v Glucose 
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Solution II (100ml) 
2mi10N NaOH 
5ml 20% w/v SDS 
Made fresh weekly. 
Solution Ill (100ml) 
60ml 5M Potassium acetate 
11.5ml Glacial acetic acid 
Store at 4° C. 
2ox sse (11) 
175.3g NaCI 
88.2g Sodium citrate 
Adjust pH to 7.0 with a few drops of 1 ON NaOH. 
Autoclave. 
SOX Tris-Acetate-EDTAITAE Buffer (11) 
242g Tris 
57.1ml Glacial acetic acid 
100ml 0.5M EDTA 
Autoclave. 
1M Tris-CI (100ml) 
121.1g Tris 
Adjust pH to required level with concentrated HCI. 
Autoclave. 
Tris-EDT AITE Buffer 
10mM Tris-CI (pH 8.0) 
1mM EDTA (pH 8.0) 
Autoclave. 
40mg/ml X-gal 
Dissolve 0.4g X-gal in 1Om I dimethyl sulfoxide (DMSO) and add 1 volume 
dH20. 
Store at -20°C in an amber bottle. 
\ 
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APPENDIX 8: Molecular weight markers used 
Molecular weight marker VI 
(Boehringer Mannheim) 
bp 
-2176 
-1766 
-1230 
-1033 
653 
517 
453 
394 
298 
234/220 
154 
1kbladder 
(Promega) 
kb 
1.5 
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APPENDIX C: pUC19 
Xmnl 
Seal 
Gsul 
Cfr10 I 
Ssp I 
Ppal 
EcoO 109 
Aat11 Ndef 
amp' pUC19 
2686bp 
Ptac 
Fig.C.1.: Schematic diagram of the plasmid, pUC19 
(taken from Ausubel eta/., 1987) 
Smal Xmal 
Hincll 
Pstl 
Sphl 
Hind Ill 
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APPENDIX 0: pGEM-T 
Scal1890 
T7 J. 
Aoal 
Aatll 
Son 1 
pGEM~-T Easy Nco! 
Bsrz 1 Vector 
Not I (3018bp) Sac II 
EcoR I 
Soel 
EcoR I 
Not I 
BstZ I 
~r' Pst I 
Sail 
Ndel 
Sac 1 
BstX I 
Ns1! 
i SP6 
Fig.D.1.: Schematic diagram of the plasmid, pGEM-T 
(taken from the pGEM-T Easy Vector manual) 
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